









To my Mum and Dad
PREFACE
The work reported in this thesis was carried out between 1st
October 1987 and 30th September 1990 under the supervision of Dr
Simon van Heyningen and Dr John Phillips at the Department of
Biochemistry, University of Edinburgh, Scotland. All material
presented in this thesis, unless otherwise stated, is the sole work of
the author, as is the composition.
-i-
ACKNOWLEDGEMENTS
I would like to express my sincere thanks to my two supervisors, Dr
Simon van Heyningen and Dr John Phillips, for their encouragement,
enthusiasm and advice during the three years I spent as their research
student. Special thanks also to Dr Steve Johnstone and Dr Stella
Hurtley for all their help and advice in the laboratory. My life in
the lab was also made much easier by the help and friendship of David,
Marianne, Margaret, Steve, Mohinder, April and Barbara. Thank you all
for lots of laughs.
Thanks also to Dr Jeff Haywood for his invaluable help with microscopy
and photography, and to Dr Gordon Atkins for carrying out the
regression analysis of the binding data. The Medical Faculty must
also be thanked for awarding me the scholarship which allowed me to
carry out this research.





List of Contents ill
List of Figures vii
List of Tables ix
Abbreviations x
Abstract xii
CHAPTER 1. INTRODUCTION 1
1.1 Clinical Definition of Tetanus 2
1.2 History of Tetanus 3
1.3 Bacteriology 6
1.4 Epidemiology 8
1.5 Treatment of Tetanus 9
1.6 Prevention of Tetanus 11
1.7 The Tetanus Toxin Molecule 12
1.8 Fixation of Tetanus Toxin 20
1.8.1 Binding to Ganglioside 20
1.8.2 Binding of Toxin to Whole Cells
and Subcellular Fractions 27
1.9 Internalisation of Bound Toxin 39
1.9.1 Introduction 39
1.9.2 Possible Mechanisms of Membrane
Translocation 40
1.9.3 Retrograde Axonal Transport and
Trans-synaptic Transfer 46
1.10 The Action of Tetanus Toxin on the Nervous System 47
1.11 Comparison of Tetanus Toxin with Other
Bacterial Toxins 51
1.12 The Adrenal Chromaffin Cell 55
1.12.1 An Overview of Secretion 56
1.13 Aims of the Project 60
CHAPTER 2. MATERIALS AND METHODS 63
2.1 Materials 64
2.2 Methods 66
2.2.1 Isolation and Culture of Adrenal
Chromaffin Cells 66
2.2.2 Preparation of Membranes from Adrenal
Medullary Microsomes 68
2.2.3 Preparation of Chromaffin Granules 69
2.2.4 Stimulation of Exocytosis from
Adrenal Chromaffin Cells 70
2.2.5 Fluorimetric Assay of Catecholamines 71
2.2.6 Inhibition of Exocytosis by Tetanus Toxin 73
2.2.7 Preparation of Fluorescent GT1 73
2.2.8 Incorporation of Fluorescent GT1 into
the Chromaffin Cell Membrane 74
2.2.9 Preparation of 125I-Labelled Tetanus Toxin 74
2.2.10 Binding of 12 5I-Labelled Tetanus Toxin to
Chromaffin Cells 76
-iii-
2.2.11 Binding of 125I-Labelled Tetanus Toxin to
Chromaffin Granules 77
2.2.12 Internalisation of Tetanus Toxin by
Chromaffin Cells 77
2.2.13 Isolation of Gangliosides from Membrane
Fractions 78
2.2.14 Thin-Layer Chromatography of Gangliosides 79
2.2.15 Sialic Acid Assay 80
2.2.16 Ganglioside Overlay with 125I-Labelled
Tetanus Toxin 81
2.2.17 Immunocytochemistry 81
2.2.17.1 Alkaline Phosphatase Staining 82
2.2.17.2 Horseradish Peroxidase Staining 83
2.2.18 Determination of Protein 83
2.2.19 SDS-Polyacrylamide Gel Electrophoresis 84
2.2.20 Autoradiography 85
2.2.21 Blotting of Proteins onto Nitrocellulose 85
CHAPTER 3. INHIBITION BY TETANUS TOXIN OF EXOCYTOSIS FROM
CULTURED ADRENAL CHROMAFFIN CELLS 86
3.1 Introduction 87
3.2 Methods 90
3.2.1 Stimulation of Exocytosis from Chromaffin
Cells 90
3.2.2 Fluorimetric Assay of Catecholamines 90
3.2.3 Inhibition of Exocytosis by Tetanus Toxin 90
3.3 Results and Discussion 92
3.3.1 Optimisation of Conditions for Stimulation
of Secretion 92
3.3.2 Effect of Tetanus Toxin on Secretion from
Intact Chromaffin Cells 97
3.3.3 Time Course of Inhibition of Secretion 99
3.3.4 Dose-Dependency of Toxin Inhibition of
Secretion 101
3.3.5 Reproducibility of Inhibition 103
3.3.6 Effect of Trypsinisation of Toxin on
Inhibition of Secretion 105
3.3.7 Effect of Tetanus Toxin on Exocytosis
Evoked by Different Secretagogues 107
3.3.8 Effect of Gangliosides on Toxin Inhibition
of Secretion 110
3.4 Concluding Remarks 113
CHAPTER 4. BINDING OF 125I-LABELLED TETANUS TOXIN TO
CULTURED ADRENAL CHROMAFFIN CELLS 116
4.1 Introduction 117
4.1.1 Parameters of Ligand-Binding that Define
a Receptor 118
4.2 Methods 120
4.2.1 Incorporation of Fluorescent GT1-LY into
Chromaffin Cell Membranes 120
4.2.2 Binding of 125I-labelled Tetanus Toxin
to Chromaffin Cells 120
-iv-
4.2.3 Binding of 125I-labelled Tetanus Toxin
to Chromaffin Granules 121
4.2.4 Internalisation of Tetanus Toxin by
Chromaffin Cells 121
4.3 Results and Discussion 122
4.3.1 Analysis of Lucifer Yellow CH-labelled
Ganglioside 122
4.3.2 Incorporation of GTl-Lucifer Yellow into
Chromaffin Cell Membranes 125
4.3.3 Iodination of Tetanus Toxin 128
4.3.4 Binding of 125I-labelled Tetanus Toxin
to Native Chromaffin Cells 130
4.3.4.1 Time Course of Toxin Binding 130
4.3.4.2 Linearity of Toxin-Binding with
Varying Cell Protein 132
4.3.4.3 Effect of Ganglioside
Concentration on Toxin-Binding 132
4.3.4.4 Characteristics of Toxin Binding
to Chromaffin Cells 135
4.3.5 Effect of Enzymic Treatments on Toxin-
Binding 152
4.3.6 Binding of 125I-labelled Tetanus Toxin
to Chromaffin Granules 160
4.3.7 Internalisation of Tetanus Toxin by
Chromaffin Cells 162
4.4 Summary and Concluding Remarks 163
CHAPTER 5. IMttJNOCYTOCHHttlCAL VISUALISATION OF TETANUS
TOXIN BINDING TO ADRENAL CHROMAFFIN CELLS 165
5.1 Introduction 166
5.2 Methods 167
5.2.1 Dopamines-Hydroxylase Staining of
Chromaffin Cells 167
5.2.2 Tetanus Toxin-Binding to Chromaffin Cells 167
5.2.3 Internalisation of Tetanus Toxin by
Chromaffin Cells 168
5.3 Results and Discussion 169
5.3.1 Dopamine-/?-Hydroxylase Staining of
Chromaffin Cells 169
5.3.2 Tetanus Toxin-Binding to Native Chromaffin
Cells 172
5.3.3 Effect of Exogenous Ganglioside on
Toxin-Binding 181
5.3.4 Effect of Enzymic Treatments on Toxin-
Binding 184
5.3.5 Internalisation of Tetanus Toxin by
Chromaffin Cells 189
5.4 Concluding Remarks 195
CHAPTER 6. BIOCHEMICAL CHARACTERISATION OF TOXIN-BINDING




6.2.1 Extraction of Gangliosides from Membranes
of Adrenal Medullary Microsomes 199
6.2.2 Analysis of Extracted Gangliosides 199
6.2.3 Ganglioside Overlay with 125I-labelled
Tetanus Toxin 199
6.2.4 Binding of 125I-labelled Tetanus Toxin
to Membrane Proteins of Adrenal Medullary
Microsomes 200
6.3 Results and Discussion 200
6.3.1 Extraction and Analysis of Gangliosides
from Adrenal Medullary Microsomes 200
6.3.2 Detection of Toxin-Binding Gangliosides
in Membranes of Adrenal Medullary
Microsomes 204
6.3.3 Detection of Toxin-Binding Proteins in
Membranes of Adrenal Medullary Microsomes 211
6.4 Concluding Remarks 212






1.1 Structure of Tetanus Toxin 16
1.2 General Structure of Tetanus Toxin after Nicking and
Nomenclature of Fragments 19
1.3 The Structure of Gangliosides 22
3.1 SDS-Polyacrylamide Gel Electrophoresis of Tetanus Toxin 91
3.2 Optimisation of Catecholamine Secretion from Chromaffin
Cells 95
3.3 Time Course of Inhibition of Secretion from Intact
Chromaffin Cells by Tetanus Toxin 100
3.4 Effect of Tetanus Toxin on Nicotine-Evoked Catecholamine
Release from Intact Chromaffin Cells 102
3.5 Time Course of Inhibition of Catecholamine Secretion from
Intact Chromaffin Cells by Tetanus Toxin Pre-Incubated
with Ganglioside 111
3.6 Effect of Ganglioside GT1 on Release of Catecholamines
from Intact Chromaffin Cells 112
4.1 Representation of Thin-Layer Chromatogram of Fluorescent
Ganglioside GT1 123
4.2 Incorporation of Fluorescent GT1 into Chromaffin Cell
Membranes 127
4.3 SDS-Polyacrylamide Gel and Corresponding Autoradiograph
of 12 5I-Labelled Tetanus Toxin 129
4.4 Time Course of Binding of 125I-Labelled Tetanus Toxin to
Chromaffin Cells 131
4.5 Linearity of Toxin-Binding with Varying Cell Protein 133
4.6 Binding of 125I-Labelled Tetanus Toxin to Native
Chromaffin Cells in pH 6.0, Low Ionic Strength Buffer 136-137
4.7 Binding of 12 5I-Labelled Tetanus Toxin to Native
Chromaffin Cells in pH 7.4, High Ionic Strength Buffer 138-139
4.8 Semi-Logarithmic Representation of the Data from Figures
4.6 and 4.7 141-143
4.9 Scatchard Transformations of the Data Presented in
Fig. 4.6 (c) and Fig. 4.7 (a) 145-146
4.10 Effect of Pre-Incubation of Chromaffin Cells with
GT1 on Subsequent Toxin-Binding Capacity 153-154
-vii-
4.11 Effect of Neuraminidase Treatment of Chromaffin Cells
on Subsequent Toxin-Binding Capacity 157-158
5.1 Dopamine-/^-Hydroxylase Staining of Chromaffin Cells 170-171
5.2 Controls for Immunocytochemical Detection of Tetanus
Toxin-Binding to Chromaffin Cells 173-175
5.3 Immunocytochemical Detection of Tetanus Toxin-Binding
to Native Chromaffin Cells in pH 6.0, Low Ionic
Strength Buffer 176-177
5.4 Immunocytochemical Detection of Tetanus Toxin-Binding
to Native Chromaffin Cells in pH 7.4, High Ionic
Strength Buffer 178-179
5.5 Binding of Tetanus Toxin to Chromaffin Cells Pre-
Incubated with Ganglioside GT1 182-183
5.6 Action of Neuraminidase on Chromaffin Cells 185-186
5.7 Binding of Tetanus Toxin to Chromaffin Cells Pre-
treated with Neuraminidase 187-188
5.8 Binding of Tetanus Toxin to Chromaffin Cells Pre-
treated with Trypsin 190-191
5.9 Internalisation of Tetanus Toxin by Chromaffin Cells 192-194
6.1 Thin-Layer Chromatography of Gangliosides Extracted
from Adrenal Medullary Microsomes 202-203
6.2 Binding of 125I-Labelled Tetanus Toxin to Standard
Gangliosides on Thin-Layer Chromatograms 206
6.3 Overlay with 125I-Labelled Tetanus Toxin of Gangliosides





1.1 The Component Structure of Various Toxins 54
3.1 Exocytosis from Chromaffin Cells Evoked by Different
Secretagogues 93
3.2 Effect of Medium Replacement on Levels of Exocytosis
from Chromaffin Cells 96
3.3 Evoked Release of Catecholamines from Adrenal Chromaffin
Cells 98
3.4 Effect of Trypsinisation of Tetanus Toxin on Inhibition
of Secretion 106
3.5 Effect of Tetanus Toxin on Exocytosis Evoked by Ba2+ Ions 108
4.1 Effect of GT1 Concentration on Toxin-Binding by Chromaffin
Cells 134
4.2 Values of Apparent Kd and Bmax Calculated for High Capacity

































Dulbecco's Modified Eagle Medium
Escherichia coli











































Tetanus toxin exerts its primary biological effect by impairing the
release of inhibitory neurotransmitters in the central nervous
system; the mechanism of this blockade, however, remains unknown.
Studies using adrenal medullary chromaffin cells, which are closely
related to the toxin's target neurones but much more accessible to
biochemical investigation, have the potential to provide
information on various aspects of the intoxication process of
tetanus. Nicotine-evoked (but not basal) secretion of catechol¬
amines from intact chromaffin cells was inhibited by tetanus toxin
in a dose-dependent fashion up to a maximum of 75%, half-maximal
inhibition being achieved at 0.7 nM toxin (in single- or double-
chain form). The time course of this inhibition was long,
approximately 16 hours. Catecholamine release evoked by Ba2+ ions
was not affected by the toxin,
Pre-incubation of cells with
ganglioside GT1, a specific ligand of the toxin, in the absence of
toxin itself inhibited nicotine-evoked release of catecholamines
(50% inhibition with 24 juM GT1), making it impossible to evaluate
the role of GT1 in mediating the action of the toxin. Tetanus
toxin (radiolabelled) was also shown to bind in a specific fashion
to chromaffin cells. Toxin binding under less physiological
conditions of pH and ionic strength was of a higher capacity (Bmax
0.7-1.2 pmol/mg protein) than that found under more physiological
conditions (Bmax 0.2-0.3 pmol/mg protein); this is also
characteristic of toxin binding to synaptic membranes. In both
cases there appeared to be at least two components to toxin
binding, a higher affinity component with an apparent Kd value of
-xii-
approximately 1 nM (which did not account for more than 20% of
total binding capacity), and a lower affinity binding with a Kd
value of 10-25 nM. As expected, pre-incubation of chromaffin cells
with ganglioside GT1 enhanced their toxin-binding capacity, but did
not noticeably affect Kd values, perhaps indicating that
gangliosides mediate binding of tetanus toxin to untreated
chromaffin cells. This was further suggested by the finding that
neuraminidase treatment of cells markedly reduced toxin-binding
capacity (by 50% at pH 7,4, 90% at pH 6.0). Mild trypsinisation of
chromaffin cells completely abolished toxin-binding under both sets
of conditions, suggesting the involvement of a protein component in
toxin binding also. Similar observations were made when toxin
binding was visualised using immunocytochemical techniques. No
binding of tetanus toxin to purified chromaffin granules was
observed. In order to analyse the nature of the interaction
between chromaffin cells and tetanus toxin further, the ganglioside
composition of membranes from adrenal medullary microsomes was
determined; a component with the same mobility on thin-layer
chromatograms as GM3 was found to be the predominant species, while
a small amount of a disialoganglioside, perhaps GDlb, was also
evident. Overlay with radiolabelled tetanus toxin of these
extracted gangliosides, separated on thin-layer chromatograms,
indicated an interaction with both the mono- and disialylated
species, as well as some toxin-binding to a GTl-like ganglioside.
There was no detectable interaction between tetanus toxin and any






1.1 CLINICAL DEFINITION OF TETANUS
The disease tetanus, with its characteristic muscular spasms, must
surely be one of the world's most feared afflictions; not only are
its victims subjected to excruciating pain, but the risk of death
is substantial as well. It is a disease of the central nervous
system, caused by the presence in a wound of the bacillus
Clostridium tetani. This micro-organism produces a neurotoxic
protein, tetanias toxin, which is solely responsible for the
symptoms of the disease.
Clinical tetanus has traditionally been divided into four types:
a) GENERALISED TETANUS: The most commonly recognised
form of the disease is termed generalised tetanus, and is
characterised by a spastic paralysis over the whole body,
starting first in the jaw, and then moving towards the trunk and
outer limbs; for this reason, this form of tetanus is sometimes
referred to as the descending type. The victim is rigid, with
arched back, clenched hands and feet and his jaw set in a
permanent grimace - the "sardonic smile" of tetanus. His
muscles are continually contracting against each other, so he
exerts tremendous energy and is in constant pain. Death usually
results from exhaustion, heart failure or the collapse of the
lungs.
b) LOCAL TETANUS: This is the second form of the disease,
consisting of paralysis of the muscles of a specifically
infected limb; indeed, it may be induced by intramuscular
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injection of the toxin. It is often mild, and may persist for
some time without further development; in some cases however, it
may precede the onset of generalised tetanus.
c) CEPHALIC TETANUS: Cephalic tetanus is an uncommon
variant of local tetanus affecting the facial and lower cranial
musculature. It usually follows head injuries, and the risk of
death is high.
d) NEONATAL TETANUS: It is a matter for debate as to
whether this type of tetanus deserves a separate classification,
since it is identical to the generalised form of the disease,
except that it is exclusive to the newborn. It is recognisable
in the first two weeks after birth, and is seen primarily in
areas where tradition dictates such practices as coating the
freshly severed umbilical cord with cow dung or wrapping it in
old rags. Neonatal tetanus carries an extremely high mortality.
For general references on the clinical features of tetanias, see
reviews by van Heyningen (1968), Habermann (1978), van Heyningen
(1980), Bleck (1986), and Cross & Sadoff (1988).
1.2 HISTORY OF TETANUS
Clear descriptions of tetanus occur in the literature throughout
medical history. Hippocrates, twenty-four centuries ago, wrote of
it as a disease whose victims "die within four days, or if they
pass these, they recover".
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Our understanding of the pathogenesis and prophylaxis of tetanus
stems from the end of the nineteenth century. Prior to this time,
a severe lack of both the knowledge and the means for effective
treatment of the disease persisted, and the physician had little
success in his attempts to arrest the disease; the first hint of a
rational therapeutic approach came with the discovery of the
muscle-paralysing properties of curare, and its subsequent use in
1859 in the treatment of a wounded soldier affected by tetanus
after the battle of Magenta.
The infectious nature of tetanus was demonstrated in 1884 by Carle
and Rattone, who took a pustule (believed to be the entry point of
the illness) from a patient and injected it as a water homogenate
into twelve healthy rabbits; all but one of the animals developed
tetanus and later died. Further, they were able to show that a
toxic agent could be transferred from the nervous tissue of these
rabbits to fresh animals. In the same year, Nicolaier succeeded in
producing experimental tetanus after injecting samples of soil into
various animals. Following microscopic examination of material
taken from the innoculation site, he described the micro-organisms
responsible for the disease as elongated, thin bacilli. He
proposed that the germ remained in the innoculation site, and
attributed the development of tetanus to a strychnine-like
substance produced and diffused in the blood. The tetanus bacilli
were demonstrated in man by Rosenbach in 1886, although he was
unable to isolate them. This was achieved three years later by
Kitasato, who was able to show their identity with Nicolaier's
bacilli; he also established the morphology of the germ, as well as
some of its biological properties.
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It is generally considered that Faber was the first to describe the
tetanus toxin, in 1890. He demonstrated that the cell-free liquid
obtained by filtering a culture of bacilli, when injected in
minimal doses into an animal, resulted in a sickness identical in
every respect to natural tetanus. The outstanding toxic power of
the culture filtrate was immediately evident; less than one hundred
thousandth of a millilitre was enough to kill an animal. It was
subsequently discovered that a protein secreted by the micro¬
organisms was responsible for this remarkable toxicity.
The discovery of tetanus antitoxin by Behring and Kitasato in 1890
was a milestone in the history of tetanus (indeed, tetanus toxin
proved to be an important tool which allowed the first steps
towards immunohaematology). They carried out active immunisation
of rabbits, and subsequently achieved passive immunisation in mice.
Passive immunisation in man was first carried out by Behring and
Knorr in 1896.
Around the turn of the century, the important pharmacokinetic and
pathobiochemical properties of the toxin were also described, such
as Wassermann and Takaki's finding in 1898 that tetanus toxin was
fixed by brain matter, or Meyer and Ransom's discovery in 1903 of
the intra-axonal ascent of the toxin to the central nervous system.
Since this time, few further fundamental insights have been gained;
the most important practical achievements of this century lie in
the application of active immunisation in man.
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1.3 BACTERIOLOGY
The genus Clostridium, to which the causative organism of tetanus
belongs, contains those Gram-positive bacilli that grow only under
strict anaerobic conditions and which are capable of forming
endospores. Included in this group along with Clostridium tetani
are a number of species pathogenic to man, such as Clostridium
botulinum, responsible for botulism, and Clostridium perfringens,
which causes gas-gangrene.
Clostridium tetani is a ubiquitous organism, commonly found in
soil, air and even on clothing. However, soil rich in animal
manure, in a sufficiently hot and wet climate, may be regarded as
the main reservoir of tetanus bacilli; in this environment, the
organism takes part in the anaerobic decomposition of organic
matter, although the role of Clostridium tetani in the biocenosis
of the soil is totally obscure. The organisms are motile rods
approximately 0.4 x 6 /um in size; young bacteria contain a single
cilium at one end, while older bacilli may have a tuft of cilia
protruding from one pole. Later still, bacilli are surrounded by
about a dozen cilia which are lost gradually with further aging.
After two to ten days in culture, the bacilli start to form
spherical terminal spores, giving the organism a characteristic
"drumstick" appearance; in the environment, low temperatures and
lack of moisture also stimulate sporulation. These spores are
resistant to oxygen, moisture and extremes of temperature, and so
enable the organism to survive in soil indefinitely. When
innoculated into a wound, the spores will germinate and if the
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oxygen tension is sufficiently low, the organisms will proliferate
and produce their exotoxins tetanospasmin, responsible for the
clinical manifestations of tetanus, and tetanolysin, a protein of
uncertain importance.
Clostridium tetani bacilli are generally cultured on synthetic
medium supplemented with beef heart infusion (Mueller & Miller,
1954) and a complex array of nutrients required for normal growth,
multiplication and toxin production (Latham et al., 1962). Optimal
growth occurs when pH is maintained between 7.0-7.6, and at
temperatures of 35-38°C, and the oxygen-reduction potential (Eh)
should be +0.01V or less, since the organism is a strict anaerobe.
Under anaerobic conditions, motile cells can film the surface of
solid media with either a continuous or broken transparent
membrane; this is known as "swarming growth". The edges of such a
translucent sheet are usually irregular and filamentous.
Like all strict anaerobes, Clostridium tetani lacks cytochromes,
cytochrome oxidase, peroxidase and catalase, and does not seem to
be very active in the majority of biochemical laboratory tests.
Gas formation is low, and proteolysis is weak, although gelatinase
activity is evident (it is not known whether gelatinase, or
tetanolysin, is produced in vivo; if so, this would enable the
organism to damage surrounding tissues, and to create better
conditions for its growth). Production of tetanus toxin is a
unique biochemical property, and is useful for identification.
For general references concerning the bacteriology of tetanus, see
Habermann (1978), Bizzini (1979) and Adams et al. (1969).
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1.4 EPIDEMIOLOGY
The World Health Organisation regards tetanus as a serious health
problem, not only because of the vast numbers of people affected
but also the lethality of the disease. Its mortality rate is
between 50% and 80%, and it is estimated that well in excess of one
million deaths occur each year due to tetanus infection (Bytchenko,
1975). Accurate figures are not available, as tetanus is not a
notifiable disease in about half the countries of the world, and is
commonest where arrangements for collecting medical data are most
primitive.
Studies on the global distribution of tetanus show that typically
it is a tropical disease, and that its incidence depends largely on
socio-economic, demographic and environmental factors. It is more
common in areas with a warm, humid climate, fertile highly
cultivated soil, a substantial population of both man and animals,
and a low standard of living. Neonatal tetanus is the most
prevalent form of the disease; in many developing countries it
still accounts for approximately 50% of neonatal deaths. It is
estimated that worldwide about one million newborn children
contract neonatal tetanus each year and that 80% of these die.
This is due to multiple failures in the health systems of these
countries; failure to protect expectant mothers with tetanus
toxoid, coupled with unhygienic practices which bring tetanus
spores in contact with the umbilical cord. The persistence of this
disease is partly due to the ignorance of health authorities about
the true scale of the problem. Recently, however, immunisation
programmes in developing countries have been undergoing a period of
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rapid acceleration. This is due to the implementation of the
Expanded Programme on Immunisation, launched in 1974 by the World
Health Organisation.
The magnitude of non-neonatal tetanus is still ill-defined.
Available data are incomplete, but suggest mortality rates of 0.5-
1.4/100,000 population in Latin America, 1.2-2.4 in South Asia and
Africa, and less than 0.2 in Europe. These figures are probably
lower than reality; it has been estimated that 400,000 deaths occur
annually due to non-neonatal tetanus. It is interesting to note
that in developing countries non-neonatal tetanus still affects
mainly young people (half to two-thirds of patients are under the
age of twenty) while in industrialised countries, the incidence
increases relative to age, with 60-90% of patients being over sixty
years of age. This pattern of "residual" tetanus can be explained
as a result of incomplete immunisation programmes, having forgotten
or neglected to immunise older adults.
For references to the above section, see Adams et al. (1969) and
Habermann (1978).
1.5 TREATMENT OF TETANUS
Treatment of the tetanus patient, an expensive and complicated
procedure, may be aimed at interrupting one or more of the three
main stages of the disease process. The first means of
intervention is to prevent the invasion of toxin from Clostridium
tetani. This may be achieved by exhaustive cleansing of the wound,
which will reduce the toxin load and improve the oxygen-reduction
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potential of the damaged tissue, making conditions less favourable
for bacterial growth. The administration of antibiotics may also
be of use; C. tetani is sensitive to penicillins, cephalosporins,
tetracyclines and erythromycin. However, apart from the fact that
a wound may not be obvious, and that antibiotic treatment will not
alter toxin already produced or inactivate spores, this form of
treatment is virtually ineffective if tetanic symptoms are already
in evidence, and so is really a preventative measure rather than a
therapeutic one.
The second form of treatment involves the neutralisation of the
toxin before it is able to reach the central nervous system and be
adsorbed to its cell receptor {see section 1.8.2). This is
primarily accomplished through the administration of tetanus anti¬
toxin, a form of treatment whose value is now beyond question.
Intramuscularly injected human anti-toxin will neutralise both
circulating tetanus toxin and that toxin in the wound not yet
intraneuronal. However, as with the first approach, it is
important that treatment is carried out as soon as possible after
injury before any toxin can reach its target cells in the central
nervous system, since as yet it is not known how to inactivate
bound toxin.
The third type of treatment is to suppress the effect of toxin
having reached the central nervous system; this mainly consists of
limiting spasticity, and of preventing and counteracting the
effects of spasms on vital functions, especially respiration.
There are many sedative and muscle-relaxing drugs available,
although the large doses often necessary carry their own risk of
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side-effects. Hypnotics and sedatives such as barbiturates and
paraldehyde lower the general state of excitability in the central
nervous system, and reduce the effect of sensory input which may
provoke spasms, while general anaesthetics also cause widespread
suppression; however, these have now been largely replaced by
centrally acting muscle relaxants such as benzodiazepines (e.g.
valium) and phenothiazines (e.g. chlorpromazine) which depress
reflex activity and reduce motor output from the central nervous
system. These drugs remain the basis of tetanus therapy in many
parts of the world.
In theory complete paralysis and artificial respiration for about
two weeks should be the ideal treatment of severe tetanus.
Respiratory management of the tetanus patient is vital; adequate
ventilation and protection of the lung largely decide the outcome
of the disease. Another point to note is that, since the amount of
tetanus toxin produced in clinical tetanus is insufficient to be
immunogenic, all patients must also receive active immunisation
(see Section 1.6) to prevent further attacks.
For general references on the therapy of clinical tetanus, see
Adams et al. (1969), Rey et al. (1981) and Bleck (1986).
1.6 PREVENTION OF TETANUS
In contrast to the treatment of tetanus, prevention of the disease
is relatively simple and inexpensive. The attainment of more
sanitary conditions in developing countries, where the disease is
most prevalent, would go a long way to reducing its incidence, but
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this is a lot easier said than done, and will not be possible until
economic conditions are improved. However, immunisation can
prevent tetanus regardless of insanitary environments. Direct
active immunisation is the most effective form of prevention
available, antibodies being elicited against tetanus toxin. The
toxin itself cannot be used directly, since its immunogenic
capacity is far exceeded by its toxicity; instead it is first
"toxoided" by treatment with formaldehyde to yield an atoxic
derivative which is still immunogenic. The usual course for
immunisation is an intramuscular injection of toxoid followed by
boosters after six weeks and six months. Further boosters may then
be given at five or ten year intervals to maintain a high antibody
titre.
Passive immunisation has some value in preventing tetanus, but the
immunity afforded is shorter lived than with active immunisation,
and there is a risk of allergic reaction, since it is not human but
equine antiserum which is generally used. For this reason, the
administration of tetanus antiserum has now been discontinued in
many countries.
For references to the above section, see Adams et al. (1969),
Habermann (1978), Veronesi (1981) and Bleck (1986).
1.7 THE TETANUS TOXIN MOLECULE
Ever since the realisation that it is a toxin secreted by
Clostridium tetani which is responsible for the production of the
tetanic state, much research has been undertaken with the aim of
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elucidating the structural properties of this molecule. The last
twenty-five to thirty years have been the most productive, with the
development of methods which enable the toxin to be prepared to a
high degree of purity. This has facilitated a concomitant increase
in our knowledge of its physical characteristics.
Tetanus toxin is produced by Clostridium tetani at the end of the
germination phase, when it can constitute more than five percent of
the dry weight of the organism (Mellanby, 1968). Purification of
the toxin may start either from an extract of the Clostridia, or
from the culture filtrate; most procedures start with cell extracts
(where for instance the toxin is released from inside washed
bacteria following ultrasonication or treatment with hypertonic
solutions; Raynaud, 1947), proceed by either salt or organic
solvent precipitation, then by filtration through a basic ionic
exchanger such as DEAE-cellulose. It is sometimes necessary to
include a gel permeation step as well, to produce a protein
homogeneous on polyacrylamide gel electrophoresis.
The toxin molecule is a simple protein without lipid or
carbohydrate, which may be purified in one of two forms; the so-
called "intracellular" and "extracellular" forms. This is due to
proteolytic processing; initially the toxin is synthesised as a
single chain polypeptide, but upon secretion into the extracellular
medium, or autolysis, it undergoes a proteolytic cleavage to yield
the dichain form of the molecule. (However, nicking of the toxin
within the bacterial cell cannot be excluded; Helting et al. (1979)
have reported that extracted tetanus toxin may consist of up to 50%
of the two-chain form). This cleavage has been shown by various
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workers (Bergey et al., 1989; Weller et al., 1988) to increase the
potency of the toxin dramatically; indeed, the weak activity of the
single-chain toxin appears to be due to small amounts of
contaminating two-chain toxin. It is assumed that under natural
conditions, "intracellular" toxin is nicked by one or more tryptic
clostridial enzymes to become "extracellular" toxin. Indeed.,
Helting et al. (1979) have succeeded in isolating an enzyme with a
molecular weight of 27 kDa from culture filtrate, which has a very
high cleaving activity against tetanus toxin.
Thus the "extracellular" toxin differs from the "intracellular"
form in that one peptide bond in the single chain precursor is
cleaved by a clostridial enzyme. Robinson & Hash (1982) have noted
that the endogenous protease or proteases which act on the unnicked
toxin produce multiple species of nicked toxin, and hence
heterogeneity in the heavy and light chains. The resulting two
chains of the extracellular toxin are still held together by one
disulphide linkage (Craven & Dawson, 1973); in agreement with this,
Matsuda & Yoneda (1974) showed that the "extracellular" toxin could
be dissociated into two polypeptide chains by treatment with
dithiothreitol and sodium dodecyl sulphate, while the
"intracellular" form was undissociable by this treatment; however,
the two chains could be obtained from "intracellular" toxin if
prior to reduction the toxin was subjected to mild trypsinisation.
Prior to the advent of modern molecular biological techniques for
obtaining molecular weight and sequence data for proteins, the
structure of the toxin was investigated by various analytical
methods. Ultracentrifugation (Mangalo et al., 1968, Robinson
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et a1., 1975), gel filtration chromatography (Murphy et al., 1968)
and polyacrylamide gel electrophoresis (Matsuda & Yoneda, 1974)
were all used to determine its molecular weight, and all yielded
values between 140 kDa and 160 kDa. This has since been confirmed
by nucleotide sequence data (see below). The molecule has also
been shown to contain ten half-cystine residues, present as two
disulphide bridges and six free sulphydryl groups (Murphy et al.,
1968). The alpha-helical content of the molecule has been
estimated to be about 20%, and data from circular dichroism studies
suggest that much of this is confined to the amino terminal of the
heavy chain (Robinson et al., 1982); according to these authors,
this may be of some importance when assigning functions to specific
parts of the toxin molecule. Beta structure is said to account for
a further 20% of the molecule. A pi value of 5.1 has been reported
(An der Lan et al., 1980), which agrees well with amino acid
composition data showing about 300 acidic but only 150 basic
residues.
The generally accepted model for the structure of tetanus toxin is
summarised in Figure 1.1; the two chains, termed "heavy" and
"light", have molecular weights of 100 kDa and 50 kDa respectively.
The individual toxin chains are non-toxic, but may be reunited to
form a toxic molecule by removal of dissociating agents by dialysis
under aerobic conditions (Matsuda & Yoneda, 1976). The two chains
of the toxin must be held together strongly by non-covalent forces
in the native molecule, since it is very difficult to separate them
quantitatively, even under conditions where the covalent disulphide
bonds are broken. This would suggest a complex three-dimensional
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FIGURE 1.1 Structure of Tetanus Toxin
Proteolytic cleavage of the "intracellular" form of the
toxin produces the "extracellular" form, composed of the
light chain (L) with a molecular weight of 50 kDa, and
the heavy chain (H) with a molecular weight of 100 kDa.
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dichroism spectra show little difference between the three-
dimensional conformation of the chains when they are isolated or
combined, suggesting that they may make up relatively separate
domains in the intact toxin (Robinson et a_Z., 1982). Recently,
structural analysis of the toxin molecule by electron
crystallography has shown that it has an asymmetric three-lobed
structure (Robinson et al., 1988).
Further attempts to probe the structure of the tetanus toxin
molecule have been made by looking at various fragments produced
from it, either by freezing and thawing or, more commonly, by
enzymatic degradation; these isolated fragments differ in their
structures and properties depending on the conditions used. For
example, fragments produced by intrinsic proteases were isolated by
Bizzini et al. (1977); a 46 kDa fragment, designated Bllb, was
found to be atoxic, although still able to bind ganglioside with an
affinity even greater than that of the toxin (see Section 1.8.1).
It could also migrate by retrograde axonal transport towards the
central nervous system. Similarly, using papain digestion, Helting
& Zwisler (1977) produced two fragments with molecular weights of
95 kDa and 47 kDa, which they called B and C respectively.
Analysis showed that the smaller fragment represented the carboxyl
end of the toxin heavy chain, while the larger B fragment consisted
of the light chain and the remainder of the heavy chain. Both
fragments reacted with tetanus antitoxin although were non-toxic
themselves. Later work by Bizzini et al. (1981) produced similar
fragments, and again the smaller one was shown to bind
gangliosides. Studies of this kind have been of much use when
looking at structure-activity relationships of tetanus toxin, which
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will be discussed in later sections of this chapter. The general
structure of tetanus toxin after nicking, and the nomenclature of
fragments (by different authors using different fragmentation
techniques) is shown in Figure 1.2.
The structural gene (tox+) for tetanus toxin has been found to be
encoded by plasmid DNA in toxigenic strains of Clostridium tetani
(Laird et al., 1980; Finn et al., 1984). The complete nucleotide
sequence of the toxin has been published (Eisel et al., 1986;
Fairweather & Lyness, 1986); it contains one open reading frame
encoding a protein of 1315 amino acids with a molecular weight of
150,491. Despite the suggestion of Taylor et al. (1983), that
there are similarities in the sequences of the heavy and light
chains of the toxin, based on their amino acid compositions, the
DNA sequence shows no significant internal duplications.
Interestingly, there is a marked homology of the light and heavy
chain sequences with those of botulinum A,B and E neurotoxins
(Eisel et al., 1986; DasGupta & Foley, 1989), suggesting that the
neurotoxins from Clostridium tetani and Clostridium botulinum are
derived from a common ancestral gene. This sequence homology with
botulinum toxins has also been detected using antipeptide
antibodies (Halpern et al., 1989). Further, there has been the
suggestion of some similarity betweun tetanus toxin and the
haemagglutinin of influenza virus (Montecucco et al., 1987), based
on the fact that both proteins are able to bind to sialic acid













or B1 lb**, llc*b
or p1***
FIGURE 1.2 General Structure of tetanus toxin after
nicking and nomenclature of fragments
* Produced from tetanu3 toxin by papain: a) Helting & Zwi3ler (1 977)
b) Bizzini etsl. (1981)
** Produced from tetanus toxin by intrinsic protea3e(3): Bizzini etsL (1 977)
*** Produced from tetanus toxin by trypsin : Mat3uda &. Yoneda (1977)
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Several different estimates of the toxicity of purified tetanus
toxin have been published. There is much variation between
laboratories, but a typical value seems to be in the region of
2x10s mouse MLD (minimum lethal doses)/mg (Dawson & Mauritzen,
1975), making it one of the most poisonous substances known.
However, no-one has yet been able to explain why Clostridium tetani
synthesises this potent toxin, and there has been much speculation
as to how it originated. One theory is that the toxin gene may
have evolved from viral DNA, while another suggests a recombination
event between viral and eukaryotic gene material. Regardless of
its origin however, the toxin is of no obvious benefit to the
bacterium; this serves to make it an extremely intriguing molecule.
1.8 FIXATION OF TETANUS TOXIN
1.8.1 Binding to Ganglioside
It is nearly one hundred years since it was first discovered that
tetanus toxin is fixed preferentially by nerve tissue when, in
1898, Wassermann & Takaki observed that the toxicity of a toxin
solution was reduced when mixed with an emulsion of brain. This
reaction appears to be a specific one, since tetanus toxoid and
other proteins are not fixed, and other tissues are relatively
ineffective in toxin binding.
Much work went into trying to identify the receptor for the toxin,
and in 1959 van Heyningen put forward the proposal that it was a
ganglioside present in nervous tissue which was responsible for
toxin binding (van Heyningen, 1959). Gangliosides are complex
sialic acid-containing glycolipids found in almost all plasma
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membranes, but with highest concentrations in neuronal tissue (for
a typical structure see Fig. 1.3). Most of the different types of
ganglioside seem to be tissue specific, with the tetanus toxin-
binding gangliosides (see below) being predominant in nerve tissue.
Gangliosides are amphiphilic compounds i.e. they contain both
hydrophobic and hydrophilic domains; they also have a strong
negative charge, due to the presence of one or more sialic acid
residues. The hydrophobic portion of the molecule consists of two
long hydrocarbon chains (one of which is a fatty acid) linked to
sphingosine, while the hydrophilic region is made up of
carbohydrates (glucose, galactose, N-acetylgalactosamine and
N-acetylneuraminic acid (sialic acid), the proportions of which
determine the type of ganglioside). This structure makes
gangliosides very suitable candidates for cell surface receptors,
since the hydrophobic portion confers lipid solubility to the
molecule, enabling it to dissolve in the lipid bilayer, while the
hydrophilic domain is dissolved in the aqueous environment outside
the cell membrane, where it can complex ligands such as tetanus
toxin.
The fact that gangliosides form micelles in aqueous solution (they
have a very low critical micelle concentration, about 10"8 M;
Formisano et al., 1979) made quantitation of ganglioside-toxin
binding difficult. The first experiments to demonstrate this
binding used the analytical ultracentrifuge, where the separation
of free toxin and toxin-ganglioside complex was shown in a
sedimentation velocity run (van Heyningen & Miller, 1961). These
authors also demonstrated that the N-acetylneuraminic acid residues
of gangliosides were crucial for toxin fixation (removal of these
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Figure 1.3 Hie Structure of Gangliosides
The structure of ganglioside GM1, with the complete tetrasaccharide
backbone, and one N-acetylneuraminic acid residue, is shown.
Ganglioside GDlb has an additional N-acetylneuraminic acid residue
substituted at the position marked 0, while ganglioside GT1 has N-
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residues abolished binding ability), and that complexing with the
toxin did not alter ganglioside structure. Another method involved
complexing ganglioside with cerebroside (an unreactive insoluble
lipid) and incubating a suspension of this complex with tetanus
toxin; binding of the toxin to the complex was then estimated by
centrifuging the suspension and determining the toxicity of the
supernatants (van Heyningen & Mellanby, 1968). By using this
approach, the relative toxin-binding capacities of different
ganglioside species could be assessed, and it was shown that GDib
and GT1 fixed tetanus toxin more than ten times better than other
gangliosides. Here the nomenclature of gangliosides needs to be
explained. It is based primarily on the number of sialic acid
residues and on the carbohydrates forming the oligosaccharide
portion of the molecule, such that GM indicates a monosialo GD a
disialo- and GT a trisialoganglioside; the numbers refer to the
oligosaccharide chain such that "1" indicates the major neutral
tetrasaccharide, "2", the chain less the terminal galactose and "3"
the chain lacking galactosyl-N-galactosamine. Subscript letters
distinguish between species containing the same number of sialic
acid residues but at different positions (Svennerholm, 1970). The
important feature of tetanus toxin binding to gangliosides is that
it shows an enzyme-like specificity for gangliosides containing two
sialic acid residues linked in tandem to the galactose residue in
the lactose moiety of the tetrasaccharide backbone, namely GDlb and
GT1 (see Fig. 1.3). This moiety appears to be essential for good
tetanus toxin-binding; the bond between the two sialic acid
residues is neuraminidase-labile, and after hydrolysis the
molecules no longer bind toxin with a high affinity.
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Other methods have also been employed to study ganglioside-toxin
interactions which have yielded more accurate and quantitative
binding data. Helting et al. (1977) demonstrated binding between
the two components using tetanus toxin adsorbed to a Sephadex
matrix and radioactively labelled ganglioside. When the
ganglioside was passed through the column, radioactivity eluting
from it was decreased by the amount of ganglioside which had bound
to the toxin. The amount of radiolabel adsorbed was shown to be
proportional to the amount of toxin applied to the column, and it
was calculated that in the nanomolar concentration range, tetanus
toxin became half-saturated at about 5 x 10-8 M ganglioside. This
suggests a very tight binding, especially as some of the
ganglioside could have been in micelles and so perhaps not directly
involved in the binding. A molar ratio of one to one, toxin to
ganglioside, was demonstrated for GDlb by this method;
surprisingly, however, it was claimed that GM1 ganglioside gave the
same result, contrary to previous reports (van Heyningen, 1963).
Holmgren et al. (1980) have used a ganglioside enzyme-linked
immunosorbent assay to measure the binding of toxin to different
gangliosides adsorbed on polystyrene. (Adsorption was through the
ceramide moiety by strong hydrophobic bonding, leaving the
oligosaccharide portion free to react with ligands). Again, a
strong specific fixation of tetanus toxin to gangliosides of the
Gib series in general, and to GDlb, GTlb and GQlb (a
tetrasialoganglioside) in particular, was observed. Gangliosides
GM1 (which binds cholera toxin very strongly; van Heyningen, 1973)
and GDla also bound toxin but with much less affinity. This is
more evidence that the disialic acid moiety is needed for toxin
binding. Holmgren postulated that the natural binding structure
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had the end sequence Gal/5l—>3GalNAc|Sl—>4Gal(24-8<XNANA2<—3CXNANA),
which occurs in the appropriate gangliosides, and possibly as
oligosaccharide chains in certain cell membrane glycoproteins (see
Section 1.8.2).
In contrast to the binding of cholera toxin to GM1 ganglioside,
which has been investigated in great detail, little has been
published on the nature of tetanus toxin binding to Gib
gangliosides. Presumably the specificity is elicited by the
carbohydrate moiety of the ganglioside molecule, since removal of
the ceramide portion does not affect the binding (Helting et al.,
1977). Toxin fixation is reversible and non-covalent, and as
mentioned already, there is no evidence to suggest that the
ganglioside is changed in any way by reacting with toxin.
Gangliosides have been shown to bind a number of different ligands
other than bacterial toxins. Strychnine, brucine and thebaine, all
drugs with the same neurophysiological effects as tetanus toxin,
bind to gangliosides (van Heyningen, 1963), as do interferon
(Besancon et al., 1976) and glycoprotein hormones such as
thyrotropin (Fishman & Brady, 1976). This would appear to support
a role for gangliosides as cell surface receptors, although in most
cases their physiological functions remain unknown. Possible roles
might include conferring structural rigidity on membranes, or as
cell differentiation and growth markers.
As well as ascertaining which particular gangliosides have the
highest affinity for tetanus toxin, it was obviously also of great
importance to determine which part of the toxin molecule
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facilitates binding. Investigation has shown that of the two
chains of the toxin, only one actually binds ganglioside. This has
been demonstrated in two different ways. In the first method (van
Heyningen, 1976a), GT1 ganglioside was insolubilised by complexing
with cerebroside as described above, then either whole toxin, heavy
chain or light chain was incubated with it. The protein:
ganglioside:cerebroside complex was then centrifuged, and the
supernatant analysed by SDS-polyacrylamide gel electrophoresis to
identify any molecular species of tetanus toxin left. Toxin bound
to the complex could be dissociated with 8 M urea and identified in
the same way. It was shown that both whole toxin and heavy chain
were quantitatively adsorbed to the complex, while light chain did
not adsorb at all. Helting et al. (1977) confirmed these results
using their Sephadex binding assay. Heavy chain exhibited a
binding activity of the same order of magnitude as that observed
with the native toxin, while the light chain showed no interaction
with ganglioside.
These experiments show that the binding site for ganglioside must
lie on the heavy chain. Further, Helting's group showed that
proteolytic fragment B (light chain and part of the heavy chain,
see earlier) did not bind any significant amount, while fragment C
showed some binding, suggesting that the binding site lies towards
the carboxyl end of the heavy chain. The fact that the heavy chain
still retains ganglioside binding ability when it is free from the
light chain suggests that the conformation of the former does not
change much on binding to the light chain; this is surprising in
view of the fact that the two are so difficult to separate.
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A point to note is that while cholera toxin complexed to purified
GM1 is completely inactive in vivo, such is not the case with
tetanus toxin and Gib gangliosides (van Heyningen & Mellanby,
1973). Only partial inactivation occurs; this could just be a
question of the tightness of binding of ganglioside to tetanus
toxin, but it does raise the question of whether gangliosides that
fix tetanus toxin are genuine in vivo receptors, or possibly only
part of a more complex receptor system; this will be discussed in
detail later.
1.8.2 Binding of Toxin to Whole Cells and Subcellular
Fractions
Since the original observation nearly a century ago that tetanus
toxin is fixed by nervous tissue, it has become possible to be
rather more specific. With the development of subcellular
fractionation methods, Mellanby et al. (1965) were able to study
the fixation of tetanus toxin by various fractions of the brain,
and to show that the synaptosomal fraction (containing isolated
nerve endings) had the greatest toxin-binding capacity. Further
fractionation demonstrated that this was a property of the synaptic
membrane, which had a ten-fold greater affinity for toxin than that
of the synaptic vesicle fraction (Mellanby & Whittaker, 1968).
Habermann (1973) also demonstrated binding of toxin to spinal cord
synaptosomes using radiolabelled ligand. Further, Habermann (1976)
was able to demonstrate that tetanus toxin could be affinity-
purified by chromatography on a column of synaptosomes adsorbed to
an insoluble support such as bromoacetyl cellulose; toxin was
adsorbed to the column at low ionic strength and eluted at a higher
ionic strength. Experiments using radiolabelled toxin fixed to the
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synaptosomes showed that even large excesses of cold toxin could
not elute all the label from the column, implying either a very
large number of possible receptor sites on the synaptosomes, or
perhaps uptake of toxin into the vesicles such that displacement of
label was no longer possible.
Working with primary cultures from neuronal tissue, Dimpfel et a_Z.
(1975) showed by autoradiography that tetanus toxin fixed
selectively to neuronal and not glial cells; this raised the
suggestion that tetanus toxin could make a good marker of neuronal
cells in culture. This work was carried further, in a thorough
study of toxin binding by different kinds of cell (Dimpfel et al.,
1977). It was found that primary cell cultures derived from
embryonic mouse central nervous system could bind 125I-labelled
tetanus toxin, but continuous cell lines failed to do so. This
binding was subsequently shown to correlate with non-synthesis of
gangliosides (see Section 1.8.1) in continuous cultures; toxin
binding could be enhanced by in vitro addition and uptake of the
relevant gangliosides into the cell membrane (this has been shown
by other workers also; Yavin (1984), working with somatic
neurohybrid cells, observed an eight-fold enhancement of binding
after ganglioside supplementation, and Pierce et al. (1986) were
able to produce a similar effect using rat brain membranes).
Further, hybrid cells (neuroblastoma and glioma fusions) which
contained relatively low levels of GDlb and GT1 gangliosides bound
only small amounts of toxin. Experiments by Yavin & Habig (1984)
gave similar results; they investigated the interaction of 12 5I-
labelled toxin with several somatic neural hybrid cell lines, and
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found that the capacity of the hybrid cells to bind tetanus toxin
correlated well with the complexity exhibited by their cellular
gangliosides.
In another type of study, Mirsky et al. (1978) used
immunofluorescence to show that tetanus toxin can distinguish
neuronal from non-neuronal cells in a wide variety of dissociated
cell cultures. They investigated cells from cortex, cerebellum,
spinal cord and dorsal root ganglia from rats, and spinal cord,
optic lobe, retina and dorsal root ganglia from chicks. Tetanus
toxin was found to bind highly specifically to neuronal cells from
all parts of the central nervous system in a ganglioside-dependent
fashion. However, although the binding specificity of the toxin
for neurones is marked, it is not absolute. Thus tetanus toxin
does not bind to some large neurones present in late culture (Raju
& Dahl, 1982), and, in the retina, binding to neurones is stronger
than to other cells but not exclusive to them (Beale et al., 1982).
The toxin will also bind to pancreatic islet cells, which are known
to have some cell surface differentiation markers in common with
neurones (Eisenbarth et al., 1982), and to thyroid plasma membranes
(Ledley et aI., 1977). This suggests that the restricted binding
of toxin to particular neurones in vivo is therefore due to limited
accessibility rather than preferential binding.
Numerous other experimental arguments favour the assumption that
specific gangliosides are involved in binding tetanias toxin in
nervous tissue. Binding of toxin to rat brain membranes has been
shown to be inhibited in a dose-dependent manner by gangliosides,
with GTlb (Ki = 6nM) and GDlb (Kj = lOnM) being the most potent
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(Rogers & Snyder, 1981); similar results were obtained by Critchley
et al. (1986) under the same conditions. Further, Rogers & Snyder
were able to show that GTlb and GDlb gangliosides could readily
release toxin associated with mammalian brain membranes in a highly
specific manner; they also observed that binding of the toxin was
not affected by pretreatment of the neuronal membranes with trypsin
or protein modification reagents, but was substantially reduced by
neuraminidase. (Neuraminidase treatment has also been shown to
reduce binding at 0°C and 37°C to neural cells in culture, while
treatment by proteases before the addition of toxin has only a
marginal effect in diminishing subsequent binding; Yavin, 1984).
Further evidence was to come from the finding that the non-toxic
fragment C of tetanus toxin, which retains the capacity to interact
with gangliosides, competes with the intact toxin for binding both
/
in vivo (Simpson, 1984) and in vitro (Goldberg et al., 1981); this
gives more support to the idea of an in vivo ganglioside receptor.
Also, it has been argued (Goldberg et al., 1981) that the large
number of toxin binding sites present in neuronal membranes is
compatible with the reported concentration of GTlb and GDlb in rat
brain (Ando et al., 1978).
Recently, some confusion arose when Lazarovici et al. (1984)
reported that radiolabelled tetanus toxin could be separated by
ganglioside-affinity chromatography into two populations, one of
which failed to bind to the solid-phase ganglioside column or to
nerve cells, but which retained full toxicity. However, this claim
not only contradicted the results obtained by affinity
chromatography on synaptosome columns (Habermann, 1976), but also
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could not be reproduced with the same type of solid-phase
ganglioside (Habermann & Tayot, 1985). The importance and
relevance of these findings is thus very much open to question.
It would seem then that there is clear evidence from experiments
using synaptosomes, brain membranes and primary neuronal cell
cultures to suggest a role for gangliosides as cell surface
receptors for tetanus toxin. However, over the past several years,
a significant number of reports have appeared which disagree
markedly with this view. One of the first suggestions of a non-
ganglioside receptor came when Zimmerman & Piffaretti (1977)
distinguished between what they interpreted as two independent
types of toxin binding. What they called "non-effective" binding,
which was observed only with non-differentiating mouse
neuroblastoma cells in culture, produced no biological effect and
was shown by neuraminidase treatment to be ganglioside-dependent.
"Effective" binding on the other hand was not associated with
gangliosides (i.e. neuraminidase was ineffective), and led to
shortening of cell processes and reduction in cell adherence to
glass; this was observed only with differentiating cells. They
postulated that non-effective binding was followed by pinocytosis
and degradation by lysosomes, while effective binding led to
internalisation of the toxin for subsequent retrograde axonal
transport (see Section 1.9.3). However, since it is not clear what
toxin concentrations were used in these experiments, it is
difficult to assess their physiological relevance.
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Several experimental observations suggest that the neurotoxic
activity of tetanus toxin may be mediated by components other than
gangliosides. For instance, Stoeckel et al. (1977) reported that
exogenous gangliosides (either GT1 alone or a bovine ganglioside
mixture) caused only a 50% blockade of the retrograde axonal
transport of the toxin, while total blockade would be expected if
gangliosides alone were responsible for toxin fixation (pre¬
incubation of 1251-labelled cholera toxin with GM1 ganglioside, to
which it binds specifically, completely blocked its retrograde
axonal transport); however, this incomplete blockade may have been
due to hydrolysis of GT1 to other ganglioside species, a phenomenon
which is known to occur since GT1 is not very stable (indeed,
rechromatography of purchased "purified" GT1 may reveal a mix of
different hydrolysis products). The existence of an extra-axonal
mode of transport for the toxin within the central nervous system
has also been cited as evidence for a non-ganglioside toxin
receptor (Erdmann et aI., 1975). Further, the observation of
Habermann (1981) that neuraminidase treatment was unable to
suppress the inhibitory effect of the toxin on the K+-evoked
release of [3H]-noradrenaline from preloaded particulate rat
forebrain cortex strongly suggests that the toxin effect is
mediated by its binding to some cell membrane component other than
a ganglioside. Similarly, Haberraann et al. (1980) showed that the
blocking effect of the toxin on the neuromuscular junction of the
mouse phrenic nerve-hemidiaphragm could not be prevented by
neuraminidase, while Bigalke et al. (1981) demonstrated the
inability of neuraminidase to suppress toxin effects on K+-evoked
release of [3H]-acetylcholine from brain slices. If toxin binding
to ganglioside is important for its mechanism of action, it can be
-32-
predicted that neuraminidase treatment should confer at least
partial protection from intoxication. Since this is not the case,
it would appear that gangliosides are not physiological toxin
receptors; the most obvious explanation for these observations is
that the interaction of tetanus toxin with the cell surface may be
more complex and require additional components.
Several other considerations suggest that the Gib gangliosides are
not solely responsible for tetanus toxin binding to neuronal
membranes. For instance, although there is no doubt that tetanus
toxin binds to gangliosides and that there is some specificity with
respect to the type of ganglioside, this specificity is not
particularly marked. While cholera toxin has a binding preference
for GM1 over other gangliosides by at least three orders of
magnitude (as expressed in moles of toxin fixed per mole of
ganglioside), tetanus toxin shows only a sevenfold preference for
GDlb ganglioside over GM1 (van Heyningen, 1974). Considering the
potency of tetanus toxin, one would expect a much greater
specificity in a true toxin-receptor interaction (however, it may
be that the specificity of binding is not a crucial factor, in
other words it may not be important how the toxin binds to the cell
as long as this binding is able to support entry of the toxin into
the cell). Further, gangliosides are present on neuronal cells in
enormous excess with respect to tetanus toxin at clinical doses
(Mellanby & Green, 1981), whereas specific receptor systems (e.g.
for hormones) are usually restricted in number. While some have
suggested that an extreme excess of binding sites may contribute to
the potency of the toxin (e.g. Habermann & Dreyer, 1986), it may be
that this large number of gangliosides represents a sink of non-
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productive toxin binding, as Zimmermann & Piffaretti (1977) have
suggested; however, since there is likely to be a vast excess of
toxin present anyway, this may not be an important consideration.
No-one has shown definitive data to correlate binding of toxin to
gangliosides and cellular responses to toxins; even experiments
where a decrease in toxicity is observed after pre-binding toxin
with gangliosides should not necessarily be interpreted as evidence
of structural similarities between the protective ganglioside and
the toxin receptor.
It is very important to note that most of the early binding studies
done with tetanus toxin (e.g. those cited previously, Rogers &
Snyder, 1981; Lee et al., 1979; Morris et al., 1980) which
suggested a receptor role for gangliosides, were carried out under
conditions previously shown to be optimum for toxin binding in
vitro i.e. in a low salt, pH 6.0 buffer (Ledley et al., 1977);
therefore it is not impossible that binding of tetanus toxin under
these conditions is to components, maybe gangliosides, that are not
necessarily involved in binding under physiological conditions.
Also, it would seem that no specific measures were taken to limit
proteolysis during membrane isolation procedures, so that candidate
proteinaceous toxin receptors might have been destroyed. More
recent binding studies have been conducted under more physiological
conditions of ionic strength and pH; this reduces toxin binding,
with a lowering of both affinity and number of sites (Weller et
al., 1986). An investigation of toxin binding to cerebral neurones
in monolayer culture by Yavin & Nathan (1986) showed that under
physiological conditions, binding could be reduced by approximately
40% if the cells were treated with trypsin prior to toxin
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incubation; trypsin-insensitive binding could be eliminated by
neuraminidase treatment or cell extraction with methanol.
Experiments looking at the effect of cross-linking agents such as
formaldehyde on binding suggested that a substantial portion of the
binding sites contained a sialo cross-linkable protein component,
but that there was also a sialo component unaffected by cross-
linkers. On the basis of these observations, the authors proposed
that cerebral neurones possess two classes of ganglioside receptor,
one of which may be modulated by cell surface proteins.
Critchley et al. (1986) did similar experiments using rat brain
membranes. Again it was demonstrated that binding at pH 7.4 (in
Tris-saline) was of lower affinity and capacity than at pH 6.0 (in
Tris-acetate). Binding under both conditions was reduced by
neuraminidase treatment, but protease treatment only decreased the
physiological binding. The authors conclude that the toxin
interaction with rat brain membrane gangliosides is much reduced
under physiological conditions; this is further supported by the
finding that the concentration of gangliosides needed to inhibit
toxin-binding was 100-fold higher at pH 7.4 than at pH 6.0. In an
attempt to analyse the nature of the toxin receptors in rat brain
membranes further, membrane components were separated by SDS-
polyacrylamide gel electrophoresis and transferred to
nitrocellulose which was then overlaid with radioactive tetanus
toxin; the toxin bound only to material that migrated at the dye
front and that was extracted by lipid solvents (presumably
gangliosides). When binding of toxin to nitrocellulose was
determined in the Tris-saline buffer (pH 7.4), the toxin bound to
the same components but the extent of binding was markedly reduced
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compared with the low salt and low pH conditions. The authors were
unable to detect any toxin binding to membrane proteins, but this
may have been because the secondary or tertiary structure of the
protein was altered such that the toxin could no longer interact
with it. Critchley concludes that membrane components other than
gangliosides, such as sialoglycoproteins, may act as toxin
receptors under physiological conditions. Pierce et al. (1986)
arrived at similar conclusions; in physiological buffers, tetanus
toxin binds with high affinity to a protein receptor, while
gangliosides represent only a low affinity site. Parton et aI.
(1988) obtained similar results working with spinal cord cultures,
as did Lazarovici & Yavin (1986) using guinea pig brain synaptic
membranes. Interestingly, the latter authors suggest that the
toxin interaction with neuronal membranes may also require an
appropriate lipid environment; they observed that binding was
facilitated, at least in part, by phospholipase-sensitive
components.
Another theoretical suggestion, which can explain many of the
findings reported above, has been put forward by Montecucco (1986);
he proposes that binding to both a ganglioside and a protein
acceptor is important to toxin action. The high concentrations of
gangliosides present in neuronal membranes are envisaged to bind
toxin through low affinity interactions trapping it at the cell
surface. Rapid diffusion of this complex in the membrane would
then lead to collision with low abundance high affinity protein
acceptors involved in toxin internalisation.
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In any case, further progress would seem to depend on purification
of the protease-sensitive toxin acceptor. Traditional methods for
purification of membrane protein receptors generally depend on a
convenient assay that can be used with solubilised material. Such
an assay system may be difficult to develop in the case of the
toxin receptor, given the large size of the toxin itself; therefore
it may be necessary to follow the more arduous route of screening
for monoclonal antibodies to neuronal membranes which block toxin
binding. Such antibodies could then be used to characterise the
receptor via Western blotting and to affinity purify the component
for reconstitution studies.
Thus our knowledge about the true physiological receptor for
tetanus toxin is incomplete. While there is no doubt that
polysialogangliosides will bind tetanus toxin, many experiments are
incompatible with the view that gangliosides are the only receptors
for the toxin; much evidence points to the existence of another
membrane component, perhaps a protein, which facilitates toxin
binding. One point which has not been considered during this
discussion is, what do we actually mean when we spoak of a toxin
receptor? It is really a matter of convenience that the cell
surface binding sites for tetanus toxin should be termed
"receptors" at all; "receptor" would imply that the main, if not
only, function of the cell surface molecule (whether it be
ganglioside or otherwise) is to bind tetanus toxin and facilitate
its subsequent internalisation. This is certainly not the case; it
is obvious that a cell will not express a receptor on its surface
sp>ecific for a toxic molecule. Thus it would seem that the toxin
acts in an opportunistic fashion, utilising a moiety present on the
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cell surface for some other purpose as a means of gaining access to
its intracellular target. It is perhaps more correct, then, to
refer to toxin binding molecules as "acceptors" rather than
"receptors".
It must be realised too, that there are no published data to show
that for instance the tetanus toxin receptor in brain is the same
as that in peripheral nerve; it is possible that receptors in
different cell types may be distinct molecular species. With this
in mind, it is interesting to note that in recent years, several
groups have used various model cell systems to study the binding
and subsequent physiological effect of the toxin. Thus, Staub et
al. (1986) investigated toxin-binding to a neuroblastoma retina
hybrid cell line N18-RE-105, and found it to be very similar to
binding to rat synaptic membranes; further, it was demonstrated
that these cells contained polysialogangliosides, although the
effect of neuraminidase or proteolytic enzymes on toxin binding was
not examined. Similarly, Wellhoner & Neville (1987) showed that
tetanus toxin bound with high affinity to neuroblastoma x glioma
hybrid cells NG108-15; this could be prevented by pretreatment with
neuraminidase, as could toxin inhibition of acetylcholine release
from these cells. These authors suggested that neuraminidase-
sensitive receptors serve as productive receptors for tetanus
intoxication in differentiated NG108-15 cells; these could be
either gangliosides or sialoglycoproteins. Finally, Walton et al.
(1988) and Fujita et al. (1990) have used phaeochromocytoma PC12
cells to study tetanus toxin binding. Walton's group reported that
the major ganglioside species present in these cells was GTlb and
that radiolabelled toxin bound with high affinity, while Fujita
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et al. observed very low levels of binding to untreated cells,
which was enhanced ten-fold after nerve-growth factor-induced
differentiation; neuraminidase treatment reduced binding by about
40%, but the nature of the neuraminidase-resistant sites was
unclear. How relevant the findings of experiments in these model
systems are to the true in vivo case, however, remains to be seen.
1.9 INTERNALISATION OF BOUND TOXIN
1.9.1 Introduction
It is generally believed that tetanus toxin shares the tripartite
mechanism of action employed by other bacterial toxins with
intracellular targets, namely binding of the toxin to the cell
membrane, as discussed above, followed by its internalisation, and
finally modification of an intracellular target (e.g. Simpson,
1986). There are two distinct binding sites for tetanus toxin in
the body; firstly, after the release of toxin at the site of
infection, it is seen to bind to nerve endings at the neuromuscular
junction, while a second binding site is at its site of action, the
pre-synaptic membranes of certain inhibitory synapses (see Section
1.10). In both instances, binding is followed by an
internalisation step; in the case of the neuromuscular junction,
this leads to subsequent axonal transport of the toxin to the
central nervous system (see Section 1.9.3), while at the inhibitory
synapse, internalisation is followed by intracellular intoxication.
There is no reason to believe that there is any difference between
the mechanisms involved in each case (if indeed a specific
internalisation mechanism does operate, see below).
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1.9.2 Possible Mechanisms of Membrane Translocation
Since toxin-binding occurs on the neuronal cell surface, and
intoxication is presumed to occur intracellularly (see Section
1.10), it would appear that the toxin must translocate across the
membrane to the cell interior. In recent years considerable
progress has been made in elucidating the morphological basis of
tetanus toxin internalisation, although it cam perhaps be argued
that a specific mechanism is not necessarily essential for
internalisation to occur. There are several possible routes into
the cell, including receptor-mediated endocytosis, pinocytosis or
even direct passage across the plasma membrane; whether one of
these phenomena occurs in preference to the others is still a
somewhat open question.
Schwab & Thoenen (1978) carried out some of the early experiments
in this area. They demonstrated that when tetanus toxin adsorbed
to colloidal gold was injected into the anterior eye chamber of
rats, it was found 1-2 hours later in smooth, membranous elements
within axons; there was very little incorporation into lysosomes.
Similar studies with peroxidase-conjugated toxin also indicated
that transport occurred via smooth vesicles (Schwab et al., 1979).
Much of the toxin was ultimately incorporated into lysosomes, but a
small amount was specifically accumulated in presynaptic nerve
terminals where it was contained within small vesicles of 50-100 run
diameter. Unfortunately, however, it could not be concluded from
these studies whether internalisation at the neuromuscular junction
(or trans-synaptic movement of the toxin) was mediated by coated
pits. Later, Montesano et al. (1982) studied the internalisation
of tetanus toxin-gold particles by cultured cells, and also found
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these to be localised in smooth vesicles. These authors found no
evidence for the involvement of coated pits; however, since
internalisation via this mechanism is a rapid process, the
experimental procedure adopted was such that it may not have been
detected even if it was in fact occurring. It should be noted also
that the neurotoxicity of the tetanus toxin-gold was not
established, and that it was used at very high concentrations (1
mg/ml). Moreover, the cells used were not of neuronal origin, so
the relevance of these findings is to be questioned.
More recent studies on tetanus toxin internalisation have been
conducted on neuronal cell cultures. Critchley et al. (1985) bound
tetanus toxin to primary mouse spinal cord cell cultures at 4°C,
and followed internalisation (after warming cells to 37°C) by
measuring the accessibility of toxin to anti-toxin. They found
that some surface-bound toxin was rapidly internalised (within 5
minutes). Immunofluorescence experiments confirmed this, and
indicated that internalised toxin was distributed in a punctate
pattern, reminiscent of ligands internalised via coated pits.
Parton et al. (1987), using the same cells, adsorbed tetanus toxin
to colloidal gold, and used electron microscopy to define the mode
of internalisation more precisely. Quantitation of the
distribution of toxin-gold particles bound to cell bodies at 4°C
showed that they were concentrated in coated pits; few particles
were found within cells under these conditions. Five minutes after
warming the cells to 37°C however, toxin-gold was found within
coated vesicles, endosomes and tubules. After 15 minutes at 37°C
internalised toxin was found mainly in endosomes, and after 30
minutes largely in multivesicular bodies. Tetanus toxin-gold was
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also shown to enter nerve terminals and axons via coated pits,
accumulating in synaptic vesicles and intra-axonal uncoated
vesicles respectively (given that the toxin inhibits the release of
neurotransmitters, toxin accumulated here may be more relevant to
intoxication than that internalised by the cell body).
Interestingly, much of the toxin-gold remained bound at the cell
surface but was not rapidly internalised. Parton suggests that
perhaps toxin internalised via coated pits is that bound to the
protease-sensitive site which has been detected in mouse spinal
cord cells and which may be equivalent to the small number of
protease-sensitive high affinity sites in rat brain membranes (see
Section 1.8.2). Toxin not rapidly internalised may represent
binding to the lower affinity sites, possibly gangliosides, which
may not be able to support internalisation via coated pits. In
agreement with this idea, it was noted that cholera toxin, specific
for ganglioside GM1, was partially excluded from coated pits; also,
Montesano et al. (1982) had previously shown that cholera toxin
entered non-neuronal cells via smooth membrane invaginations.
In an attempt to determine whether tetanus toxin bound to
gangliosides can enter cells via coated pits, Parton et al. (1988)
incorporated ganglioside GT1 into the plasma membrane of mouse
fibroblast Balb/c3T3 cells which lack endogenous toxin-binding
activity. Using toxin-gold, it was demonstrated that at 4°C, toxin
was concentrated in non-coated cell surface membrane invaginations;
on warming to 37°C, toxin was internalised via non-coated vesicles
and accumulated within multivesicular bodies and lysosomes. In
contrast, there was negligible labelling of coated pits. These
results, the authors conclude, show that toxin bound to ganglioside
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receptors does not enter cells via coated pits, and thus lend
support to the view that toxin internalised by neuronal cells in
this fashion must be that bound to a protein receptor. While it is
highly likely that some of the toxin bound to neuronal cells is
associated with the abundant low affinity ganglioside receptors,
toxin-gold particles were not observed to enter neuronal cells via
non-coated invaginations. However, it is not impossible that this
phenomenon occurs; cholera toxin can undergo retrograde axonal
transport (see Section 1.9.3), suggesting that ligands bound to
gangliosides can indeed be internalised into a vesicular
compartment in nerve terminals. If this is so, then the question
must be asked: does tetanus toxin internalised via both coated pits
and non-coated invaginations contribute to intoxication? The fact
that cholera toxin, unlike tetanus toxin, does not undergo trans-
synaptic transfer (see Section 1.9.3) suggests that perhaps ligands
entering neurones via a ganglioside receptor may be processed
differently from those internalised via a protein receptor.
Tetanus toxin entering cells via coated pits passes into the acidic
endosomal compartment where it remains bound to the limiting
endosomal membrane; this may account for the ability of a
significant portion of the toxin to escape degradation and hence
exert its neurotoxic effects. On the other hand, toxin bound to
gangliosides and internalised via non-coated invaginations (at
least in fibroblasts) would seem to be directly routed to
lysosomes; assuming that this can be extrapolated to neuronal
cells, it appears that toxin internalised by this route is largely
degraded and therefore probably not neurotoxic. The view that an
acidic compartment is important to toxin action is supported by the
observation that lysosomotropic agents which raise the pH inside
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endosomes (e.g. ammonium chloride, methylamine hydrochloride) cause
a significant delay in the onset of toxin-induced spastic paralysis
(Simpson, 1983); however, it would be interesting to know whether
an in vitro effect of these agents could also be observed.
Once within the inhibitory neurone, trapped inside the endosome,
the toxin molecule must presumably reach the cell cytoplasm to
exert its toxic effect. It has been proposed that the low pH which
is achieved in the lumen of the endosome somehow causes a
conformational change in the toxin, such that its hydrophobic
surfaces are exposed, facilitating its penetration and
translocation of the endosome membrane (Boquet & Duflot, 1982).
These workers demonstrated that tetanus toxin fragment B (light
chain plus the amino-terminal half of the heavy chain) could
release K+ ions from single-walled asolectin vesicles at low pH;
since light chain alone was unable to provoke K+ release, it was
concluded that the amino-terminal of the heavy chain could
facilitate the formation of a channel that might be involved in the
transport of an active toxin fragment (presumably the light chain)
into the cytosol.
Hoch et a1. (1985) also found that the heavy chain formed channels
at low pH in planar lipid bilayer membranes. Selectivity
experiments with different cations and anions showed that the
channel was potentially large enough to serve as a "tunnel protein"
for translocation of the light chain. In agreement with this, Roa
& Boquet (1985) have demonstrated that two polypeptides which
localise to the amino-terminal of the heavy chain are protected
against proteolysis when a mixture consisting of asolectin vesicles
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and 125I-labelled tetanus toxin is subjected to a pH drop from 7.2
to 3.0. Further, Johnstone et ai. (1990) have demonstrated that the
heavy chain of tetanus toxin can facilitate the entry of gelonin (a
cytotoxic cell-impermeant analogue of the ricin A chain) into
intact cultured HT29 cells (a human colonic carcinoma cell line).
Although this experiment provides no information about the actual
mechanism of toxin internalisation, it does lend further support to
the notion that the heavy chain may mediate the entry of the light
chain into cells.
However, Montecucco et al. (1986) have shown, using hydrophobic
labelling with radioactive photoactivatable phospholipids, that
both toxin chains interact with the fatty acid portion of the lipid
bilayer at low pH. (This is supported by the finding that, at low
pH, many binding sites for Triton X-100 appear on both toxin
chains; Boquet et al., 1984). On the basis of these findings,
Montecucco proposes a model in which both chains of tetanus toxin
penetrate the bilayer, with their hydrophobic surfaces exposed to
the membrane lipids and their hydrophilic residues facing each
other. He further suggests that this penetration is not
necessarily followed by translocation of the toxin across the
membrane, as proposed by Hoch et al. (1985), and that it is not
impossible that the toxin may carry out its enzymatic function
while embedded in the endosome membrane. Indeed, it should be
pointed out that although there is mounting evidence to suggest
that endocytosis is a prerequisite for intoxication (Simpson,
1986), it has not been conclusively proven that tetanus toxin does
not reach its cytoplasmic substrate from the plasma membrane, as is
the case with cholera and pertussis toxins.
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(One point to bear in mind when looking at many of these
experiments is that they were conducted in very artificial systems.
Therefore their true similarity to the in vivo situation, and thus
their biological relevance, is perhaps open to question.)
1.9.3 Retrograde Axonal Transport and Trans-synaptic
Transfer
(This is a very large field, which will only be discussed in brief,
as it is of little relevance to the work presented in this thesis).
The fact that the site of tetanus infection and the focus of the
disease are not the same is obvious, implying that there must be
some transport of the toxin to its site of action. The mechanism
of this transport has been studied in great detail and is one of
the few problems concerning the action of tetanus toxin which can
perhaps be said to have been solved at least in outline. For many
years there were two basic theories, one proposing that the toxin
reached the spinal cord via the blood (e.g. Abel et al., 1935)
while another idea, first introduced by Meyer & Ransom (1903),
suggested that it reached the spinal cord via a neural route of
some sort. The latter has since been shown to be the means by
which tetanus toxin reaches its site of action. Transport of the
toxin has been observed to be intra-axonal (Erdmann et al., 1975)
and in a retrograde direction (Price et al., 1975). Further,
Stoeckel et al. (1975) have demonstrated that toxin is transported
in all peripheral neurones, especially in motor, sensory and
adrenergic types, although it seems likely that it is that which
ascends in motor neurones which constitutes the bulk of the toxin
reaching the CNS. Transport in motor neurones is mainly confined
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to CX-neurones (Green et aI., 1977), with little or no transport via
&-neurones. Toxin has been shown to be transported within vesicles
and branched cisternae of the smooth endoplasmic reticulum (Griffin
et al., 1977).
Once the toxin has reached the motor neuronal cell body by axonal
transport, it may either be transported up the next motor neurone,
or interact with the pre-synaptic membrane of an inhibitory neurone
synapsing with the motor neurone. Either way, the toxin is
required to cross a synaptic cleft. This trans-synaptic migration
of the toxin has been demonstrated by Schwab & Thoenen (1976), and
appears to be specific to the toxin; other macromolecules such as
cholera toxin, wheat germ agglutinin and ricin, which may be
transported in the same motor neurones as tetanus toxin, are not
transferred (Schwab et al., 1979). Finally, evidence suggests that
it is the intact whole toxin which is transported (Dumas et al.,
1979).
For further discussion on the transport of tetanus toxin, see
Bizzini, 1979; van Heyningen, 1980; Mellanby & Green, 1981;
Habermann & Dreyer, 1986.
1.10 THE ACTION OF TETANUS TOXIN ON THE NERVOUS SYSTEM
Once within the inhibitory neurone, the toxin is able to express
its biological effects. It has been well established that tetanus
toxin blocks the action of inhibitory neurones, much as strychnine
does, although the molecular mechanism involved in producing this
effect remains unclear. It is known, however, that the toxin acts
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pre-synaptically (in contrast to strychnine), and it is the release
of inhibitory neurotransmitter (both spontaneous and evoked) rather
than its synthesis which is impaired (Curtis & DeGroat, 1968;
Fedinec & Shank, 1971; Osborne & Bradford, 1973).
The toxin has been shown to block neurotransmission at a number of
different sites in the central nervous system, including pre- and
post-synaptic inhibitory synapses where 8-aminobutyric acid (GABA)
is the transmitter (Curtis et al., 1973; Davies & Tongroach, 1979),
as well as post-synaptic inhibitory synapses utilising glycine
(Curtis & DeGroat, 1968). This indicates that tetanus toxin action
is not specific to a particular transmitter or to a particular type
of synapse. Indeed, although central inhibitory synapses are the
main target of the toxin, clinical observations and experiments
with in vivo administration of tetanus toxin show that the toxin
also affects peripheral neurotransmission, albeit with a lower
potency. Duchen & Tonge (1973) have shown the toxin to block
transmission at excitatory neuromuscular junctions in the mouse,
while Diamond & Mellanby (1971) have demonstrated the toxin-
sensitivity of the neuromuscular junction of the skeletal muscle in
the goldfish fin. A peripheral toxin effect has also been
demonstrated in the rabbit iris, where cholinergic parasympathetic
synapses are affected (Ambache et al., 1948). The relevance of
this peripheral blockade remains unclear, although studies on these
relatively simple peripheral systems might help us to understand
the complex central effects of the toxin. There is also some
experimental evidence for a direct action of tetanus toxin on the
autonomic nervous system (Paar & Wellhoner, 1973).
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The effects of the toxin are very long-lasting and indeed it seems
that, at least in the case of the neuromuscular junction, recovery
requires nerve-terminal sprouting and the formation of new synapses
(Duchen & Tonge, 1973). It is unclear whether this longevity of
toxicity is due to the continued presence of the toxin at the site
of action, or to an immediate action of the toxin with prolonged
sequelae.
In recent years, there have been several reports of tetanus toxin
action in vitro, e.g. on particulate preparations, synaptosomes and
cultured cells. Some experiments have shown a direct paralytic
effect of the toxin in vitro (e.g. Habermann et aI., 1980), while
others have concentrated on demonstrating the inhibitory effect of
tetanus toxin on the uptake and release of neurotransmitters (e.g.
Bigalke et al., 1978; Habermann et al., 1981; Bigalke et al., 1981;
Collingridge et al., 1981; Collingridge & Davies, 1982; Pearce et
al., 1983; Wendon & Gill, 1982). These kinds of neurophysiological
experiments serve to demonstrate that the toxin can exert its
effects in a wide variety of in vitro systems, but do not yield any
information on the mechanism by which inhibition of secretion is
achieved. It is also important to keep in mind that it is very
difficult to assess the relevance of this kind of experiment to the
in vivo situation; there may be substantial differences between
results obtained using in vitro systems and what occurs in vivo.
Recent experiments have been able to provide more useful
information about tetanus toxin action. Firstly, evidence has been
provided which strongly suggests that the toxin does in fact act
intracellularly to block secretion (up until recently this was only
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an assumption). This has come from the work of Penner et al.
(1986), who have demonstrated that intracellularly injected tetanus
toxin is able to strongly inhibit exocytosis in bovine adrenal
chromaffin cells. Further, experiments have been carried out which
indicate that it is the light chain of the toxin molecule which is
responsible for intracellular poisoning. Ahnert-Hilger et al.
(1989) have shown that when chromaffin cells permeabilised with
streptolysin 0 are incubated with solutions of the light chain, and
subsequently challenged with secretagogues, an inhibition of
exocytosis is observed. Also, in a series of very elegant
experiments, Mochida et al. (1990) have succeeded in expressing
exogenous mRNA encoding tetanus toxin light chain in Apl.vsia
neurones and demonstrating a subsequent inhibition of
neurotransmitter release.
Thus the predominant, although not the only, effect of tetanus
toxin in vivo is a preferential blockade of inhibitory
neurotransmitter release, resulting in a loss of activity of
inhibitory pathways acting on both °< and & motor neurone systems.
This causes hyperactivity of spinal cord motor neurones, which in
turn results in increased muscle tone and the dramatic spasms of
tetanus. It would appear that it is the light chain of the tetanus
toxin molecule which facilitates intracellular poisoning, but the
molecular mechanism responsible for this is not known. Various
proposals have been put forward, and these will be discussed
elsewhere in this thesis.
For more detailed reviews on the action of tetanus toxin, see
Mellanby & Green (1981); Habermann & Dreyer (1986).
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1.11 COMPARISON OF TETANUS TOXIN WTTH OfflER BACTERIAL TOXINS
Tetanus toxin may be compared with other bacterial protein toxins
on the basis of similarities in either toxin structure or the
nature of the toxin receptor; since the molecular basis of tetanus
intoxication remains unclear, comparisons with regard to the
mechanism of toxin action are not possible.
Of all the other bacterial toxins studied, it is not surprising
that those produced by Clostridium botulinum, a micro-organism
closely related to the causative agent of tetanus, show the
greatest similarity to tetanus toxin. The various strains of
C. botulinum produce at least eight different toxins, seven of
which (A, B, CI, D, E, F and G) are neurotoxins (botulinum C2 toxin
is not neurotoxic but cytotoxic, acting to ADP-ribosylate actin
(Aktories et a_Z., 1986) and so decreasing the ability of the
microfilament protein to polymerise). Like tetanus toxin, these are
produced as exotoxins formed in the bacterium mainly during the
stationary phase and are released upon cell lysis. They are
synthesised as single-chain polypeptides with a molecular weight of
150 kDa, and like tetanus toxin undergo a proteolytic cleavage to
yield a two-chain molecule consisting of a heavy chain (100 kDa)
and a light chain (50 kDa) held together by a disulphide bond.
Further, there is a marked similarity between the gene sequences of
the heavy and light chains of tetanus toxin and botulinum toxins A,
B and E (Eisel et al., 1986; DasGupta & Foley, 1989), suggesting a
common ancestral gene.
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However, it is not only at the structural level that tetanus and
botulinum toxins show common features. These molecules act in a
similar fashion as well, by blocking the evoked and spontaneous
release of neurotransmitters; the main difference lies in their
sites of action within the body. While the principal effect of
tetanus toxin is the blockade of central inhibitory mechanisms,
botulinum toxin has been shown to impair neuromuscular
transmission, so that tetanus characteristically involves
spasticity with convulsions, while botulism causes a generalised
flaccid paralysis. It seems possible that the mode of action of
both toxins at the molecular level might be similar, and that the
differences in their clinical effects are due to some as yet
undefined properties of the toxin molecules that determine which
synapses they act upon. (Originally, when it was found that
tetanus toxin bound fairly specifically to nervous tissue and that
this was apparently due to gangliosides, it seemed that it was this
that directed tetanus toxin towards the CNS; however, it has been
shown that botulinum toxin can also bind to nervous tissue
(Habermann & Heller, 1975), albeit less avidly than tetanus toxin,
so it is no longer thought that the synaptic specificity exhibited
by the two toxins is due to their different affinities for
gangliosides. Furthermore, botulinum toxin can also be transported
by retrograde axonal transport up motor neurones (Wiegandt &
Wellhoner, 1974), so this is not the explanation either.)
Tetanus toxin may further be compared to several other bacterial
toxins on the basis of similar structures or receptors. For
instance, the receptor for cholera toxin is also a ganglioside, in
this case the monosialoganglioside GM1. The structure of cholera
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toxin however, (which incidentally is similar to tetanus toxin in
that it also affects secretion across a cell membrane, causing
electrolyte and water losses from epithelial cells of the small
intestine) is quite different to that of tetanus toxin; it is
composed of two different types of subunit (five identical B
subunits and one A subunit). However, both toxins contain specific
parts (the heavy chain in tetanus toxin, the B subunit in cholera
toxin) responsible for binding to receptors; also, the A subunit of
cholera toxin is the active moiety, and similarly it would appear
that the light chain of tetanus toxin is the active part of the
molecule (see Section 1.10). These comparisons may also be made
between tetanus toxin and the heat-labile toxin of E. coli, since
the latter has the same subunit structure (Clements et al., 1980),
and indeed the same biological effects, as cholera toxin.
Structurally, the diphtheria toxin molecule, synthesised and
secreted by Corynebajcterium diphtheriae, is very similar to tetanus
toxin in that it is also composed of two chains linked by a
disulphide bridge. It has an A chain, which again is the active
part of the molecule, and a B chain, required for toxicity but
atoxic by itself, which presumably facilitates binding of the toxin
to the cell surface. Diphtheria toxin, like tetanus toxin, is
synthesised as a single polypeptide and must be nicked by a
protease to form the active molecule (van Heyningen, 1976b). This
structural similarity is also shared with exotoxin A of Pseudomonas
aeruginosa (Vasil et al., 1977).
A summary of the comparative features of bacterial toxins is
presented in Table 1.1.
-53-













































































1.12 THE ADRENAL CHROMAFFIN CELL
Mammalian adrenal glands, situated in the body just above the
kidneys, consist of two morphologically distinct tissues, the
medulla and the cortex, both of which may be observed following a
lateral section of a gland. The cells of the adrenal medulla
function to manufacture, store and secrete a mixture of hormones,
the most important of which is adrenaline; in the case of the
bovine adrenal medulla, approximately 75% of the cells produce
adrenaline, while only about 25% synthesise noradrenaline (these
numbers vary to some extent between species). These specialised
cells were termed chromaffin cells by Alfred Kohn at the beginning
of this century, owing to the chemical reaction of adrenaline with
chromium salts, which produces a yellowish-brown colour.
Chromaffin cells are closely related to sympathetic neurones,
sharing the same embryological origin in the neural crest. When
allowed to differentiate in vitro, they develop long axon-like
processes or "paraneurones". Like the neurones of the sympathetic
system, the adrenal medulla is controlled by nerves originating in
the spinal cord (see below), and its primary hormone, adrenaline,
is closely related to noradrenaline, the characteristic neuro¬
transmitter of the sympathetic nerves. Moreover, the adrenal
medulla itself secretes some noradrenaline, and it also releases
neurologically active neuropeptides (see below). The implications
of these similarities will be discussed further in Section 1.13.
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The catecholamine hormones of chromaffin cells are not stored as
free molecules in the cytosol, but are contained within subcellular
organelles known as chromaffin granules, small vesicles
approximately 0.3 ym in diameter, which may number up to 30,000 in
a single chromaffin cell. In addition to the catecholamines, these
granules contain several proteins, at a total concentration of
approximately 200 mg/ml; chromogranins A and B (which are as yet of
unknown function) are the major protein components in bovine cells
(Winkler et al., 1986), together with the enzyme dopamine-/?-
hydroxylase (which is involved in noradrenaline synthesis), and a
variety of derivatives of proenkephalin. Adrenaline and
noradrenaline (about 0.5 M), ATP (0.1 M) and ascorbate (which
serves as a co-factor for dopamine-/?-hydroxylase) are the major
small molecules. ATP, a very important granule constituent, serves
to maintain osmotic stability within the granule.
Chromaffin cells not only store all these compounds, but release
them as a mixture, by the process of exocytosis. These cells are
particularly suitable for the studv of exocytosis, since they are
readily available in a relatively pure form, and so their secretory
mechanism has been extensively researched. However, detailed
knowledge still remains sparse.
1.12.1 An Overview of Secretion
In exocytosis a vesicle moves towards the surface of the cell, the
vesicle membrane fuses with the plasma membrane, and the vesicle is
opened to the exterior of the cell. The entire content of the
vesicle is thereby emptied into the extracellular space. This is a
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very efficient mechanism of release; it delivers compounds to the
cell exterior at a much higher concentration than would be possible
if they were secreted from the cytosol.
Exocytosis from chromaffin cells in vivo is triggered by
stimulation of the splanchnic nerve, which provides cholinergic
innervation to the adrenal medulla from the sympathetic nervous
system. This stimulation evokes the release of acetylcholine from
nerve terminals synapsing on the chromaffin cells, which in turn
stimulates secretion from the chromaffin cells themselves. It is
believed that acetylcholine sets up a chain of events in which its
binding to a nicotinic acetylcholine receptor leads to the opening
of a receptor-linked Na+ channel, generating action potentials and
the opening of voltage-dependent Ca2 + channels. The resulting
increase in the intracellular concentration of Ca2 + is thought to
be the signal for secretion to begin; this is supported by the work
of Baker & Knight (1978) showing that, in a "leaky cell"
preparation, secretion can be triggered without a cholinergic
stimulus simply by raising intracellular Ca2+ concentrations to
micromolar levels. Just how this comes about, though, is not
clear.
In view of the fact that exocytosis is a Ca2+-dependent event, much
effort has gone into looking for Ca2+-dependent interactions of
chromaffin granules (or resealed granule membranes) with
cytoskeletal or cytosolic components, in an attempt to identify
some of the molecular events involved in secretion. For instance,
with respect to cytoskeletal components, it has been shown that
chromaffin granule membranes can bind F-actin (Fowler & Pollard,
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1982), and that at least part of this binding appears to result
from the presence of the actin-binding protein 0(-actinin on the
cytoplasmic surface of the granule membrane (Aunis et al., 1980).
The fact that non-muscle OC-actinins are calcium-sensitive with
respect to their ability to cross-link actin filaments (this being
inhibited by free Ca2+ levels of approximately 1juM; Burridge &
Feramisco, 1981) suggests that the interaction of granule membranes
with actin via o(-actinin could be Ca2+-sensitive. This is
consistent with a model in which Ca2 + -influx following stimulation
of intact chromaffin cells results in the release of chromaffin
granules from their association with an actin network; this release
may be necessary to allow granule movement to the site of
exocytosis. However, it must be remembered that these are
experiments conducted in vitro, and the question remains as to
whether or not chromaffin granules interact with actin in vivo.
Various cytosolic components have also been shown to interact with
chromaffin granules in vitro. Thus, Geisow & Burgoyne (1983) have
demonstrated that there are calmodulin binding sites (both Ca2+-
dependent and Ca2+-independent) present on the chromaffin granule
membrane. Binding of calmodulin to granule membranes results in
the stimulation of a calmodulin-dependent protein kinase and the
binding of other cytosolic proteins (see below). The high affinity
of these calmodulin binding sites and the level of Ca2+ required
for binding (Burgoyne & Geisow, 1981) are consistent with an
increase in the binding of calmodulin to the Ca2 + -dependent sites
following Ca2+ influx; this suggests that granule-bound calmodulin
may play a role at some stage of the secretory process, perhaps at
the level of fusion of granule and plasma membranes. Further
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evidence comes from the finding of Trifaro & Kenigsberg (1983) that
exocytosis is inhibited when antibodies against calmodulin are
microinjected into chromaffin cells.
As well as calmodulin, several minor cytosolic proteins also show
reversible Ca2 + -dependent binding to the cytoplasmic surface of
granule membranes (Geisow & Burgoyne; 1982,1983), suggesting that
they too become associated with the chromaffin granule membrane in
vivo following stimulation. The binding of several of these
proteins to the granule membrane appears to depend on the presence
of calmodulin; however, the functions of these proteins are as yet
unknown.
The requirement of Mg-ATP for secretion suggests the possibility
that protein phosphorylation may also be involved in exocytosis;
however, it is not clear whether or not this is the case.
Examination of protein phosphorylation in chromaffin granule
membrane fractions (Burgoyne & Geisow, 1981) has shown that the
granule membrane contains an endogenous calmodulin-dependent
protein kinase (activated half-maximally at around 5 pM Ca2 +) which
phosphorylates various granule membrane polypeptides; whether the
phosphorylation of any of these proteins is regulated during
secretion, however, is not yet known. Similarly, experiments
examining the effects of a phorbol ester on secretion from leaky
chromaffin cells have suggested the possible involvement of protein
kinase C in exocytosis (Knight & Baker, 1983a), since the phorbol
ester was seen to increase the sensitivity of exocytosis to Ca2+ ;
however, the identity of the substrate for protein kinase C,
involved in the regulation of exocytosis, is unknown.
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On the basis of these findings, then, it is possible to construct a
hypothetical scheme of some of the events involved in secretion
from chromaffin cells. The scheme suggests that the translation of
a rise in intracellular Ca2 + levels into an exocytotic event
involves, at least in part, the dissociation of actin filaments
from granules, the binding of calmodulin and other cytosolic
granule-binding proteins to granules, and phosphorylation of some
granule membrane proteins. It remains to be determined if any or
all of these events are indeed essential aspects of the secretory
process.
1.13 AIMS OF THE PROJECT
From the preceding discussion, it is clear that adrenal medullary
chromaffin cells provide an ideal system in which to study
exocytotic mechanisms. Further, since both chromaffin cells and
sympathetic neurones synthesise and store catecholamines, and
release them in response to cholinergic stimulation, it is not
unreasonable to regard the chromaffin cell as a model of the
neurone. Indeed, much has been learnt about the production and
secretion of neurotransmitters through studies of the chromaffin
cell. Also, as already mentioned, chromaffin cells cultured in
vitro develop axon-like "paraneurones", so in this respect they are
perhaps a better model of neuronal cells than many preparations of
more directly neuronal origin that lose the ability to behave in
this way when cultured in vitro.
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It is also apparent that tetanus toxin interferes with
neurotransmitter release at certain inhibitory synapses in the
central nervous system. There is no reason to believe that the
mechanism of this release in one type of nerve cell is any
different to that operating in any other type of neurone, or,
indeed, in other secretory cells. It seems probable that tetanus
toxin could inhibit secretion in a variety of cell types, provided
that the toxin could gain access to them.
This cell system has previously been used to investigate the
inhibition of secretion by various neurotoxins. One of the first
reports of an effect of toxins on secretion from chromaffin cells
came in 1985, when it was shown that both basal and evoked
secretion were inhibited by 50% or more after pre-incubation for up
to several days with botulinum toxins A, B and D (Knight et aI.,
1985; Knight, 1986). At about the same time, Figliomeni & Grasso
{1985) reported that tetanus toxin inhibited catecholamine release
from PC12 cells (phaeochromocytoma cells, a permanent cell line
derived from a rat adrenal tumour), while Penner et al. (1986)
demonstrated depressed exocytosis from chromaffin cells following
intracellular injection of tetanus toxin. More recently
neosurugatoxin, from the Japanese ivory mollusc, has been shown to
inhibit catecholamine release (Bourke et al., 1988), while it has
also been reported that pertussis toxin facilitates this process
(Tanaka et al., 1987).
Thus the main aim of this project was to investigate the
interaction between tetanus toxin and the intact adrenal chromaffin
cell. It was thought that the chromaffin cell would provide an
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excellent model system for studying the effect of tetanus toxin on
its target cell; they are available in a relatively pure form and
are more accessible to biochemical investigation than sympathetic
neurones, which are widely distributed throughout the body.
Further, expertise in primary culture of chromaffin cells was
already available in the department. Some preliminary work in the
laboratory had suggested that there might be some effect of tetanus
toxin on secretion from intact chromaffin cells, so the project was
aimed firstly at confirming this, and then characterising this
effect. Once it had been established that tetanus toxin was indeed
capable of inhibiting exocytosis from these cells, the binding of
the toxin to the cells was to be investigated and characterised as
far as possible, and its similarity to binding to neurones
assessed. Binding was to be studied by various techniques,
including direct binding studies with radiolabelled tetanus toxin,
and immunocytochemical methods. The project also aimed to analyse
toxin-binding to chromaffin cells at a more biochemical level, by
extracting various components from cell membranes and investigating
the interaction, if any, of toxin with these components. It was
also anticipated that internalisation of the toxin by chromaffin
cells could be demonstrated, using either biochemical or
immunocytochemical methods. Finally, we hoped that the results
obtained from this work would enable us to decide one way or the
other whether the chromaffin cell is indeed a suitable neuronal






Tetanus toxin was the kind gift of Dr N.F. Fairweather, Wellcome
Biotechnology Ltd, Beckenham, Kent, and also of Dr E. Habermann,
Buchheim Institut fur Pharmakologie der Justus-Liebig-Universitat,
Giessen, West Germany. It was prepared using the method of
Ozutsumi et a1. (1985). Briefly, cells from 10 1 of a 3-day
culture of C. tetani were collected by centrifugation and lysed in
1 M NaCl, 0.1 M sodium citrate; after removal of cell debris, the
toxin was precipitated with 40% ammonium sulphate, resuspended in
0.1 M sodium/potassium phosphate buffer, pH 7.5 and freeze-dried.
The toxin from Wellcome was almost entirely in the single-chain
form as judged by polyacrylamide gel electrophoresis in SDS (see
Fig. 3.2), while the Giessen toxin was predominantly in the nicked
form. Because of its high toxicity, great care was taken in
handling the toxin; all glassware and surfaces that became
contaminated were washed immediately in dilute acid, which destroys
the toxin very rapidly.
Radiolabelled iodine (Na125I, from Amersham International, Little
Chalfont) was generously supplied by the Radioimmunoassay Section,
Department of Clinical Chemistry, University of Edinburgh. Iodogen
was from Pierce & Warriner (UK) Ltd., Chester.
Standard gangliosides, collagenase, protease (type XIV),
neuraminidase, adrenaline bitartrate and noradrenaline bitartrate
were obtained from Sigma Chemical Co., Poole, Dorset.
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Thin-layer chromatography plates were obtained from BDH Ltd, Poole,
Dorset, or Camlab (Cambridge).
For tissue culture, Dulbecco's Modified Eagle Medium, foetal calf
serum, gentamycin, penicillin/streptomycin and fungizone were
purchased from Gibco Ltd., Paisley, Scotland; cytosine arabinoside
was obtained from Aldrich Chemical Co., Gillingham, Dorset;
deoxyribonuclease and fluorodeoxyuridine were purchased from Sigma
Chemical Co., Poole, Dorset; Percoll was obtained from Pharmacia
Ltd., Milton Keynes.
Multiwell tissue culture plates (24- and 96-well) were from Gibco
Ltd., Paisley, Scotland; petri dishes and culture flasks were
obtained from Beeton Dickinson Ltd. , Oxford.
All antibodies were purchased from Sigma Chemical Co., Poole,
Dorset, with the exception of the human anti-tetanus antibody,
which was a gift from the Scottish National Blood Transfusion
Service, Edinburgh.
Phosphate-buffered saline routinely used had the following
composition: 154 mM NaCl, 1.9 mM NaH2P04, 8 mM Na2HP04, 3 mM KC1,
pH 7.4.
All other reagents were of analytical grade.
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2.2 METHODS
2.2,1 Isolation and Culture of Adrenal Chromaffin Cells
Bovine adrenal medullary chromaffin cells were isolated essentially
by the method of Knight & Baker (1983b), with minor modifications.
All solutions used in the isolation procedure were either obtained
sterile or were prepared in deionised water and sterilised by
filtration, and all glassware was autoclaved prior to use. Usually
four glands were processed at one time.
Fresh, intact adrenal glands were obtained from the local slaughter
house and transported at ambient temperature to the laboratory in
calcium- and magnesium-free Krebs-Ringer buffer (145 mM NaCl, 5 mM
KC1, 1.2 mM Nath PO4, 10 mM glucose, 20 mM HEPES, pH 7.4) containing
50 units/ml penicillin and 50 jug/ml streptomycin. After removal of
adhering fat, each gland was perfused with 20 ml of buffer to flush
out red blood cells and tissue debris; this was achieved by
applying gentle pressure to a buffer-filled syringe introduced into
the adrenal vein. Proteolytic digestion was then carried out using
a 0.2% solution of protease (Sigma Type XIV) in Krebs-Ringer
buffer; 5 ml was injected into each gland through the adrenal vein,
and the glands incubated in a 37°C water bath for 15 minutes. The
whole digestion procedure was carried out a second time, and the
glands were then sliced laterally and the medullae dissected out
and minced finely in a petri dish with a small amount of buffer.
The material was then transferred to a 75 cm2 tissue culture flask,
gassed thoroughly with a mixture of 95% 02/5% CO2 , and incubated,
with shaking, in 50 ml of Krebs-Ringer buffer containing 0.1%
collagenase and 15 ^jug deoxyribonuclease (Type I) per ml for 20
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minutes. After filtration through 250 jjm nylon mesh (or
alternatively, muslin cloth), dissociated cells were collected by
centrifugation at 1000 r.p.m. for 10 minutes in a bench centrifuge,
then resuspended in Krebs-Ringer buffer, filtered through 85 yum
nylon mesh and centrifuged again at 1000 r.p.m. for 10 minutes.
This was carried out twice, after which time the cells were
resuspended in 28 ml of Dulbecco's Modified Eagle Medium (DMEM) ,
and mixed with 25 ml of balanced salt-Percoll (prepared by mixing 9
volumes of Percoll with 1 volume of lOx Krebs-Ringer buffer, and
adjusting to pH 7.4 with 2.0 M HC1). The cell suspension was
placed in sterile polycarbonate centrifuge tubes with caps and
centrifuged at 21,000 g (15,000 r.p.m., 50.2 Ti rotor) for 20
minutes (Wilson & Viveros, 1981). The chromaffin cell fraction was
then collected by aspiration, washed twice by centrifugation in
DMEM and finally resuspended in plating medium (DMEM containing
20 mM HEPES, 2% foetal calf serum, 100 units/ml penicillin, 100
^ug/ml streptomycin, 50yug/ml gentamycin, 0.25 jag/ml fungizone,
25 /ig/ml fluorodeoxyuridine, 50 /og/ml ascorbic acid (pH 7.4) and
3 ^Mg/ml cytosine arabinoside). Cells were counted in a
haemocytometer, their viability being estimated using trypsin blue;
this was usually greater than 90%. The cells were then diluted in
plating medium to yield 0.5 x 106 cells/ml (for transfer to 24- or
96-well tissue culture plates) or 0.3 x 106 cells/ml (for transfer
to petri dishes containing cover slips). After plating, cells were
incubated at 37°C in a humidified atmosphere containing 5% CO2 , and
were generally used for experimental purposes within three to six
days of preparation. The yield from this preparation procedure was
typically 50 x 106 cells per gland.
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2.2.2 Preparation of Membranes from Adrenal Medullary Microsomes
The method of Gavine et al. (1984) was used in the preparation of
microsomal membranes from adrenal medullae. Bovine adrenal glands
(usually 15-20) obtained fresh from the local slaughterhouse were
kept on ice, then laterally dissected and the medulla scraped away
from the cortex with a scalpel and placed in ice-cold 0.3 M
sucrose, 20 mM HEPES-Tris pH 7.0. The medullae were then passed
through a steel mincer with holes of 2 mm diameter, and homogenised
in 8 volumes of ice-cold buffered sucrose (in a motor-driven
homogeniser with a loose-fitting teflon pestle) until no large
lumps of tissue remained. All subsequent procedures were performed
at 0-4°C. The homogenate was centrifuged at 800 g (3300 r.p.m.,
JA20 rotor) for 10 minutes, and the supernatant thus obtained
recentrifuged one more time under the same conditions; the
supernatant obtained here was then centrifuged at 20,000 g (16,000
r.p.m., JA20 rotor) for 20 minutes. This supernatant was then
centrifuged over a cushion of 1.4 M sucrose for 60 minutes at
160,000 g (45,000 r.p.m., 45Ti rotor). Membranes from the 0.3
M/1.4 M sucrose interface were collected using a Pasteur pipette,
diluted in 20 mM HEPES, pH 7.0 and centrifuged for 90 minutes at
160,000 g (45,000 r.p.m., 45Ti rotor). The pelleted membranes were
then taken up in approximately 2 ml of buffered sucrose (0.3 M),
and stored at -20°C until required, either for protein estimation
or ganglioside extraction (see Section 2.2.13).
In order to achieve some degree of fractionation of microsomal
membranes, an additional step was sometimes included in the
protocol, after collection of membranes from the 0.3 M/1.4 M
sucrose interface. The membranes were made 1.4 M in sucrose (using
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2 M sucrose stock, and determining sucrose molarity using a
refractometer), and 5 ml aliquots were then overlaid with 6.7 ml of
1.15 M sucrose, 6.7 ml of 0.85 M sucrose and 5 ml of 0.5 M sucrose
in 50.2Ti centrifuge tubes. These discontinuous sucrose gradients
were then centrifuged at 180,000 g (45,000 r.p.m., 50.2 Ti rotor)
for 60 minutes, after which time material at each interface was
recovered using capillary tubing attached to a peristaltic pump.
Each of the three membrane fractions thus obtained was then diluted
to a volume of 70 ml with 20 mM HEPES, pH 7.0 and centrifuged at
160,000 g (45,000 r.p.m., 45Ti rotor) for 60 minutes. Membranes
were finally resuspended in approximately 2 ml of buffered sucrose
(0.3 M), and stored at -20°C until required.
2.2.3 Preparation of Chromaffin Granules
A crude preparation of chromaffin granules was produced by the
method of Phillips (1974). An homogenate of adrenal medullary
material was made in the same way as outlined in Section 2.2.2,
diluted in 0.3 M sucrose, 20 mM HEPES-Tris pH 7.0 and centrifuged
at 1700 g (4,000 r.p.m., JA14 rotor) for 5 minutes to remove cell
debris. The supernatant thus obtained was then centrifuged at
18,500 g (14,000 r.p.m., JA14 rotor) for 30 minutes. The pellet
after this centrifugation consisted of a lower layer of chromaffin
granules with overlaying mitochondria; the latter were removed by
gently swirling buffer over the surface of the pellet. The
granules were then resuspended in buffered sucrose, homogenised
again and centrifuged at 18,000 g (15,000 r.p.m., JA20 rotor) for
20 minutes. Washing, resuspension and centrifugation was generally
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carried out a second time to give a visibly clean pellet of
granules, which was finally collected in approximately 5 ml of
buffered sucrose.
This "crude granule" fraction was then purified by centrifugation
on discontinuous Percoll gradients, composed of 4 ml 60% (bottom),
3 ml 45% (middle) and 4 ml 20% (top) Percoll (in 0.35 M sucrose,
20 mM HEPES-Tris pH 7.0) in 15 ml Corex tubes. 0.5 ml aliquots of
granules (10-20 mg protein/ml) were layered on top of the
gradients, which were then centrifuged at 11,000 g (12,000 r.p.m.,
JA20 rotor) for 20 minutes at 4°C. Purified chromaffin granules
were collected from the 60% Percoll region and the 60%/45% Percoll
interface, diluted in 0.35 M sucrose 20 mM HEPES-Tris, pH 7.0, and
recentrifuged at 18,000 g (15,000 r.p.m., JA20 rotor) for 20
minutes to remove the Percoll. The granule pellet was then
resuspended in a small volume of 0.35 M sucrose, 20 mM HEPES-Tris,
pH 7.0, kept on ice and used within a few hours.
2.2.4 Stimulation of Exocytosis From Adrenal Chromaffin Cells
Chromaffin cells were routinely tested after two days in culture
for their ability to release their granule contents by exocytosis,
using secretagogues such as nicotine. Medium was removed from
cells in 24-well plates by aspiration, and 1 ml of Locke's
solution, composed of 154 mM NaCl, 5.6 mM KC1, 5.6 mM glucose, 5 mM
HEPES, 2.2 mM CaCl2, 1.2 mM MgSCh , (Kilpatrick et al., 1980)
containing 10^uM nicotine was added to each well; cells were then
incubated for 10 minutes at room temperature, after which time the
supernatant was carefully removed, and stored at 4°C until assayed
for catecholamines. Cells were then lysed using 1 ml of Locke's
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solution containing 1% (w/v) Triton X-100, and collected for
determination of unreleased catecholamines. Basal release of
catecholamines was also measured, using cells incubated with
Locke's solution alone.
2.2.5 Fluorimetric Assay of Catecholamines
Catecholamines were assayed fluorimetrically using the
trihydroxyindole method of von Euler & Lisha.jko (1961). 0.5 ml
aliquots of supernatant or 0.2 ml aliquots of cell suspension were
adjusted to pH 6.2 with 0.1 ml of 0.1 M potassium phosphate buffer
(pH 6.2), and diluted to a final volume of 1 ml with distilled
water. Oxidation of catecholamines was carried out for three
minutes by the addition of 0.1 ml of 0.25% (w/v) potassium
ferricyanide (freshly prepared), then 2 ml of alkaline ascorbate
solution (4 M NaOH/ethylene diamine/2% ascorbic acid 9:0.2:1) was
added to each tube and mixed in thoroughly. Addition of the alkali
causes formation of strongly fluorescent trihydroxyindoles, which
are stabilised by including ascorbic acid and ethylene diamine in
the mixture. Blanks were prepared in the same way using Locke's
solution (both with and without 1% w/v Triton X-100). The
fluorescence of samples was then read after 15 minutes (but within
two hours) using a Perkin Elmer 300 fluorescence spectrophotometer
at two sets of wavelengths; (a) excitation 395 ran, emission 490 ran,
and (b) excitation 436 nm, emission 540 nm. Calibration was
carried out by using comparison with known adrenaline and
noradrenaline standards, which fluoresce with different intensities
at the two sets of wavelengths.
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Catecholamine content was calculated as follows:
Aa = fluorescence of 1 nmol of adrenaline at wavelengths a)
Ab = fluorescence of 1 nmol of adrenaline at wavelengths b)
Na = fluorescence of 1 nmol of noradrenaline at wavelengths a)
Nb = fluorescence of 1 nmol of noradrenaline at wavelengths b)
Noradrenaline (nmol) : y = (M.Ab/Aa) - N
(Na.Ab/Aa) - Nb
Adrenaline (nmol) : x = N - y.Nb
Ab
where M = sample fluorescence at 395/490 ran
N = sample fluorescence at 436/540 nm.
(The derivation of these equations is given in Appendix 1).
Results were corrected to give catecholamine content (nmol/ml) and
secreted catecholamines were expressed as a percentage of the total
catecholamine content of the cells. All release experiments were
carried out on triplicate wells.
This method allowed a differential estimation of noradrenaline and
adrenaline to be made by measuring the fluorescence of a single
sample at two different sets of wavelengths. Fluorescence readings
were found to be stable for at least two hours (after an initial
increase in the first 15 minutes), allowing many samples to be
processed simultaneously. Standards were always assayed in
triplicate, dilutions being made fresh each time from a stock
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solution (the concentration of the stock was adjusted by measuring
the absorbance at 280 rim of a 1/100 dilution, and using a molar
extinction coefficient (£) of 27 1 mol~1 cm-1; the stock
(approximately 10 mM) was then diluted accordingly to give a
working concentration of 1 mM).
2.2.6 Inhibition of Exocytosis by Tetanus Toxin
Plating medium was removed from cells in 24-well plates after
approximately three days in culture, and the cells were incubated
(in triplicate) at 37°C in DMEM containing different concentrations
of toxin (7 pM - 70 nM, equivalent to 1 ng/ml - 10 ^ug/ml) for
various times as indicated. After toxin incubation, the medium was
removed, the cells washed once with Locke's solution and then
stimulated with 10 uM nicotine, as outlined at Section 2.2.4.
2.2.7 Preparation of Fluorescent GT1
Fluorescent ganglioside was prepared by the method of Spiegel
(1985). Ganglioside GT1 (3 mg) was dissolved in 3 ml of 100 mM
sodium acetate buffer (pH 5.5) containing 150 mM NaCl and 2 mM
NalCh , and oxidised for 30 minutes at 0°C. The reaction was
stopped by the addition of 0.3 ml of 50% glycerol, and the solution
was dialysed extensively against water, then lyophilised. The
oxidised GT1 was then dissolved in 3 ml of PBS and, after addition
of Lucifer Yellow CH to 5 mM, the solution was incubated overnight
at 0°C and dialysed against PBS. The material was reduced with
10 mM NaCNBlb (15 minutes at 23°C), dialysed against distilled
water, and lyophilised. The modified GT1 was analysed by thin-
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layer chromatography (see Section 2.2.14), and visualised with
resorcinol reagent (see Section 2.2.15); it was also easily
detected on chromatograms under UV illumination.
2.2.8 Incorporation of Fluorescent GT1 into the Chromaffin Cell
Membrane
The method of Spiegel et a1. (1984) was used for studying the
incorporation of fluorescent ganglioside into chromaffin cell
membranes. Cells cultured on coverslips were washed extensively
with Locke's solution (see Section 2.2.4) to remove any serum-
containing medium which would interfere with ganglioside uptake by
the cells, then incubated in serum-free medium containing GT1-
Lucifer Yellow (0.25 jug/ml) for various times at 37°C in a
humidified incubator. The coverslips were then thoroughly washed
in Locke's solution, and the cells fixed in 10 mM PBS containing
3.7% formaldehyde and 5% sucrose for 60 minutes. After further
washing in Locke's solution, coverslips were mounted in 50%
glycerol and the cells examined for fluorescence using a Leitz
Ortholux 2 microscope. Fluorescence of single cells was measured
using the photometer of a Leitz Vario Orthomat 2 automatic
microscope camera, and compared with that of control cells
incubated with medium containing no fluorescent ganglioside.
2.2.9 Preparation of 1 25I-Labelled Tetanus Toxin
Radiolabelled tetanus toxin was prepared essentially by the method
of Salacinski et al. (1981), using the reagent 1,3,4,6-tetrachloro-
3«,6o(-diphenyl glycouril (Iodogen). Usually 100 jag. of toxin was
iodinated each time, using 0.5 mCi of Na125 I.
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Iodogen (1 mg) was dissolved in 2 ml of chloroform, and 200 jal of
this solution dispersed in the bottom of a small glass vial. The
solution was then evaporated to dryness at room temperature under
nitrogen; this removed the chloroform to produce a film of Iodogen,
ensuring that the Iodogen did not form a suspension, which could
give variable iodinations. These dried vials could be stored for
up to six months at -20°C.
Prior to iodination, the coated vial was rinsed with buffer
(usually PBS, pH 7.2), then the toxin* was added (100 pg in 0.1 ml
of 0.15 M potassium phosphate buffer, pH 6.5), followed by Na125 I
(0.5 mCi, 11 ^/uM, 5jul). The iodination was allowed to proceed for
15 minutes at room temperature, then terminated by decanting the
reaction mixture. To separate iodinated protein from free iodide,
the mixture was centrifuged through a Biogel P6-DG column (packed
in an Eppendorf tube) at 1400 r.p.m. in a bench centrifuge for one
minute; 125I-labelled tetanus toxin was eluted, while free 125I-
remained on the column. The radiolabelled toxin was stored at 4°C,
and 0.25% bovine serum albumin was added to increase its stability.
Protease inhibitors were also added, to the following final
concentrations: benzamidine (5 mM), 6-aminohexanoic acid (10 mM),
EDTA (10 mM), N-ethyl maleimide (1 mM) and freshly prepared
phenylmethylsulphonylfluoride (1 mM).
* Tetanus toxin was generally supplied to our laboratory as a
10 mg/ml solution in 1.5 M potassium phosphate buffer, pH 6.5.
For iodination, 10 yul of this solution was diluted to 0.1 ml
with double-distilled water.
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2.2.10 Binding of 125I-Labelled Tetanus Toxin to Chromaffin Cells
Measurement of binding of radiolabelled tetanus toxin to chromaffin
cells was performed essentially by the method of Staub et al.
(1986). Growth medium was removed from cells cultured for 5-7 days
in 96-well tissue culture plates, and the cells in each well washed
twice with 200 ^ul of ice-cold rinse buffer (either 0.25 M sucrose,
20 mM Tris-HCl, 1 mM CaCl2, 1 mM MgCl2 , pH 6.0 (low ionic strength
buffer), or 0.25 M sucrose, 20 mM Tris, 1 mM CaCl2, 1 mM MgCl2 ,
30 mM NaCl, pH 7.4 (high ionic strength buffer), as indicated in
the text). Cells were then incubated for three hours (unless
otherwise indicated) at 0°C in 100 jj.1 of binding buffer (rinse
buffer supplemented with 2.5 mg/ml BSA) containing 0-20 nM 12 51-
labelled tetanus toxin; incubations were carried out in triplicate.
After toxin incubation, the radioactive medium was removed, and
cells were washed three times in ice-cold rinse buffer, before
being lysed in 200 ^il of 0.5 M NaOH. The resulting cell lysates
were then carefully transferred to test-tubes and their
radioactivity determined using a 2f-radiation counter (with a
counting efficiency of 83%). Non-specific toxin binding was
determined by incubating cells with radiolabelled toxin in the
presence of a 100-fold excess of unlabelled toxin.
For investigating the effect of exogenously added gangliosides on
the toxin-binding capacity of chromaffin cells, the cells were
incubated in serum-free medium containing 25 yug/ml of the specified
ganglioside for two hours at 37°C, then washed extensively with
ice-cold rinse buffer, prior to toxin addition. Similarly, when
evaluating the effect of neuraminidase or trypsin treatment on
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toxin binding, cells were pre-incubated with the enzymes prior to
addition of toxin (0.1 IU/ml neuraminidase for one hour at 37°C, or
25 ^ug/ml trypsin for 10 minutes at 37°C).
2.2.11 Binding of 1251-Labelled Tetanus Toxin to Chromaffin
Granules
The method of Lazarovici et al. (1989) was used to measure tetanus
toxin-binding to chromaffin granules. Fresh granules (prepared as
outlined in Section 2.2.3) were assayed for protein, then diluted
in 0.32 M sucrose, 25 mM Tris-HCl pH 7.4 to achieve a final protein
concentration of 3.6 mg/ml. Aliquots of 50 yul were then pippetted
into Eppendorf tubes (pre-coated with bovine serum albumin to
reduce binding of toxin to the plastic), and 50 ^ul of radiolabelled
toxin (0-40 nM in 0.32 M sucrose, 25 mM Tris-HCl pH 7.4) was added
to each tube to give final toxin concentrations in the range
0-20 nM. The granules were then incubated in suspension with the
tetanus toxin for 2 hours at 4°C; incubations were performed in
triplicate. After 2 hours, the suspensions were centrifuged for 5
minutes in a microfuge at maximum speed (13,000 r.p.m.) and the
supernatants removed by aspiration. The pellets were washed with
incubation buffer and recentrifuged; this was carried out a second
time to ensure adequate washing. After aspiration of the
supernatant, the radioactivity bound to the pellets was measured in
a ^-counter.
2.2.12 Internalisation of Tetanus Toxin by Chromaffin Cells
The protease assay of Staub et al. (1986) was used to investigate
possible internalisation of 125I-tetanus toxin by chromaffin cells.
Cells grown in 24-well tissue culture plates were washed with 2 ml
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of rinse buffer (pH 7.4; see Section 2.2.10), and then incubated in
triplicate with 2 nM 12 5I-labelled tetanus toxin in 1 ml of binding
buffer (pH 7.4) for three hours at 0°C or 37°C. The incubation
medium was then removed by aspiration, and the cells washed three
times with 2 ml of rinse buffer. Cells were then incubated at 37°C
for 10 minutes in 1 ml of rinse buffer containing either 0, 5, 20
or 100 ^ig/ml of pronase; proteolytic activity was stopped by the
addition of 100 yul of an inhibitor cocktail containing 1 mM PMSF,
1 mM benzamidine and 5 mM 3-aminocaproic acid. After gentle
washing three times with 2 ml of rinse buffer, cells were lysed
in 1 ml of 0.5 M NaOH, and their radioactivity counted using a ir¬
radiation counter.
2.2.13 Isolation of Gangliosides from Membrane Fractions
Preparation of gangliosides from chromaffin cell membrane fractions
was carried out using the procedure of Svennerholm & Fredman
(1980). Membranes, in 0.3 M sucrose, 20 mM HEPES pH 7.0, were
homogenised for two minutes with a Potter-Elvehjem homogeniser, and
the homogenate poured into 10.8 ml of methanol at room temperature
under constant stirring. 5.4 ml of chloroform was then added to
the mixture, which was left to stir for 30 minutes at room
temperature. Following this, the mixture was centrifuged at 2000 g
(5000 r.p.m., JA20 rotor) for 30 minutes at 4°C, and the
supernatant removed and saved. The pellet was re-extracted once by
homogenisation in 2 ml of distilled water, then poured into 8 ml of
chloroform/methanol (1:2) and left to stir for a further 30 minutes
at room temperature; centrifugation was then performed as before.
The two supernatants were then combined in a separating funnel, and
distilled water added to achieve a final chloroform/methanol/water
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(+tissue) ratio of 1:2:1.4. The solvents were carefully mixed by
turning the funnel up and down several times (shaking was omitted
to prevent emulsification), and the phases left to separate
overnight. After separation, the lower phase was removed and the
upper phase set aside; 0.5 volumes of methanol was then added to
the lower phase, followed by 0.22 volumes of 0.01 M KC1 (in water).
After thorough mixing, phases were separated by centrifugation at
2000 r.p.m. in a bench centrifuge for 10 minutes and the upper
phase removed. The two upper phases were then combined and
evaporated to dryness, after addition of 10 ml of isobutanol to
prevent foaming. The dried residue was taken up in 2 ml of
distilled water, sonicated for 5 minutes, and then dialysed
extensively against distilled water over a 3-4 day period (with
several changes of water). The dialysed material was then
lyophilised, redissolved in 500 ul of chloroform/methanol (2:1) and
stored at -20°C until required.
2.2.14 Thin-Layer Chromatography of Gangliosides
Chromatographic separation of ganglioside species was carried out
using a modification of the method of Dreyfus et al. (1975).
Gangliosides, dissolved in chloroform:methanol (1:1 v/v), were
applied as thin streaks to precoated silica gel thin-layer plates
(0.25 mm thickness), and the plates developed in chloroform:
methanol:0.02% CaCl2 (60:40:10 v/v) in a saturated chamber. After
development, plates were air-dried and then subjected to one of
three treatments:
i) overlaying with radioactive tetanus toxin (see
Section 2.2.16);
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ii) spraying with resorcinol reagent, a specific stain
for sialic acid residues (see Section 2.2.15); or
iii) exposure to iodine vapour, a non-specific stain for
double bonds, which will therefore stain all lipids.
2.2.15 Sialic Acid Assay
The yield of gangliosides from each isolation was measured with the
assay of lipid-bound sialic acid using the resorcinol method of
Svennerholm (1957). Aliquots of the lipid extract, containing 10-
30 nmol of sialic acid were added to pyrex tubes and made up to a
volume of 2 ml with distilled water; standards, in the range 0-30
nmol sialic acid, were prepared in the same way. To each tube was
added 2 ml of resorcinol reagent (10 ml of 2% aqueous resorcinol,
added to 80 ml of concentrated HC1 containing 0.25 ml of 0.1 M
CuSQi , and made up to 100 ml with distilled water); tubes were then
capped securely and heated for 15 minutes in a boiling water bath.
The tubes were then cooled quickly in an icebath, the chromogen
extracted with 4 ml of butyl acetate/butanol (85:15 v/v) (Miettinen
& Takki-Luukkainen, 1959), and the solvent mixture centrifuged at
500 r.p.m. in a bench centrifuge for 5 minutes. The absorbance of
the upper organic phase was then read at 580 nm.
The same resorcinol reagent was used in the detection of
gangliosides separated on TLC plates. Developed plates were air-
dried, sprayed with the reagent and then sandwiched between two
glass plates before being incubated at 110°C for 15 minutes, or
until ganglioside spots appeared.
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2.2.16 Ganglioside Overlay with 125I-Labelled Tetanus Toxin
Binding of 12 5I-labelled tetanus toxin to gangliosides on TLC
plates was performed using the method of Magnani et al. (1980),
with minor modifications. Chromatograms developed in the usual
manner (see Section 2.2.14) were air-dried, and then soaked in
40 ml of pre-chilled phosphate-buffered saline (0.15 M NaCl, 10 mM
sodium phosphate, pH 7.2) containing either 1% polyvinylpyrrolidone
and 0.2% BSA, or 1% BSA and 0.2% Tween (as indicated), to decrease
non-specific binding of tetanus toxin. The plates were shaken in
this solution for approximately one hour, then placed in fresh
buffer containing 10® cpm/ml of 125I-labelled tetanus toxin and
incubated for a further 60 minutes. The radioactive medium was
then carefully pipetted off, and the chromatograms given several
quick rinses with PBS. Further washing was carried out over the
next 4-5 hours (with the rinse buffer being renewed approximately
every 30 minutes); chromatograms were then air-dried, wrapped in
clingfilm and exposed to X-ray film for 1-4 days as outlined in
Section 2.2.20.
2.2.17 Immunocytochemistry
Chromaffin cells cultured on glass coverslips were used for immuno-
cytochemical experiments. The typical procedure is outlined here;
variations and additional steps are as described in the text.
After 5-7 days in culture, cells on coverslips were washed twice
with PBS and then incubated with tetanus toxin (10 ^jg/ml in the
specified buffer) for at least three hours at 4°C. After thorough
washing with PBS (3x5 minute washes), cells were fixed in 3.7%
formaldehyde in PBS for 10 minutes, followed by extensive washing
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with Tris-buffered saline (TBS; 150 mM NaCl, 10 mM Tris-HCl pH 7.4)
to wash out excess fixative. Cells were then incubated with a
1/100 dilution of human anti-tetanus antibody (IgG) in TBS/5% FCS
for 1 hour at room temperature. Coverslips were again washed
extensively with TBS, and then incubated for 3-4 hours at room
temperature with a 1/400 dilution of secondary antibody (either
alkaline phosphatase-conjugated goat anti-human IgG, or
biotinylated goat anti-human IgG) in TBS/5% FCS. After further
washing with TBS, cells treated with alkaline phosphatase-
con,iugated antibody were ready for incubation with chromogen, while
those treated with biotinylated antibody were first incubated for
one hour with a 1/300 dilution of streptavidin-horseradish
peroxidase (in TBS supplemented with 1 mg/ml BSA), prior to
incubation with chromogen. It should be noted that in each
experiment, controls omitting toxin, anti-tetanus antibody or
secondary antibody were routinely included.
2.2.17.1 Alkaline Phosphatase staining (Ormerod & Imrie, 1989)
5 mg of naphthol AS BI phosphate (sodium salt) were dissolved in
a few drops of dimethylformamide in a glass tube, and added to
5 mg of Fast Red TR salt dissolved in 10 ml of 20 mM Tris, pH
9.2. Levamisole, at 1 mg/ml, was also added to block endogenous
enzyme. The solution was filtered through glass fibre paper, and
coverslips were then incubated at 37°C for one hour or until
cells were sufficiently stained relative to controls. Coverslips
were then washed thoroughly in water, mounted in Uvinert mountant
(BDH) on glass microscope slides and examined using a Leitz
Ortholux 2 microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
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2.2.17.2 Horseradish Peroxidase staining (Graham & Karnovsky,
1966)
10 mg of 3,3',4,4'-diaminobenzidine was dissolved in 10 ml of
0.1 M Tris-HCl, pH 7.4. To this was added 0.3 ml of 1% NiCl2 (to
enhance staining) and 10 pi of 30% hydrogen peroxide. Cells were
incubated for 30 minutes in this solution, washed thoroughly in
TBS, then mounted and examined as above.
2.2.18 Determination of Protein
Protein was determined by one of two methods. The protein content
of membrane fractions and granule preparations was estimated by a
modification of the method of Bradford (1976). A stock solution
was first prepared by dissolving 100 mg of Coomassie Brilliant Blue
G in 50 ml of 95% ethanol, and adding 100 ml of 85% orthophosphoric
acid. 18 ml of this stock solution was then diluted to 100 ml with
distilled water, and filtered through Whatman No. 1 paper. For
protein estimation, 0.5 ml of sample (containing 10-50 ^ug of
protein) was added to 2.5 ml of the diluted Bradford reagent, and
the absorbance at 595 nm measured after 30 minutes. A standard
curve was constructed using bovine serum albumin.
Cell lysates were assayed for protein using a modified version of
the method of Markwell et al. (1978). 0.1 ml of lysate (containing
10-100 ^jug of protein) was made up to 0.5 ml with 0.5 M NaOH, and to
this was added 2 ml of reagent C, an alkaline copper reagent
(reagent C was made by mixing 100 parts of reagent A [2% Na2CO3,
0.4% NaOH, 0.16% sodium tartrate, 1% SDS] with 1 part of reagent B
[4% CUSO4.5H2O]). Samples were incubated at room temperature for
30 minutes, and then mixed vigorously with 0.2 ml of Folin-
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Ciocalteu phenol reagent, diluted 1:1 with water. The absorbance
of samples was read at 660 nm after 45 minutes. A standard curve
was constructed using bovine serum albumin dissolved in 0.5 M NaOH.
2.2.19 SDS-Polyacrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis was routinely carried out under
denaturing conditions by the addition of 0.1% (w/v) SDS in both the
separating and stacking gels. The gel and buffer system used was
based upon that of Laemmli (1970), with the addition of 2 mM EDTA
to chelate any metal ions which may interfere with the
polymerisation of acrylamide and cause aggregation of proteins
(Douglas & Butow, 1976). Protein samples were applied to the gel
and electrophoresed for one hour at 100 volts while the proteins
moved into the stacking gel, and then at 50 volts overnight. Gels
were fixed in 20% (v/v) methanol, 10% (v/v) acetic acid for 15
minutes, stained in 0.25% Coomassie Brilliant Blue R-250, 45% (v/v)
methanol, 9% (v/v) acetic acid for 15 minutes at 60°C, then
destained in 5% (v/v) methanol, 7.5% (v/v) acetic acid at 60°C
until the gel background was sufficiently clear. The addition of
pieces of polystyrene foam quickened the destaining process by
absorbing the dye.
For determination of molecular masses, gels were calibrated with
the following standard proteins: bovine erythrocyte carbonic
anhydrase (29 kDa), egg albumin (45 kDa), bovine serum albumin
(66 kDa), rabbit muscle phosphorylase b subunit (97.4 kDa),
E. coli -galactosidase subunit (116 kDa) and rabbit muscle myosin
subunit (205 kDa). These proteins were supplied as a high
molecular weight standard mixture from Sigma Chemical Co.
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2.2.20 Autoradiography
Polyacrylamide gels containing 125I-labelled tetanus toxin, after
destaining, were dried using a Bio-Rad model 443 slab gel dryer
onto Whatman 3 mm filter paper under vacuum for 1 hour at 80°C.
Before drying, gels were covered with Saran Wrap, a non-porous
plastic film. Once dried, the gels were exposed to Agfa-Gevaert X-
ray film in a Dupont Cronex cassette containing "lightning plus"
intensifying screens, and left at -70°C for 1-4 days, depending on
the amount of radiolabel present; overlaid thin-layer chromatograms
were exposed under the same conditions. Films were developed
automatically using a Fuji RG 11 X-ray film processor.
2.2.21 Blotting of Proteins onto Nitrocellulose
Proteins separated by polyacrylamide gel electrophoresis were
transferred to nitrocellulose sheets essentially by the method of
Towbin et al. (1979). A sheet of nitrocellulose (0.45 jum pore
size) was wetted with water and laid on a Scotch-Brite pad
supported on a plastic grid. The gel was placed on the
nitrocellulose, care being taken to remove any air bubbles trapped
between the two layers. Another pad and plastic grid were added
and the "sandwich" was firmly clipped together so that the gel was
firmly and evenly pressed against the nitrocellulose. The assembly
was put into an electrophoretic blotting tank containing electrode
buffer (25 mM Tris, 192 mM glycine, pH 8.3), with the nitro¬
cellulose facing the anode. A voltage gradient of 6V/cm was then
applied for one hour.
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CHAPTER THREE.
INHIBITION BY TETANUS TOXIN OF EXOCYTOSIS
FROM CULTURED ADRENAL CHROMAFFIN CELLS
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3.1 INTRODUCTION
As discussed in Section 1.10, it has become well established that
the primary action of tetanus toxin in vivo is an inhibition of
neurotransmitter secretion from certain synapses; the mechanism of
this inhibition, however, remains unknown. This situation has
largely arisen because of the limitations imposed by the gross
anatomy of the toxin's target neurones; they are widely distributed
throughout the body, making them relatively difficult to isolate
and culture in vitro.
However, it should not be assumed that this is the only site where
the toxin can exert its effects. Indeed, as discussed earlier, it
does not seem unreasonable to suppose that tetanus toxin could
inhibit secretion from a wide variety of cell types, provided that
the toxin could gain access to them. In support of this idea, Ho &
Klempner (1985) have pointed out the similarities between neuronal
neurotransmitter release and stimulation-secretion in phagocytes,
and have demonstrated a dose-dependent inhibition of secretion of
lysosomal contents from human macrophages by tetanus toxin. While
this clearly indicates the potential of tetanus toxin to act as an
inhibitor of secretion in a wide variety of cell types, not
necessarily neuronal, the question must always be borne in mind:
"how relevant is the action of tetanus toxin on these cells to
neurotoxicity?" Clearly, a cell-culture model of neuronal origin
would be more appropriate for studying the mechanism of toxin
action. According to Wellhoner & Neville (1987) a model system
should "consist of only one type of cell of neuronal origin, the
quality of action of tetanus toxin should be in the inhibition of
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the stimulated transmitter release, and cells should be sensitive
to toxin concentrations comparable to those found in animals
suffering from tetanus".
The virtues of chromaffin cells for this kind of study have already
been discussed; indeed, experiments with chromaffin cells have
already provided some useful information on the action of tetanus
toxin (see Section 1.10). However, these studies have not been
carried out using "intact" chromaffin cells as such; either ceils
have been permeabilised with digitonin or streptolysin 0, or the
toxin has been introduced into the cell by microinjection, thereby
artificially bypassing the chromaffin cell membrane. To date there
have been no convincing reports of an effect of tetanus toxin on
exocytosis from intact chromaffin cells; Marxen & Bigalke (1989)
have reported a very slight inhibitory effect of tetanus toxin
(less than 10%) if offered in low ionic strength solution to
ganglioside-untreated chromaffin cells, but this is hardly a
significant result. On the other hand, there have been several
reports stating emphatically that tetanus toxin does not affect
exocytosis from intact chromaffin cells (e.g. Knight et al., 1985;
Bittner & Holz, 1988; Marxen & Bigalke, 1989).
However, some work carried out previously in our laboratory
indicated that there might in fact be some effect of tetanus toxin
on these cells. Since it is generally believed that the mechanisms
of botulinum toxin and tetanus toxin are virtually the same at the
molecular level, it was thought that the results obtained by Knight
and his coworkers (i.e. botulinum toxin effective at inhibiting
secretion from chromaffin cells, while tetanus toxin was
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ineffective) might be caused by the inability of tetanus toxin to
bind to and enter these cells. If this were the case, pre-
incubating chromaffin cells with gangliosides should introduce
binding sites; when ganglioside micelles are incubated with cells
in vitro, they are incorporated into the membrane and behave in all
known respects like endogenously synthesised lipid (see Section
4.3.2). This sort of experiment has been done often with cholera
toxin and GM1 (van Heyningen, 1983). Experiments showed that, as
expected, tetanus toxin inhibited nicotine-evoked secretion from
ganglioside-treated cells, but that there was also some
reproducible inhibition using cells not pre-treated with
ganglioside. The effect was more marked, however, when the cells
had been pre-incubated with ganglioside; in this case, an
inhibition of approximately 30% was achieved. Other workers have
similarly reported an enhancement of toxin effect following
incubation of cells with toxin-binding gangliosides (e.g. Marxen et
al., 1989; Marxen & Bigalke, 1989).
Thus this cell system seemed valuable for future work. It appeared
relatively easy to work with, and displayed one of the most marked
inhibitory effects of tetanus toxin so far reported. The aim of
the work presented in this chapter, then, was to confirm these
preliminary findings of an effect of tetanus toxin on intact
chromaffin cells, and to characterise this effect as much as
possible, with respect to time course, dose-dependency and so on.
It was also of interest to investigate whether single- and double-
chain forms of the toxin were equally active in producing this
effect, and to determine whether the toxin could inhibit secretion
evoked by different secretagogues. It was hoped that the results
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obtained would provide evidence that the chromaffin cell is indeed
a valid model system for studying the intoxication process of
tetanus.
Note: Much of the work presented in this chapter was carried out in
collaboration with Dr M.K. Bansal, Department of Biochemistry,
University of Edinburgh.
3.2 METHODS
3.2.1 Stimulation of Exocytosis from Chromaffin Cells
Release of granule contents from chromaffin cells by exocytosis was
evoked using secretogogues such as nicotine and Ba2+ ions, as
outlined in Section 2.2.4. Cells were routinely tested for their
ability to respond to these secretogogues prior to experiments
investigating the effect of tetanus toxin on this process.
3.2.2 Fluorimetric Assay of Catecholamines
Exocytosis from chromaffin cells was quantitated by measuring the
levels of catecholamines both released into the supernatant or
remaining intracellular, using the fluorimetric assay of von Euler
& Lishajko (1961), as described in Section 2.2.5.
3.2.3 Inhibition of Exocytosis by Tetanus Toxin
The effect of tetanus toxin on evoked secretion from chromaffin
cells was determined basically as outlined in Section 2.2.6, or
with modifications as described in the text. The toxin used was
almost entirely in the single-chain form, as judged by polyacryl-
amide gel electrophoresis in SDS (Fig 3.1).
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Figure 3.1 SDS-Polyacrylamide Gel Electrophoresis of Tetanus Toxin
Samples of toxin (10 jug) reduced with/S-mercaptoethanol
were subjected to electrophoresis as outlined in Section
2.2.19; bands were visualised by staining with Coomassie
Blue. Lane 1: molecular weight markers (kDa); Lane 2:
native tetanus toxin; Lane 3: toxin treated with trypsin
(see text for details).
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3.3 RESULTS AND DISCUSSION
3.3.1 Optimisation of Conditions for Stimulation of Secretion
Since the main objective of this work was to demonstrate an
inhibitory effect of tetanus toxin on exocytosis from chromaffin
cells, it was important first to establish conditions that promoted
optimal levels of secretion; obviously changes in the extent of
exocytosis occurring will be more evident if "control" levels are
high. The secretagogue of choice was nicotine (even though others
may evoke higher levels of secretion; see Table 3.1), the main
reason for this being that nicotine had been used in the
preliminary studies reported in Section 3.1.
Nicotine evokes exocytosis by binding to nicotinic acetylcholine
receptors in the chromaffin cell membrane, thus setting in motion
the chain of events described in Section 1.12.1. (Bovine
chromaffin cells have muscarinic cholinergic receptors also, but
only the nicotinic receptors are involved in acetylcholine-induced
secretion of catecholamines). High concentrations of K+ ions (e.g.
56 mM) cause direct depolarisation of the cell membrane, thus
facilitating movement of Na+ and Ca2 + ions, while veratridine is an
alkaloid which activates Na+ channels. The mechanism by which Ba2 +
ions stimulate secretion is not certain, but it is thought that
they may be able to permeate the cell membrane more readily than
Ca2+ (i.e. without the need for depolarisation), so that they can
gain access to the cell interior where they may be able to activate
secretion directly.
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Table 3.1 Exocytosis from Chromaffin Cells Evoked by Different
Secretogogues
Chromaffin cells were stimulated by incubation for 10
minutes in Locke's solution containing secretagogue.
Released catecholamines were then measured as described
in Section 2.2.5.
SECRETAGOGUE EVOKED RELEASE
(% of cell content)
Nicotine (10 ^juM) 7.8 + 0.7
Ba2+ ions (5 mM) 24.4 + 1.2
K+ ions (55 mM) 7.5 + 0.4
Acetylcholine (100 juM) 16.1 + 1.0
Veratridine (100 juM) 3.0 + 0.4
The values shown are typical of 3 independent
experiments. Variability between data obtained in
different experiments was less than 10%.
Students t-test: p < 0.01 for stimulatory effect of
nicotine, Ba2+ ions, K+ ions and acetylcholine on
catecholamine release; p< 0.05 for effect of
veratridine.
N.B. Evoked release = total release - basal release
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10 ^uM nicotine was found to be sufficient to evoke maximal levels
of secretion, as measured by release during a 10 minute incubation
(Fig. 3.2a); concentrations higher than this (up to 40yuM) did not
cause any further enhancement of the response. In similar
experiments, Kilpatrick et al. (1980) have found that nicotine
concentrations higher than 30 jjM may produce a sub-maximal response
as a result of receptor desensitisation. On investigating
the effect of different incubation times on evoked secretion, it
was found that approximately 65% of the maximal response was
achieved within five minutes, with a slow increase to maximal
levels of exocytosis after 10-15 minutes (Fig. 3.2b); presumably
receptor desensitisation is significant.
The effect of replacing the maintenance medium on levels of basal
and evoked secretion was also examined. Perhaps not surprisingly,
it was found that cells which had not recently been subjected to
medium replacement (i.e. within the 24 hours immediately prior to
experimentation) showed significantly lower levels of basal
secretion and higher levels of evoked secretion than cells which
had (Table 3.2). In accordance with this observation, Wilson &
Viveros (1981) have commented that chromaffin cells seem to thrive
better if the medium is not replaced too frequently; presumably
some kind of conditioning factor(s) is produced by the cells that
facilitates cell survival and maintenance of cell function.
To check for non-exocytotic release of catecholamines occurring
during experiments i.e. that due to "leakiness" of cells, the














































Figure 3.2 Optimisation of Catecholamine Secretion from Chromaffin
Cells
.
{at) Chromaffin cells were incubated for 10 minutes with
various concentrations of nicotine between 0-40 uM,.
(b) Chromaffin cells were stimulated with 10 uM nicotine
for various times up to 25 minutes. ; ,
Released categholamines were then measured as outlined
in Section 2.2.5; each result is the mean of 3 different
wells ± standard deviation. Results shown in each case
are typical of 2separate experiments; variability
between experiments in each case was less than 10%.
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Table 3.2 Effect of Medium Replacement on Levels of Exocytosis from
Chromaffin Cells
Catecholamine release was stimulated and measured as
outlined in Sections 2.2.4 and 2.2.5. Figures represent
the mean of 3 different wells + standard deviation.
CELL TREATMENT BASAL RELEASE EVOKED RELEASE
(% of cell content) (% of cell content)
Cells not subjected to
medium replacement 2.9 (+0.6)
Medium on cells
replaced 24 hours prior to 5.5 (+_ 0.9)
stimulation with nicotine
16.9 ■{ + 0.9)
12.2 (+ 0.5)
N.B. Evoked release = total release - basal release
The values shown are typical of two independent experiments;
Variability between data obtained in separate experiments was not
| more than 5%
Students t-test: p < 0.01 for effect of medium replacement on basal
j catecholamine release and evoked catecholamine release.
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dehydrogenase into the medium was measured (these assays were
carried out by Dr M.K. Bansal); negligible quantities of this
protein were found in the medium, confirming that the cells were
intact and that catecholamines present in the medium had been
secreted by exocytosis.
(In all experiments, Ca2+ was maintained at 2.2 mM, the optimal
concentration, as suggested by Fenwick et al. (1978).
3.3.2 Effect of Tetanus Toxin on Secretion from Intact Chromaffin
Cells
Table 3.3 shows the results of a preliminary experiment in which
the nicotine-evoked release of catecholamines from cells subjected
to various treatments was determined. The effect of tetanus toxin
10 ^ig/ml, 67 nM) on secretion from native chromaffin cells was
investigated, and the influence of ganglioside GT1 (50yug/ml, 33
yuM) on this effect was also examined. (It should be noted here
that cells incubated with tetanus toxin, when viewed under the
microscope, were indistinguishable from untreated cells, plated
down normally and excluded trypan blue, suggesting that cell
integrity was not affected by the toxin). The results indicate
that, as suggested by the earlier experiments, tetanus toxin does
have a significant inhibitory effect on catecholamine release from
intact, native chromaffin cells; treatment of these cells with
toxin for 24 hours at 37°C led to a 69% inhibition of evoked
exocytosis (there was little or no effect on basal secretion).
This inhibition was more marked when the cells had been pre-
incubated with ganglioside; under these conditions, evoked
exocytosis was reduced by 80%.
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However, if the toxin was pre-incubated with ganglioside GT1 and
the toxin-ganglioside complex then added to the cells for 24 hours,
exocytosis was completely abolished, suggesting that this preformed
complex was being taken up by the cells very efficiently. This
result was of interest since there had been no previous
demonstration of an in vitro effect of the toxin which could be
significantly enhanced by the introduction of gangliosides into the
cell membrane, and was clearly worth further investigation (see
Section 3.3.8).
3.3.3 Time Course of Inhibition of Secretion
Having observed an inhibition of exocytosis by tetanus toxin, we
next characterised the time course of this inhibition; the results
presented in Table 3.3 were obtained following a 24 hour incubation
of chromaffin cells with tetanus toxin, and it seemed reasonable to
assume that a shorter incubation time should be sufficient to
produce the same effect. Figure 3.3 shows that there was no
significant inhibition of secretion of catecholamines when
chromaffin cells were incubated with toxin for various times up to
6 hours; maximal inhibition, of 70%, was observed after 16 hours
incubation, and this was maintained during further prolonged
incubation. This incubation time is longer than has been observed
by some workers using PC12 cells (e.g. Sandberg et ai., 1989a),
where maximal levels of inhibition were reached within 4 hours, but
shorter than the three to six day incubation found by Marxen &
Bigalke (1989) for maximal inhibition by tetanus toxin of [3H]-
























INCUBATION WITH TOXIN (HOURS)
Figure 3.3 Time Course of Inhibition of Secretion from Intact
Chromaffin Cells by Tetanias Toxin
Chromaffin cells were incubated for various times up to
60 hours with tetanus toxin (70 nM) in DMEM. Medium was
then removed, the cells stimulated with 10 /jM nicotine
and released catecholamines measured as outlined in
Sections 2.2.4 and 2.2.5. Each result is the mean of 3
different wells + standard deviation.
Variability between data obtained in 3 independent,
replicate experiments was less than 10%.
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It is not possible from this type of experiment to determine which
stage of the intoxication process is responsible for this long time
course. Indeed, this is still an unanswered question; work with
PC12 cells has indicated that binding and internalisation are
relatively rapid events, and that this lag phase probably results
from steps that occur in the intracellular compartment after
internalisation (Sandberg et al., 1989a), while experiments with
permeabilised cells suggest that the intracellular action of the
toxin is rapid also (e.g. Bittner & Holz, 1988; Bittner et al.,
1989a).
3.3.4 Dose-Dependency of Toxin Inhibition of Secretion
Experiments were next carried out to determine the toxin
concentration dependence of inhibition. The dose-response curve
thus obtained (typical of several different experiments) is shown
in Fig. 3.4. When chromaffin cells were incubated for 16 hours in
the presence of increasing concentrations of native tetanus toxin,
catecholamine release was inhibited by up to 75% (the maximum
observed); the half-maximal effect was found at 0.7 nM toxin. It
is unclear why the remaining 25-30% of evoked release could not be
inhibited, but it is possible that this relates to the exocytosis
of those secretory granules already positioned close to the plasma
membrane, such that if, for instance, the toxin acts to inhibit the
movement of the granules to the cell surface, those already there
will not be affected. This incomplete inhibition has been noted by
other workers; Marxen & Bigalke (1989) were not able to achieve
higher than 80% inhibition using chromaffin cells pre-incubated
with ganglioside GT1, while Bittner et al. (1989b) and Stecher et
al. (1989) have reported similar findings with botulinum toxin A.
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Figure 3.4 Effect of Tetanus Toxin on Nicotine-evoked Catecholamine
Release from Intact Chromaffin Cells
Cells were incubated for 16 hours in the presence of
concentrations of tetanus toxin between 7 pM and 70 nM
in DMEM, then treated as described in Section 2.2.6.
Each result is the mean of three different wells ±
standard deviation.
The values shown are typical of 3 independent
experi men t.s; variability between data obtained in separate
experiments was not more than 10%.
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The concentrations of tetanus toxin that were found to inhibit
catecholamine release by intact chromaffin cells are comparable to
those found to be effective in PC12 cells (Sandberg et al., 1989a),
and are considerably lower than the concentrations found to be
required when the cells are permeabilised (Penner et al., 1986;
Bittner & Holz, 1988). The reason why a higher concentration is
needed when the cells are permeabilised is not clear, but receptor-
mediated endocytosis may be an important feature in the mechanism
of toxin action.
3.3.5 Reproducibility of Inhibition
Although this effect of toxin was seen in many of our experiments,
an inhibition of secretion was not always observed; only about half
of our cell preparations (of which there were about thirty) that
responded to secretagogue also showed sensitivity to toxin. It
should be stressed, however, that the inhibitory effect of the
toxin was observed on numerous occasions, and is undoubtedly a
genuine phenomenon. The data presented in the figures are
representative of the cells that responded, and depict the largest
responses seen, since the effectiveness of the toxin on different
cell preparations was all-or-nothing and not graded i.e. the cells
responded similarly to the results shown in the figures or not at
all.
The reasons for this inconsistency are not clear, but it may be
that some completely undiscovered property of the chromaffin cells
affects their response to toxin. It is perhaps worth pointing out
that Sandberg et al. (1989a) have reported that cultures of PC12
cells will only bind tetanus toxin with high affinity and therefore
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become sensitive to the toxin after treatment with nerve growth
factor; apparently the differentiation state of these cells is a
critical factor in determining their sensitivity to toxin. It is
not impossible that a similar explanation applies in the case of
chromaffin cells. Another reason for the observed lack of
consistency could be that the toxin-binding sites on the surface of
chromaffin cells are damaged by the enzymes used during the
isolation of the cells, and are not restored over the culture
period. As mentioned in Section 1.8.2, there have been several
reports of a trypsin-sensitive component in the toxin receptor on
nerve cells (e.g. Yavin & Nathan, 1986; Pierce et al., 1986), and
it is also well known that the responsiveness of chromaffin cells
to secretagogues such as nicotine can be impaired as a result of
collagenase digestion (Almazon et al., 1984).
As indicated above, other groups have not observed inhibition of
release from intact cells. It is likely that this is related to
the inconsistency of the cell preparations that we observe. It may
be relevant that, in our experiments, we measured release of
endogenous catecholamines directly using a fluorescent assay,
whereas other groups have measured the release of radioactive
catecholamines with which the cells have been preloaded. It is
well known that such loading with labelled catecholamine does not
label chromaffin granules uniformly; rather, the radioactive amine
is more readily released than endogenous amine.
It appears that the toxin has little or no inhibitory effect on
basal levels of secretion from chromaffin cells, which is somewhat
surprising since it is well established that tetanus toxin not only
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blocks evoked release of transmitter but is also able to block most
(if not all) of the spontaneous neurotransmitter release from the
synapses on which it acts. However, the precise mechanism of the
basal release that is always observed is unclear.
3.3.6 Effect of Trypsinisation of Toxin on Inhibition of
Secretion
The experiments reported thus far had been carried out using
tetanus toxin in its single-chain form (as judged by SDS-
polyacrylamide gel electrophoresis; see Fig. 3.1). To determine
whether the two-chain form was equally active at inhibiting
exocytosis, nicked toxin was prepared by proteolysis wih trypsin
(trypsin:toxin ratio 1:50) for 30 minutes at room temperature,
followed by addition of soybean trypsin inhibitor (2.5 ^jg/ml);
formation of the heavy and light chains was confirmed by gel
electrophoresis (see Fig. 3.1). Single-chain toxin and toxin
nicked with trypsin (both 70 nM) were subsequently found to be
equally potent, each causing approximately 65% inhibition of
nicotine-evoked release (Table 3.4), and so it would seem that if
there is any, the gain in toxicity by nicking is small. However,
it is possible that the originally intact toxin had been nicked
during the incubation by slight residual proteolytic activity in
the toxin preparation or in the cell culture; other workers (e.g.
Ahnert-Hilger et al. (1989), studying inhibition of Ca2+-stimulated
catecholamine release from permeabilised chromaffin cells) have
reported that the single-chain form of the toxin is ineffective,
and that chain separation, as well as reduction of the interchain
disulphide bridge, must precede inhibitory action on exocytosis (in
disagreement with the latter condition, however, is the report by
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Table 3.4 Effect of Trypsinisation of Tetanus Toxin on Inhibition
of Secretion
Chromaffin cells were incubated with or without 70 nM
toxin (native or trypsinised) in DMEM for 16 hours, and
then treated as described in Sections 2.2.4 and 2.2.5.
The toxin was nicked as outlined in the text. Each
result is the mean of 3 different wells +_ standard
deviation.
CELL TREATMENT SECRETION % INHIBITION
(% of cell content)
None (i.e. basal secretion) 4.5 ( + 0.3)
Nicotine stimulation 17.0 (± 0.9)
Native toxin, then nicotine 8.9 < + 0.5) 65%
Trypsinised toxin, then nicotine 9.1 (± 0.7) 63%
Trypsin*, then nicotine 18.9 (± 0.8) 0%
* Cells were exposed to trypsin itself (in the presence of excess
soybean trypsin inhibitor) to check for any effect of this
treatment on levels of secretion.
Results shown are typical of 2 separate experiments; variability
between data obtained in separate experiments was less than 10%
Students t-test: p < 0.01 for effect of toxin on nicotine-evoked
secret ion .
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Schiavo et al. (1990) that an intact interchain disulphide bond is
required for the neurotoxicity of tetanus toxin). Similarly,
Bittner et al. (1989b) report increased potency of botulinum toxins
B and E in inhibiting exocytosis from permeabilised chromaffin
cells following mild trypsinisation.
3.3.7 Effect of Tetanus Toxin on Exocytosis Evoked by Different
Secretagogues
As discussed in Section 3.3.1, catecholamine release from
chromaffin cells can be stimulated by a number of different
secretagogues. Having established that tetanus toxin inhibits
nicotine-evoked release, it was of interest to determine whether
exocytosis evoked by other means was also affected. Previously,
Sandberg et al. (1989a), using NGF-treated PC12 cells, have
reported that tetanus toxin inhibits secretion of [3H]acetylcholine
evoked by Ba2+ ions, veratridine and carbachol (which induces
secretion via muscarinic receptor activation), suggesting that a
crucial step common to secretion evoked by distinctly different
secretagogues is inhibited by the toxin. Similarly, Knight et al.
(1985) observed an inhibitory effect of botulinum toxin type D on
the response of intact chromaffin cells to acetylcholine,
veratridine, high [K+] and Ba2+.
Table 3.5 clearly demonstrates that tetanus toxin had no inhibitory
effect on catecholamine release from chromaffin cells evoked by
Ba2+ ions. This is in sharp contrast to the findings of Sandberg
and her coworkers, who reported that tetanus toxin inhibited
barium-evoked release by as much as 82%. However, it is perhaps
dangerous to assume that exocytotic mechanisms operating in PCI2
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Table 3.5 Effect of Tetanus Toxin on Exocytosis Evoked by Ba2 + ions
Chromaffin cells were incubated for 16 hours with or
without tetanus toxin (70 nM) in DMEM, and then
stimulated with either nicotine (10 juM) or Ba2 + ions
(5mM). Released catecholamines were measured as
described in Section 2.2.5. Each result is the mean of
3 wells + standard deviation.
CELL TREATMENT % RELEASE OF %
CATECHOLAMINES INHIBITION
None i.e. basal release 5.8 (± 0.7)
Nicotine 16.2 ( + 1.1)
Toxin, then nicotine 8.4 <± 0.9) 75%
Ba2 + ions 37.1 ( + 1.7)
Toxin, then Ba2+ ions 38.3 (± 2.1) 0%
The results shown are typical of 2 independent experiments;
variability between data obtained in separate experiments was less
than 8%.
Students t-test: p < 0.01 for effect of toxin on catecholamine
secretion evoked by nicotine.
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cells (which have really been studied in very little detail) are
identical to those found in chromaffin cells. Further, it is maybe
not surprising that tetanus toxin does not affect Ba2+-evoked
release; while Ba2 + can substitute for Ca2+ in entering nerve
terminals and stimulating neurosecretion (Nachshen & Blaustein,
1982), the mechanism by which Ba2 + ions promote exocytosis is not
well defined. Evidence is accumulating, though, to suggest that
this may involve processes that are not entirely identical to those
utilised by Ca2+ . For instance, Robinson & Dunkley (1985) have
reported that while Ca2+ ions are able to modulate depolarisation-
dependent protein phosphorylation and dephosphorylation (presumably
through activation of protein kinases), Ba2+ ions cannot do this;
presumably, then, Ba2+ ions stimulate secretion via a different
route. Further, the observation of Armstrong & Taylor (1980) that
Ba2+ ions can interact with K+ channels and competitively inhibit
K+ fluxes suggests that Ba2+ ions, in addition to utilising Ca2+
transport mechanisms, may also be able to obtain access to
intracellular release sites via K+ channels.
In further experiments conducted in the laboratory, it was found
that K+-evoked secretion from intact chromaffin cells was inhibited
much less than that evoked by nicotine: about 30% after 3 days
incubation with 70 nM toxin (data not shown; experiments carried
out by Dr M.K. Bansal). This difference between the effectiveness
of the toxin on nicotine- and K+-evoked release suggests that it
might be acting on some component of the cytoskeleton. It has been
reported by Cheek & Burgoyne (1986) that nicotinic stimulation of
chromaffin cells results in cortical actin disassembly, whereas
depolarisation with high K+ does not, suggesting that with K+ there
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is mainly exocytosis of those granules already close to the plasma
membrane, while with nicotine there is mobilisation of more distant
granules. Since some inhibition of K+-evoked release by toxin was
observed, it is possible that the toxin may also have a target at
the plasma membrane.
3.3.8 Effect of Gangliosides on Toxin Inhibition of Secretion
In Section 3.3.2, it was described how pre-incubation of tetanias
toxin with ganglioside GT1, prior to its introduction to chromaffin
cells, resulted in an enhancement of the toxin's inhibitory action.
This observation prompted, us to carry out more experiments using
this preformed toxin-ganglioside complex, with a view to evaluating
the role of gangliosides in mediating the action of the toxin. In
an initial experiment to determine the dose-dependency of the toxin
effect in the presence of ganglioside, different concentrations of
tetanus toxin from 0.01-33 jug/ml (67 pM-220 nM) were pre-incubated
with 50 jug/ml GT1 for one hour prior to addition to cells. However
it was soon apparent that even at the lowest tetanus toxin
concentration (0.01 jug/ml) , maximal inhibition of catecholamine
secretion was still occurring. This was a somewhat puzzling result
until, on running a ganglioside control (i.e. incubating cells with
ganglioside only, then evoking secretion), it was discovered that
all the inhibition observed could be attributed to a ganglioside-
mediated effect. Further evidence that this was not a toxin effect
came from the finding that the time course of inhibition with the
toxin-ganglioside complex was complete within one hour (see Fig.
3.5); tetanus toxin alone requires much longer than this to exert
its inhibitory effects (Section 3.3.3). On investigating the dose-
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Figure 3.5 Time Course of Inhibition of Catecholamine Secretion
from Intact Chromaffin Cells by Tetanus Toxin Pre—
Incubated with Ganglioside
Cells were incubated for various times up to 4 hours
with tetanus toxin (70 nM) which had been pre-incubated
for one hour with ganglioside GT1 (50 ^ug/ml) in DMEM.
The medium was removed, the cells stimulated with
10 joM. nicotine, and released catecholamines measured as
outlined in Sections 2.2.4 and 2.2.5. Each result is
the mean of three different wells Hh standard deviation.
This result is typical of 2 independent experiments;
variability between data obtained in replicate
experiments was less than 7%.
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CONCENTRATION OF GANGLIOSIDES (^M)
Figure 3.6 Effect of Ganglioside GTT1 on Release of Catecholamines
from Intact Chromaffin Cells
Cells were incubated for 16 hours in the presence of
various concentrations of ganglioside GT1 in DMEM. The
medium was then removed, the cells stimulated with
10 juM nicotine, and released catecholamines measured as
outlined in Sections 2.2.4 and 2.2.5. Each result is
the mean of three different wells + standard deviation.
This result is typical of 2 independent experiments;
variability between data obtained in replicate
experiments was less than 10%.
-112-
dependency of this ganglioside-mediated effect, it was discovered
that as little sis 5 juM ganglioside GT1 inhibited catecholamine
release by 12% (Fig. 3.6).
Thus incubation of chromaffin cells with ganglioside alone is
inhibitory to nicotine-evoked secretion. This makes it very
difficult, if not impossible, to determine whether pre-incubation
of the cells with ganglioside, which should increase the binding of
tetanus toxin, would also increase its inhibition of exocytosis.
(An alternative approach would perhaps have been to investigate the
effect of neuraminidase treatment of chromaffin cells on the
ability of tetanus toxin to inhibit their catecholamine release).
It is unclear how the ganglioside is interfering with the secretory
process; one can only speculate that it is perhaps acting at the
level of the cell membrane to interact with nicotinic receptors in
some way. One point to note is that in the experiment reported in
Section 3.3.2, cells pre-incubated with ganglioside GT1 (50 ^pg/ml,
33 juM) alone did not show a significant level of inhibition of
evoked catecholamine release; this may have been due to the fact
that in this case, the cells were replaced in maintenance medium
for 24 hours after incubation with GT1 and prior to nicotinic
stimulation; perhaps this allowed the cells time to "recover" from
the effects of incubation with ganglioside.
3.4 CONCLUDING REMARKS
The work presented in this chapter clearly demonstrates that
tetanus toxin is able to inhibit catecholamine release from intact
chromaffin cells, lending considerable support to the notion that
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the toxin may have the potential to act as a general inhibitor of
secretion from a wide variety of cell types, not necessarily
neuronal, as long as it can gain access to these cells; the
specificity of the toxin's action on the nervous system in vivo,
then, may well be a result of limited accessibility rather than
preferential binding of the toxin to particular neurones.
Essentially nothing is known about how the toxin inhibits
exocytosis once it has entered the cell; exhaustive experiments in
many laboratories including our own have failed to find any ADP-
ribosylation catalysed by tetanus or botulinum neurotoxins (see
Adam-Vizi et al., 1988), an enzymatic activity found in other
toxins such as cholera, diphtheria and pertussis, while Wendon &
Gill (1982) were unable to find any toxin-catalysed protein
phosphorylation. Mellanby (1988) has suggested that the toxin
might be a specific phospholipase, acting on a membrane component
such as phosphatidylserine which is required to increase the
sensitivity to Ca2+ of protein kinase activation; this would reduce
the sensitivity to Ca2+ of the exocytotic mechanism. Recently an
involvement of tetanus toxin in the mobilisation of protein kinase
C in NG-108 cells has been reported (Considine et al., 1990), and
Sandberg et al. (1989b) have suggested that its action in PC12
cells is connected with alterations in the metabolism of cyclic
GMP. More recently, Marxen & Bigalke (1991) have proposed that
tetanus and botulinum A toxins inhibit exocytosis by interfering
with stimulus-evoked F-actin rearrangement. It remains to be seen,
however, whether any of these possible actions of the toxin do in
fact occur in vivo.
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Other work in our laboratory (carried out by Dr M.K. Bansal) has
concentrated on characterising the effect of tetanus toxin on
catecholamine release from permeabilised chromaffin cells; similar
results to those recently published have been obtained. The effect
of tetanus toxin on pertussis toxin-stimulated exocytosis has also
been examined. (Pertussis toxin catalyses the ADP-ribosylation of a
40 kDa GTP-binding protein in chromaffin cells; this stimulates
secretion by increasing the affinity of exocytosis for Ca2 + ,
suggesting that G proteins are involved in the direct control of
exocytosis). Tetanus toxin has been found to inhibit catecholamine
release stimulated by pertussis toxin, showing that the two toxins
probably act at different sites i.e. tetanus toxin probably does
not inhibit exocytosis by affecting G proteins. This finding is in
accord with the inability of workers to find evidence of any ADP-
ribosylation .
In summary, then, it can be said that intact chromaffin cells are
indeed sensitive to externally applied tetanus toxin, given the
appropriate conditions. Unfortunately this effect, although
quantitatively reproducible, is not very consistent, for reasons
that are by no means obvious. Chromaffin cells may therefore have
the potential to provide useful information on the mechanism of
action of this toxin.
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CHAPTER FOUR.
BINDING OF 12 sI-LABELLED TETANUS TOXIN
TO CULTURED ADRENAL CHROMAFFIN CELLS
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4.1 INTRODUCTION
In Chapter 3, evidence was presented to show that tetanus toxin is
a potential inhibitor of exocytosis from intact chromaffin cells.
Since it is generally thought that tetanus toxin shares the same
mechanism of action as that displayed by other bacterial toxins
(e.g. cholera, diphtheria), which involves binding of the toxin to
the cell membrane, internalisation of the toxin and finally
intracellular poisoning, it would seem that a binding event must be
occurring prior to chromaffin cell intoxication and inhibition of
secretion. For the purposes of this project, it seemed a logical
step to go on from demonstrating an inhibition of secretion to
attempt to show that this binding did in fact take place, and to
characterise it as fully as possible.
To date there have been no published reports of tetanus toxin-
binding by adrenal chromaffin cells; in fact, there have been
several which state that tetanus toxin does not bind to these
cells. Most of these claims, however, have come from workers who
have been unable to demonstrate an inhibitory effect of tetanus
toxin on exocytosis from intact chromaffin cells, and who have
concluded that this must be a reflection of the inability of these
cells to bind and internalise the toxin (Knight et al., 1985;
Bittner & Holz, 1988; Penner et al., 1986; Marxen et al., 1989).
It seems that little effort has been made to demonstrate tetanus
toxin binding to chromaffin cells directly. (Lazarovici et al.
(1989) have reported that they were unable to observe any binding
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of 125I-labelled tetanus toxin to intact chromaffin cells; however,
they provide no details of the binding assay or of the toxin used,
so it is difficult to assess the validity of this report.)
It would obviously be advantageous, then, if toxin-binding could in
fact be demonstrated in our system. Further, since one of the aims
of this project was to assess the suitability of the chromaffin
cell as a model for studying the intoxication process of tetanus,
it was of interest to compare the characteristics of toxin-binding
by chromaffin cells to binding by true neuronal tissue. For
instance, does binding of tetanus toxin to chromaffin cells exhibit
the same dependence on pH and ionic strength as binding to rat
brain membranes? Does pre-treatment of chromaffin cells with
neuraminidase or trypsin have any effect on their subsequent toxin-
binding capacity? Further, what effect does pre-incubation of
cells with ganglioside GT1 have on toxin-binding, and is the
binding seen in these cells of the same nature as that seen with
native cells? Also, if it is possible to demonstrate the specific
fixation of tetanus toxin to chromaffin cells, can any subsequent
internalisation of the toxin be detected? By answering these
questions, we may be better placed to draw conclusions as to how
similar the binding of tetanus toxin by chromaffin cells is to
binding occurring to toxin receptors in vivo.
4.1.1 Parameters of Ligand Binding That Define a Receptor
There are several biophysical characteristics of ligand binding
that define a true receptor (although it must be borne in mind that
the cell-surface moieties which bind tetanus toxin in vivo can not
strictly be regarded as "receptors", for reasons stated earlier).
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The first of these is saturation; this is a direct consequence of
the limited number of receptors that should be present on a target
cell. Associated with this is the concept of high affinity; not
only should there be a finite number of receptors but in addition,
their affinity for the ligand should be high. The dissociation
constant, Kd , is a measure of the tightness of ligand binding and
can be defined as Kd = [R][L]/[RL], where the brackets signify the
concentrations at equilibrium, of the respective components R
(receptor), L (ligand) and RL (ligand-receptor complex). Further,
according to simple dissociation theory, Kd will also be equivalent
to the concentration of ligand that produces half-saturation of the
available binding sites; the smaller the value of Kd, the higher
the binding affinity. There is no absolute value for Kd that
defines high affinity; however, a value greater than 1-10 pM is
relatively weak and represents the lower-affinity end of the range
for ligand-receptor binding constants, whereas Kd values less than
100 pM are rare and define the upper limits.
The third criterion defining a true receptor is reversibility;
after forming, a ligand-receptor complex will dissociate with time,
according to the dissociation rate constant, koff . A consequence
of this is that, if ko tf is small, then toxin molecules may spend a
long time on their receptors, allowing plenty of time for extensive
cellular processing to occur. The final biophysical criterion to
satisfy is specificity; that is, the binding of a ligand to its
specific receptor should be affected by other ligands that interact
with the same receptor. In all instances, the addition of an
excess of the same unlabelled ligand should compete for the binding
measured.
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An important point to keep in mind when carrying out these kinds of
studies is that there may exist ligand-binding sites with all the
biophysical features characteristic of a true receptor, yet those
sites have nothing to do with mediating the biological response to
the ligand. Therefore, as well as meeting biophysical criteria, a
receptor must possess a number of biological correlates i.e. a
definite correlation between ligand-binding and the biological
response must be observed. It is interesting to note that as yet
such a correlation has not been clearly demonstrated for tetanus
toxin binding to gangliosides (or any other cell surface
molecules).
4.2 METHODS
4.2.1 Incorporation of Fluorescent GT1-LY into Chromaffin Cell
Membranes
Fluorescent ganglioside GT1 was prepared as outlined in Section
2.2.7, and analysed by thin-layer chromatography (Section 2.2.14).
This ganglioside derivative was then used to determine the time
course of incorporation of exogenous gangliosides into the plasma
membranes of intact chromaffin cells, as described in Section
2.2.8.
4.2.2 Binding of 12sI-labelled Tetanus Toxin to Chromaffin Cells
The binding of radiolabelled tetanus toxin to cultured chromaffin
cells was measured using the procedure described in Section 2.2.10.
Experiments were first carried out to determine the time course of
toxin-binding, the linearity of toxin-binding with respect to the
amount of cell protein, and the effect of pre-incubation of
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chromaffin cells with different concentrations of GT1 on subsequent
toxin-binding ability. These experiments established i) the
optimal length of incubation of chromaffin cells with tetanus
toxin, ii) the optimal amount of cell protein to have present in an
assay well, and iii) the optimal concentration of GT1 to use to
achieve maximal (or near-maximal) enhancement of toxin-binding
ability.
4.2.3 Binding of 125I-labelled Tetanus Toxin to Chromaffin Granules
The binding of radiolabelled tetanus toxin to chromaffin granules
was measured as described in Section 2.2.11. In some cases,
granules were pretreated with 50 mU/ml neuraminidase or 1 mg/ml
trypsin (in incubation buffer) for 30 minutes at 37°C prior to
incubation with toxin. Non-specific binding of toxin was measured
by incubating granules with radiolabelled toxin in the presence of
a 100-fold excess of unlabelled toxin.
4.2.4 Internalisation of Tetanus Toxin by Chromaffin Cells
The procedure outlined in Section 2.2.12 was used to investigate
toxin internalisation by chromaffin cells. This method makes use
of the fact that surface-bound toxin is susceptible to pronase
digestion, while internalised tetanus toxin is pronase-resistant.
All incubations were performed in triplicate. Optimal conditions
for the degradation of 125I-labelled tetanus toxin were determined
by assessing toxin degradation on an SDS-polyacrylamide gel after
the toxin had been exposed to different concentrations of enzyme
(as described below).
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4.3 RESULTS AND DISCUSSION
4.3.1 Analysis of Lucifer Yellow CH-Labelled Ganglioside
Oxidation of the sialic acid residues of ganglioside GT1 with
sodium periodate, and subsequent reaction of the resulting
aldehydes with the hydrazide moiety of the naphthylamide dye
Lucifer Yellow CH led to the formation of fluorescent derivatives
of GT1 ganglioside. The oxidation conditions used (2 mM sodium
periodate for 30 minutes at 0°C) ensure the specific oxidation of
the sialic acid residues, and not the periodate-sensitive galactose
residue of GT1 (Veh et al., 1977).
Three fluorescent ganglioside derivatives were produced, which
could be readily separated by thin-layer chromatography, as shown
in Fig. 4.1. All of these derivatives reacted with resorcinol
reagent, indicating the presence of sialic acid residues and
suggesting that they were indeed gangliosides. A small amount of
underivatised GT1 was also evident; this may have been due to
incomplete oxidation of the ganglioside prior to the addition of
the Lucifer Yellow, which was present in considerable excess. Two
of the derivatives had a lower mobility on thin-layer chromatograms
than native GT1; this is not unexpected, since Lucifer Yellow is
both polar and negatively charged. The third fluorescent compound,
however, was more mobile than native GT1; it seems unlikely that
this is a derivative of GT1, but rather of some minor contaminating
ganglioside species present in the GT1, perhaps a disialo-
ganglioside. It is worth noting that the fluorophore itself is
immobile in the solvent system used here, so anv fluorescence due











Figure 4.1 Representation of Thin-Layer Chromatogram of Fluorescent
Ganglioside GTT1
Standard and fluorescently-labelled GT1 were subjected
to thin-layer chromatography as described in Section
2.2.14. Gangliosides were visualised by resorcinol
staining: fluorescent derivatives were also visible
under ultraviolet illumination.
N.B. Thin-layer chromatography of GT1-LY was carried out
three times, with identical results.
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There are several possible explanations to account for the
formation of more than one derivative of GT1. Since this
ganglioside species contains three sialic acid residues, it is
possible that different GT1 molecules were conjugated with Lucifer
Yellow CH on different residues; indeed, it could even be that some
ganglioside molecules had more than one sialic acid residue
modified. Another possibility is that residues on different
molecules could be derivatised on different carbon atoms; oxidation
of gangliosides with sodium periodate can form aldehydes at
Carbon-7 or Carbon-8 of sialic acid residues (Veh et al., 1977).
Further, Lucifer Yellow has a free amino group in addition to
hydrazide (the usual reactive part of the molecule), which could
react with aldehyde groups. It is not easy, however, to establish
which of these explanations is the correct one.
Further purification of the individual GT1 derivatives could have
been carried out by performing preparative thin-layer
chromatography, then scraping the bands from the chromatograms and
eluting the silica gel with solvent. However, this was deemed
unnecessary since it seemed evident that all the fluorescent
material was indeed ganglioside (owing to its reactivity with
resorcinol and its mobility relative to standard ganglioside on
thin-layer chromatograms). The fact that there was more than one
ganglioside derivative was not considered to be a problem for our
purposes, since all gangliosides are likely to incorporate into
membranes at essentially the same rate and to the same extent,
regardless of their hydrophilic moiety.
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4.3.2 Incorporation of GTl-Lucifer Yellow into Chromaffin Cell
Membranes
The reason for preparing a fluorescent derivative of ganglioside
GT1 was that this provided a convenient means of monitoring the
incorporation of exogenous gangliosides into chromaffin cell
membranes. Since one of the questions to be addressed later in
this study was whether or not exogenous ganglioside could enhance
the ability of adrenal chromaffin cells to bind tetanus toxin, it
was important i) to establish that these cells did in fact
incorporate exogenous ganglioside into their plasma membranes and
ii) to determine the time course of this process. This sort of
experiment has been done often with cholera toxin and its receptor
ganglioside GM1; Cuatrecasas (1973) showed that the response of fat
cells to cholera toxin was increased ten-fold when the cells were
pre-incubated with ganglioside, while Gill & King (1975) reported
similar findings with pigeon erythrocytes. In these experiments,
incorporation of tritiated ganglioside into the cell membrane was
shown directly and correlated with toxin binding. Similarly,
Hollenberg et al. (1974) demonstrated that transformed mouse
fibroblasts which contained no GM1 (but which did have an adenylate
cyclase that responded to cholera toxin after lysis of these cells)
and were therefore normally unresponsive to toxin when intact,
could take up as much as 105 molecules of [3H]GM1 per cell and then
respond to toxin. All these experiments provide good evidence that
when ganglioside molecules in solution are incubated with cells,
their hydrophobic portions insert into the lipid membrane and they
presumably become indistinguishable from endogenous ganglioside.
-125-
When cultures of chromaffin cells were incubated with the
ganglioside derivatives at 37°C they became highly fluorescent, in
a time-dependent manner. The fluorescence was evenly spread over
the whole of the cells, suggestive of surface labelling. Fig. 4.2
shows the results of a typical "incorporation experiment"; values
plotted are an average of 20 measurements taken at each time point,
and are typical of three such experiments. The graph indicates
that after a two hour incubation period, there is very little
further increase in the level of incorporated ganglioside. This
time course agrees well with that found by other workers; Facci et
al. (1984) observed that incorporation of [3H]GM1 by neuroblastoma
cells reached 95% of its maximum after approximately two hours,
while Leskawa et al. (1989) reported very similar findings using
the same cells.
It was concluded, therefore, that a two hour incubation of
chromaffin cells with ganglioside was sufficient to achieve maximum
incorporation into the plasma membrane. Although it is likely that
some of the cell fluorescence was due to internalised ganglioside,
the fact that the whole of the cells appeared to be evenly
labelled, without any obvious signs of compartmentalisation, was a
good indication that much of the ganglioside was present at the
level of the cell membrane. Further, the finding by Spiegel (1985)
that fluorescent GM1 could act as a receptor for cholera toxin in
GM1-deficient rat glioma C6 cells after a three hour incubation
under the same conditions as used here strongly suggests stable
incorporation into the cell membrane, as it seems unlikely that
different cell types will vary much in their ability to incorporate
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Figure 4.2 Incorporation of Fluorescent GT1 into Chromaffin Cell
Membranes
Chromaffin cells were incubated with GT1-LY as outlined
in Section 2.2.8. then the fluorescence of single cells
was measured using the photometer of a Leitz Vario
Orthomat 2 automatic microscope camera. Each result
represents the mean of 20 measurements + standard
deviation.
This experiment was conducted three times; variability
between data obtained in separate experiments was less
than 10%.
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can really only be assumed that the gangliosides are inserted into
the plasma membrane in the correct orientation, one would expect on
energetic grounds that both hydrocarbon chains would be inserted
into the bilayer, leaving the carbohydrate portion exposed at the
cell surface (indeed, Spiegel's results suggest this to be the
case). Presumably, also, only the monomeric and not the micellar
form of ganglioside is stably inserted. Extensive work in other
systems has never shown any difference between endogenous and
exogenous ganglioside.
4.3.3 Iodination of Tetanus Toxin
Radiolabelled tetanus toxin was routinely prepared to a specific
radioactivity of 0.5-1.5 |iCi/jug protein. Its purity was determined
by SDS-polyacrylamide gel electrophoresis and subsequent analysis
of the distribution of radioactivity on the gel by autoradiography.
A typical result is shown in Fig. 4.3. Three bands of radio¬
activity comigrating with holotoxin (150 kDa), heavy chain (100
kDa) and light chain (50 kDa) were detected; very little
contaminating radioactivity was present. Most of the radiolabel
appeared to be incorporated into the heavy chain of the toxin; this
is perhaps due to the presence of more tyrosine residues in the
heavy chain, or maybe reflects easier accessibility of the heavy
chain to the iodinating reagents. Each batch of iodinated toxin
was kept for a maximum of two months, and was checked routinely by






Figure 4.3 SDS-Polyacrylamide gel (a) and corresponding autoradio¬
graph (b) of 1251-Labelled Tetanus Toxin
Gel electrophoresis and autoradiography were carried
out as outlined in Sections 2.2.19 and 2.2.20. Track 1
contains non-reduced tetanus toxin; track 2 contains
reduced tetanus toxin. Molecular weight markers ran at
the positions indicated.
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4.3.4 Binding of 125I-Labelled Tetanus Toxin to Native Chromaffin
Cells
The objective of this section of work was to produce some
quantitative information about the tetanus toxin-binding capacity
of chromaffin cells, and to characterise this binding as much as
possible. Since at temperatures higher than about 15°C some uptake
or internalisation of the toxin could possibly occur (which would
complicate interpretation of results), the decision was made to
conduct all binding experiments (both at pH 6.0 and 7.4) at 0-4UC,
at which temperature no significant sequestration of radiolabelled
toxin by the cells should occur.
4.3.4.1 Time Course of Toxin Binding
To determine the optimum length of time for incubating cells with
toxin, a time course experiment was conducted in which cells were
incubated with a fixed concentration of radiolabelled toxin (2 nM)
for various times; the amount of cell-associated toxin was then
determined in each case. The experiment was carried out using
native cells, cells pre-incubated with ganglioside GDla or cells
pre-incubated with ganglioside GT1 (see below). The results for
the experiment carried out in pH 7.4 incubation buffer are shown in
Fig. 4.4; a virtually identical result was obtained when cells were
incubated at pH 6.0. Three conclusions can be drawn from this
graph. Firstly, the fixation of tetanus toxin to chromaffin cells
is complete after a three hour incubation period; this agrees well
with the incubation times used by workers investigating tetanus
toxin binding by other cell types e.g. Wellhoner & Neville (1987)
working with neuroblastoma x glioma NG108-15 hybrid cells, and




Figure 4.4 Time Course of Binding of 125I-Labelled Tetanus Toxin
to Chromaffin Cells
Chromaffin cells were pre-incubated for 2 hours with
either DMEM alone, or medium containing gangliosides
GDla or GT1 (50 jug/ml). Cells were then incubated with
tetanus toxin (2 nM) for various times in pH 7.4
binding buffer, and bound toxin measured as described
in Section 2.2.10.
This result is typical of 3 independent experiments;
variability between data obtained in replicate
experiments was less than 10%.
Students t-test: p < 0.01 for effect of ganglioside GT1
in enhancing toxin-binding (at 3-5 hours incubation
time).
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Secondly, pre-incubation of chromaffin cells with ganglioside GT1
causes, as expected, a significant enhancement of the toxin-binding
capacity of these cells, without altering the time course over
which maximal binding occurs. Thirdly, this enhancement is not a
non-specific effect, since pre-incubation of cells with GDla
ganglioside, which is known not to bind tetanus toxin to any great
extent, has virtually no effect on the level of toxin binding.
4.3.4.2 Linearity of Toxin-Binding with Varying Cell Protein
In order to detect variations in ligand binding to cells, it is
essential that experiments are carried out under conditions in
which binding is linear with respect to the amount of cell protein
present. Fig. 4.5 shows that, under both sets of conditions used,
binding of toxin to chromaffin cells is linear up to approximately
40 pg of cell protein. Future experiments were therefore conducted
using cells plated at a density of 1 x 105 cells/assay well; this
corresponds to approximately 25 pg, protein, which is within the
range of linear toxin-binding.
4.3.4.3 Effect of Ganglioside Concentration on Toxin Binding
Since it was intended that binding of tetanus toxin (at both pH
values) would be studied both in native chromaffin cells and cells
treated with ganglioside GT1, the question of what concentration of
ganglioside to pre-incubate cells with, prior to incubation with
tetanus toxin, had to be addressed. So as to avoid using
unnecessarily high concentrations of GT1, it was important to
determine the minimum concentration of ganglioside that could be
used which would give maximal, or near-maximal, enhancement of
toxin binding. Table 4.1 shows the results of such an experiment.
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Figure 4.5 Linearity of Toxin-Binding with Varying Cell Protein
Chromaffin cells plated at various densities between
5 x 104 and 2 x 105 cells/assay well were incubated for
3 hours at 0°C with 20 nM 125I-labelled tetanus toxin in
either pH 6.0, low ionic strength, or pH 7.4, high ionic
strength buffer; bound toxin was then measured as
described in Section 2.2.10, and cell protein determined
as outlined in Section 2.2.18.
Similar results were obtained in 3 independent
experiments; variability between data from separate
experiments was less than 10%.
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Table 4.1 Effect of GT1 Concentration on Toxin-Binding by
Chromaffin Cells
Cells were pre-incubated for 2 hours with different
concentrations of GT1 as indicated, then toxin-binding
was measured as described in Section 2.2.10. Figures
represent the mean of three different wells ± standard
deviation.
[GT1 ] (jug/ml) TOXIN BOUND (pnol/mg protein)
0 0.027 (+ 0.002)
10 0.043 (+ 0.003)
25 0.062 (+ 0.001)
50 0.069 (+ 0.003)
This result is typical of 2 independent experiments;
variability between data from separate experiments was
not more than 10%.
Students t-test: p < 0.01 for effect of ganglioside GT1
in enhancing toxin-binding (at all concentrations tested).
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It is clear that a significant increase in toxin binding occurs
when the concentration of GT1 is raised from 10 jug/ml to 25jjg/ml,
but that by doubling the GT1 concentration to 50 ^og/ml, only a
negligible increase in binding is achieved. Thus subsequent pre¬
incubations of chromaffin cells were carried out using a
ganglioside concentration of 25 ^og/ml.
4.3.4.4 Characteristics of Toxin-Binding to Chromaffin Cells
It was now possible to begin to investigate the binding of tetanus
toxin to native chromaffin cells. Binding was to be studied under
two different conditions; i) in physiological, high ionic strength
buffer, pH 7.4, and ii) in non-physiological, low ionic strength
buffer, pH 6.0. Previous binding studies with tetanus toxin and
rat brain membranes (e.g. Critchley et al., 1986; Pierce et al.,
1986) had shown that while binding could be observed under
physiological conditions of pH and ionic strength, this appeared to
be non-saturable, and was of a lower capacity and affinity than
that seen under low-salt and -pH conditions; further, binding under
the latter conditions was shown to be saturable. In this study, we
wished, first, to demonstrate whether chromaffin cells are capable
of binding tetanus toxin in a specific fashion and, second, to
evaluate whether any binding found is similar to that observed with
true neuronal tissue, such as rat synaptic membranes.
Binding curves obtained upon incubation of native chromaffin cells
with various concentrations of 125I-labelled tetanus toxin (in the
range 0-20 nM), under both sets of conditions, are shown in Fig.
4.6 and Fig. 4.7; in each case, non-specific binding (which




Figure 4.6 Binding of 125 I-Labelled Tetanus Toxin to Native
Chromaffin Cells in pH 6.0, Low Ionic Strength Buffer
Chromaffin cells plated at 1 x 105 cells/assay well were
incubated for 3 hours at 0°C with various concentrations
of 1251-labelled toxin (in the range 0-20 nM) in 100 pi
of binding buffer. Bound toxin was then measured as
described in Section 2.2.10. Each point is the mean of
3 wells ± standard deviation: separate graphs represent
the results of binding experiments conducted on






Figure 4.7 Binding of 125 I-Labelled Tetanus Toxin to Native
Chromaffin Cells in pH 7.4, High Ionic Strength Buffer
Chromaffin cells plated at 1 x 105 cells/assay well were
incubated for 3 hours at 0°C with various concentrations
of 1251-labelled toxin (in the range 0-20 nM) in 100 jal
of binding buffer. Bound toxin was then measured as
described in Section 2.2.10. Each point is the mean of
3 wells +_ standard deviation; separate graphs represent
the results of binding experiments conducted on
different preparations of cells.
A
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due to adsorption of the toxin to the plastic surface of the cell
culture wells) has been corrected for, by incubating cells with
radiolabelled toxin in the presence of a 100-fold excess of
unlabelled toxin. The first point to note is that, as with
synaptic membranes, binding at pH 6.0 is of a markedly higher
capacity than that observed at pH 7.4; typically, under the
experimental conditions used, maximal binding at pH 6.0 appeared to
be approximately five times greater than that occurring at pH 7.4.
Second, it would appear from looking at these graphs (prior to any
thorough analysis of the data) that binding at pH 6.0 is saturating
within the range of toxin concentrations used, while, perhaps
unexpectedly, pH 7.4 binding also appears to be beginning to
saturate, an observation not previously made in other binding
studies with tetanus toxin. This is also suggested when the data
are plotted on a semi-logarithmic scale (as in Fig. 4.8), where
saturation is indicated by the curve flattening out to a plateau.
(This suggestion of saturation, however, really only rests on data
obtained using one toxin concentration, albeit from several
independent experiments; ideally there should be more points on
these graphs at higher toxin concentrations to show definite
plateaux. However, the amount of toxin that could be used in any
one experiment was limited by the availability of pure toxin, and
it was impracticable to increase the scale of these experiments).
It is worth pointing out that these curves do not follow the shape
of a "classical" isotherm of saturable binding; they tend to be
linear over a substantial part of the graph i.e. the increase in
bound toxin (at lower concentrations of free toxin) is more gradual
than would be expected for single-site binding.
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A
Figure 4.8 Semi-Logarithmic Representation of the Data from
Figures 4.6 and 4.7
Graphs (A), (B) and (C) represent the data from binding
experiments conducted in pH 6.0, low ionic strength
buffer, while graphs (D) and (E) represent the data from
experiments conducted in pH 7.4, high ionic strength
buffer.
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The semi-logarithmic plots shown in Fig. 4.8 suggest that there are
at least two components to the binding of tetanus toxin to these
cells. The curves are not symmetrical; in both cases (pH 6.0 and
pH 7.4) there is a definite tailing of the graph at lower toxin
concentrations. The simplest interpretation of this finding is
that, in addition to the high capacity binding indicated by these
graphs, there is also a higher affinity, low capacity component.
After having presented the binding data in this most direct form,
the usual procedure would be to transform the data and carry out
Scatchard analysis in order to obtain values for K<i (a measure of
the binding affinity) and Bmax (the total number of binding sites).
In Scatchard analysis, the data obtained from a binding isotherm
are used to calculate the bound and free ligand concentrations at
each experimental point, and the ratio of bound to free ligand is
plotted against the bound ligand. A straight line is taken as
evidence of a single class of binding sites, with a dissociation
constant defined by the slope of the line and Bma * determined by
the x-intercept.
However, when the data from these isotherms were transformed for
Scatchard analysis, it was immediately apparent that it would not
be at all easy, or indeed possible, to obtain any accurate
quantitative information using this approach. When Scatchard data
are plotted, there is always a strong, sometimes irresistible
temptation to fit them to a straight line, either by eye or by
least squares methods; however, the plots obtained are clearly non¬
linear (see Fig. 4.9), with several possible interpretations. It
could be that there are two or more classes of binding site, with
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Figure 4.9 Scatchard transformations of the Data presented in
Figures 4.6 (c) and 4.7 (a)
Graph (A) is a Scatchard transformation of data obtained
from a binding experiment conducted in pH 6.0, low ionic
strength buffer; graph (B) represents the same
transformation of data obtained from an experiment
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different but fixed affinities that do not change with extent of
occupancy by the toxin (as suggested above), or alternatively there
could be a single class of identical binding sites whose affinity
decreases with increasing occupancy by the toxin (negative co-
operativity); there is no way of telling from binding data alone
which of these factors is responsible for the observed curvature in
these plots. It was felt that an alternative means of analysing
the data should be used, since even when the curvature of a
Scatchard plot is not overlooked, the graph can easily entice one
into drawing incorrect conclusions. A common over-simplification
is to draw two straight lines through the data, and to ascribe one
of the lines, that of higher slope, to "high affinity" sites, and
the other to low affinity sites. Even if one knows for certain
that there are two classes of binding sites, the slopes and
intercepts of such lines are complex functions, and are generally
unsuited for evaluation of binding constants.
In order to gain some quantitative information from the binding
data obtained, we decided to assume that there are two major
components to the binding of tetanus toxin to chromaffin cells, the
simplest interpretation of the previous plots. The "high affinity,
low capacity" component is small, and thus difficult to quantitate,
but from careful inspection of the semi-logarithmic plots (Fig.
4.8), it seems that at both pH values it has an apparent Kd value of
approximately 1 nM, and that it does not account for more than 20%
of the toxin-binding capacity of the cells. We could, however, be
somewhat more quantitative with respect to the lower affinity
binding component. Data were analysed using a non-linear
regression method, as carried out by Dr. G. Atkins, Department of
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Biochemistry, University of Edinburgh; a regression of the
concentration of bound toxin versus the concentration of free
ligand was performed. The model used was
b = Nf/(Ka + f)
where b = concentration of bound ligand, N = concentration of
binding sites, K<i = the dissociation constant of binding sites for
the ligand, and f = concentration of free ligand. All data were
weighted equally.
The values calculated for apparent Kd and Bmax for each set of data
(for binding of tetanus toxin to native chromaffin cells) are shown
in Table 4.2. The data appeared to fit satisfactorily to this
model; residuals of positive and negative value were evenly
distributed, and in all cases the number of iterations required to
reach a minimum value for the sum of squares of residuals was
acceptable.
It is clear that there is a significant degree of variation between
results obtained when the same binding experiment is carried out
using different cell preparations; this is perhaps not very
surprising considering the biological nature of the system we are
using. But, in addition to this variation, there were preparations
of cells for which no binding of tetanus toxin was observed. There
is no obvious explanation for this, but it seems more likely to be
a feature of the cells than of the toxin, as the same preparation
of radiolabelled toxin was used for several experiments, some of
which did result in detectable binding, while others did not. Just
what this feature of the cells is, however, remains unknown.
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Table 4.2 Values of Apparent Kd and Bmax Calculated for High Capacity
Binding of 12 5I-Labelled Tetanus Toxin to Native
Chromaffin Cells
Apparent Kd Bmax Bmai
(nM) (pmol/mg protein) (molecules/cell)
Binding in pH 6.0 low
ionic strength buffer
(a) 7.1 + 2.7 0.19 + 0.03 29,000 + 4,000
(b) 24.4 +_ 8.2 0.73 ± 0.15 109,000 _+ 23,000
(c) 12.4 + 3.9 1.17 + 0.18 175,000 +_ 27,000
Binding in pH 7.4 high
ionic strength buffer
(d) 18.6+ 3.6 0.20+0.02 30,000+ 3,000
(e) 22.2+17.3 0.27+0.12 41,000+19,000
Letters (a) to (e) refer to experiments with various preparations
of cells. Experiments (b) and (d) were conducted on the same cell
preparation, as were experiments (c) and (e). Experiment (a) has
no counterpart at pH 7.4; no binding was observed at this pH with
this batch of cells.
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Since this problem of inconsistency was also encountered in the
inhibition of secretion studies reported in Chapter 3, the obvious
question to ask is whether or not it is possible to correlate the
lack of binding of tetanus toxin to a particular cell preparation
to the inability of the toxin to inhibit exocytosis from those
cells. Unfortunately, however, these two separate aspects of the
project were not carried out concurrently, so we do not have the
relevant data to address this question.
Because of the inconsistency of the cell preparations and the not
apparent
insignificant errors associated with the calculated^Kd and Bma*
values, it is not possible to draw firm conclusions from the data.
However, one or two points seem clear. Firstly, it would appear
that in fact tetanus toxin binds with similar affinity to
chromaffin cells at pH 6.0 and at pH 7.4; this is in contrast to
binding to neurones, which displays markedly higher affinity under
the less physiological condition of pH 6.0. (There is perhaps a
apparent
slight suggestion of lower^Ka values at pH 6.0, at least for the
lower affinity binding component, but the variation in the data
apparent
prevents us from putting much weight on this). The^Kd values
reported here, especially for the higher affinity binding
component, are nonetheless comparable to those found with neuronal
tissue. Most other published Kd values for tetanus toxin binding
are in the range 0.2-4.0 nM e.g. Rogers & Snyder (1981), Goldberg
et al. (1981), Staub et al. (1986), Critchley et al. (1986), Parton
apparent
et al. (1989). One conclusion from the higher^Kd values found with
the lower affinity toxin binding to chromaffin cells is that the
binding experiments should ideally have been conducted over a wider
range of toxin concentrations, so that experimental points could
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have been collected for free toxin concentrations significantly
greater than the apparent Kd value; however, as discussed earlier,
this was not possible in practice.
The second point to note from Table 4.2 is that the toxin-binding
capacity of chromaffin cells seems consistently to be greater at
pH 6.0 than at pH 7.4; this, too, is in agreement with previous
toxin-binding studies. It is difficult to compare the results
reported here with those published for neuronal material, since in
most cases, toxin-binding capacity is given in the literature in
terms of weight of membrane protein; obviously one cannot make
direct comparisons between the relative toxin-binding capacities of
membrane preparations and whole cells. Fu.jita et al. (1990) have
reported a Bmax value of 70 pmol toxin/mg protein for binding to
PC12 cells, a value substantially higher than the figures reported
here; however, they do not quote a Ka value for this binding, which
may be of relatively low affinity and therefore somewhat non¬
specific. When the Bmax values obtained for chromaffin cells are
expressed as toxin molecules bound per cell, however, the numbers
obtained are not at all unreasonable for specific, high capacity
binding.
Thus it would seem that specific binding of tetanus toxin to
adrenal chromaffin cells can and does occur, given the appropriate
conditions. This is similar to the binding of toxin to cells of a
more direct neuronal origin, with a substantial capacity and a
similar dependence on ionic strength and pH. However, the nature
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of the cell surface acceptor that mediates the binding of the toxin
is not clear, nor whether the same acceptor is involved under both
sets of conditions investigated.
Binding of 1251-labelled tetanus toxin to chromaffin cells pre-
incubated with ganglioside GT1 was investigated at the same time as
the experiments with native cells, to see whether incorporation of
exogenous ganglioside GT1 into the chromaffin cell membrane did in
fact cause an enhancement of toxin-binding capacity, or result in
a different binding affinity. Typical results are shown in Fig.
4.10; the data were analysed by non-linear regression as described
above. The toxin-binding capacity of the cells was increased to
3.7 +_ 0.7 pmol/mg protein at pH 6.0 and 2.4 +_ 0.2 pmol/mg protein
at pH 7.4. These values correspond to the incorporation of an
additional 450,000 toxin-binding sites per cell at pH 6.0, and an
extra 300,000 sites at pH 7.4, numbers easily achievable with the
concentration of GT1 used in the pre-incubations. Perhaps more
apparent
interesting is the observation that the Kd values calculated for
A
GTl-treated cells (16.7 + 5.9 nM at pH 6.0, 22.5 +2.7 nM at pH
7.4) are much the same as those values obtained for toxin binding
to native chromaffin cells. On the basis of this observation, it
is tempting to suggest that perhaps gangliosides are the receptors
involved in mediating the binding of tetanus toxin to native
chromaffin cells. However, this is mere speculation, and obviously
further experiments are needed.
4.3.5 Effect of Enzymic Treatments on Toxin-Binding
The approach taken to investigate the nature of the toxin-binding
moiety on the surface of the adrenal chromaffin cell was to
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Figure 4.10 Effect of Pre-Incubation of Chromaffin Cells with
Ganglioside GT1 on Subsequent Toxin-Binding Capacity
Chromaffin cells were pre-incubated with either DMEM
alone, or DMEM containing GT1 (25 ^ug/ml), for 2 hours at
37°C, then toxin-binding was measured as described in
Section 2.2.10. Graph (A) shows the result of the
experiment when conducted in pH 6.0, low ionic strength
buffer; graph (B) shows the result of the experiment
conducted in pH 7.4, high ionic strength buffer.
The results shown in each case are typical of 3 separate
experiments; variability between data obtained in
different experiments was not more than 10%.
Students t-test: p < 0.01 for effect of GT1 on toxin-
binding capacity under both buffer conditions (at










determine the effect of various enzymic treatments on toxin-
binding. This method has been used previously by other workers
(see Section 1.8.2), and has helped to shape current opinion on the
nature of tetanus toxin receptors in neuronal tissue. Briefly, the
consensus seems to be that, at least with brain suid spinal cord
tissue, gangliosides play a relatively minor role in toxin fixation
under physiological conditions (as indicated by experiments using
neuraminidase), while experiments with trypsin and other
proteolytic treatments suggest the involvement of a protein
(perhaps a sialoglycoprotein) in physiological toxin-binding.
Toxin-binding under less physiological conditions of pH and ionic
strength is very sensitive to neuraminidase, so therefore
gangliosides would appear to bind tetanus toxin with high affinity
under these conditions.
The effect of neuraminidase treatment on toxin-binding by
chromaffin cells was investigated by pre-incubating cells with 0.1
IU/ml of the enzyme in pH 6.0 rinse buffer (see Section 2.2.10) for
1 hour at 37°C, and then comparing the binding of 125I-labelled
tetanus toxin to these cells (under both sets of conditions) with
that to cells pre-incubated with buffer alone. The reason for
using this buffer is that neuraminidase has a pH optimum of
approximately 5.5, and so a relatively low pH buffer was needed to
ensure adequate enzyme action on any chromaffin cell membrane
gangliosides. It should be noted that protease inhibitors were
also present in the pre-incubation buffer, since some preparations
of neuraminidase are known to contain small quantities of such
enzymes.
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The results of these experiments are shown in Fig. 4.11. It is
immediately apparent that the neuraminidase treatment has a much
more marked effect at pH 6.0, as is the case with neuronal tissue;
this is consistent with the notion that gangliosides are the major
toxin-binding components in these cells under these conditions of
pH and ionic strength. Compared with native chromaffin cells, the
tetanus toxin-binding capacity of neuraminidase-treated cells is
reduced by approximately 90% (Bmax 1.17 +_ 0.18 pmol/mg protein for
native cells, Braax 0.128 ^ 0.03 pmol/mg protein for treated cells).
Neuraminidase also had a significant effect on toxin binding under
physiological conditions of salt and pH, although the reduction in
this case was less pronounced, around 50% (Bmax 0.27 +_ 0.12 pmol/mg
protein for native cells, Bmax 0.136 +_ 0.09 pmol/mg protein for
treated cells). On the basis of these results, then, it would
appear that binding of tetanus toxin to chromaffin cells in both
cases is mediated at least in part by gangliosides, or perhaps some
other sialic acid-containing molecule.
Since there have been reports suggesting that tetanus toxin-binding
to neuronal tissue may be mediated by some kind of protein
component in vivo (e.g. Critchley et al., 1986; Pierce et al.,
1986; Lazarovici & Yavin, 1986), the effect of trypsinisation of
the cells on their subsequent toxin-binding ability was
investigated. (Limited proteolysis is a widely used approach to
studv surface macromolecule interactions with ligands and the
subsequent biological signals that follow). The cells were
subjected to mild proteolysis, using 25 ^ag/ml trypsin (from bovine
pancreas) in pH 7.4 rinse buffer (see Section 2.2.10) for 10
minutes at 37°C; the enzyme activity was then inhibited by dilution
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Figure 4.11 Effect of Neuraminidase Treatment of Chromaffin Cells
on Subsequent Toxin-Binding Capacity
Chromaffin cells were pre-incubated with either pH 6.0
rinse buffer alone, or buffer containing neuraminidase
(0.1 IU/ml), for 1 hour at 37°C, then toxin-binding was
measured as described in Section 2.2.10. Graph (A)
shows the result of the experiment when toxin-binding
was conducted in pH 6.0, low ionic strength buffer;
graph (B) shows the result of the experiment conducted
in pH 7.4, high ionic strength buffer.
The results shown in each case are typical of 3 separate
experiments; variability between data obtained in
different experiments was not more than 10%.
Students t-test: p < 0.01 for effect of neuraminidase
on toxin-binding capacity under both buffer conditions






with ice-cold buffer containing excess soybean trypsin inhibitor
(0.5 mg/ral). The binding of tetanus toxin to these cells was then
compared to that to untreated control cells. (It is important to
note here that the cells did not appear to be affected
morphologically by the trypsinisation; they still remained attached
to the tissue culture plates, and retained their integrity as
judged by their ability to exclude trypan blue).
Using this method, Yavin & Nathan (1986) have shown that after
treatment of cerebral neurons with trypsin, a reduction in tetanus
toxin binding of approximately 40% is observed. Similarly, Fujita
et a_Z. (1990) have demonstrated that trypsinisation of guinea pig
brain synaptosomes leads to a 90% reduction in toxin-binding under
physiological conditions. In our experiments, however,
trypsinisation of chromaffin cells led to a complete abolition of
toxin-binding under both sets of conditions, even when lower
concentrations of trypsin were used. It is not easy to reconcile
this observation with those made in other studies. The fact that
trypsin is totally effective at abolishing toxin binding at pH 7.4,
while neuraminidase is less so, is similar to previous findings,
and perhaps indicates the importance of a membrane protein
component under these conditions, with gangliosides taking a lesser
role, or maybe a sialoglycoprotein that is more sensitive to
proteolysis than to desialylation. The results at pH 6.0, however,
are less straightforward; trypsin has not previously been shown to
be effective at reducing toxin-binding under these less
physiological conditions. It is perhaps somewhat unwise to read
too much into the results of the trypsinisation experiments; it is
not impossible that the trypsin is somehow exerting some kind of
-159-
indirect inhibitory effect on toxin binding. However, assuming
that the results obtained are valid, how can we interpret them?
Since binding at pH 6.0 appears to be totally abolished by both
neuraminidase and trypsin, this suggests the crucial involvement of
both gangliosides and a membrane protein, or of a sialoglyco-
protein. Perhaps, in line with the suggestion of Montecucco
(1986), tetanus toxin binds first, rather loosely, to a ganglioside
and this complex subsequently forms a more stable association with
a protein; in the absence of gangliosides (i.e. after neuraminidase
treatment), little or no toxin fixation can occur, while in the
absence of the appropriate protein, the toxin dissociates from the
ganglioside and is observed experimentally as an abolition of toxin
binding. Under more physiological conditions, however, the
ganglioside assumes a lesser role, with the toxin perhaps able to
form an association with the protein independently.
It is not possible to conclude from these experiments the exact
nature of the interaction between adrenal chromaffin cells and
tetanus toxin. The results obtained suggest the involvement of
neuraminidase-sensitive, and perhaps also protease-sensitive,
components in toxin-binding, but beyond this it is difficult to be
specific. For this purpose experiments of a more biochemical
nature, as will be described later in this thesis, are necessary.
4.3.6 Binding of 125I-labelled Tetanus Toxin to Chromaffin Granules
Since we were able to demonstrate the specific binding of tetanus
toxin to adrenal chromaffin cells, and since an inhibition by the
toxin of exocytosis from intact chromaffin cells was also observed
(as reported in Chapter 3), it seemed logical to assume that the
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toxin must be acting on an intracellular target of some kind.
Obviously there are many possible ways in which the toxin could be
interfering with the secretory mechanism, a thorough investigation
of which would be a major undertaking beyond the scope of this
thesis. However, it was considered that it might be worthwhile,
since we were conducting toxin binding experiments anyway, to
determine whether or not any binding of the toxin to isolated
chromaffin granules could be detected; one possibility is that the
toxin could perhaps be exerting its effect by interacting with
these secretory vesicles in some way such that their movement or
their fusion with the plasma membrane is prevented. Previously,
Lazarovici et al. (1989) have reported that tetanus toxin binds to
intact chromaffin granules and isolated granule membranes in a
neuraminidase-sensitive fashion; they assayed this biochemically
and also claimed to visualise binding to the cytoplasmic face of
the chromaffin granule membrane using electron microscopic
techniques (interestingly though, they were unable to demonstrate
any toxin-binding to intact chromaffin cells, either in suspension
or as monolayers; however, as mentioned earlier, few experimental
details are provided, so it is difficult to assess the validity of
this report). On carrying out this same experiment twice, we were
unable to detect any binding to chromaffin granules, even using
concentrations of 1 25 I-labelled tetanus toxin as high as 20 nM.
This is perhaps a more acceptable observation than that of
Lazarovici et al.', they admit themselves that theirs is an
unexpected result, since gangliosides are generally believed to
reside solely on the inner face of the granule membrane (Westhead &
Winkler, 1982). This seems logical enough, considering that on
exocytosis it is the inner surface of the granule membrane that
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becomes exposed to the cell exterior. Thus it would appear that
the intracellular action of tetanus toxin, at least in adrenal
chromaffin cells, does not involve an association of the toxin with
the secretory vesicles but with some other as yet undetermined
component of the exocytotic machinery.
4.3.7 Internalisation of Tetanus Toxin by Chromaffin Cells
Specific binding of tetanus toxin to chromaffin cells, if it is to
lead to an intracellular poisoning event as documented in Chapter
3, is presumably followed by some kind of internalisation step, and
so it was of interest to see if it was possible to demonstrate
this. The rationale behind the method used is that toxin bound to
cells at 0°C should remain at the cell surface and therefore be
susceptible to proteolysis, while if cells are incubated with toxin
at 37°C, a significant proportion of the toxin should be
internalised and hence become protease-resistant.
Before conducting the experiment, it was necessary to establish
conditions under which tetanus toxin was completely degraded by
protease. Staub and his coworkers found that treatment of 12 5I-
labelled toxin with 5 /ug/ml pronase at 37°C for 5 minutes could
completely degrade free toxin, while 20 jug/ml pronase was required
for toxin bound to microsomes. Similarly, it was found that in our
hands 5 ^ug/ml of pronase was sufficient for degradation of free
toxin (as analysed by gel electrophoresis of treated toxin samples
and subsequent autoradiography), and so it was assumed that 20
jug/ml would be adequate for chromaffin cell-associated toxin.
However, when two internalisation experiments were carried out, there
was no difference observed between the proportions of pronase-
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resistant radiolabel present at 0°C or 37°C; in both cases,
approximately 75-80% of cell-associated toxin was removed. This
unexpected result did not appear to be due to any morphological
effect on the cells by the pronase; the cells remained attached to
the tissue culture dishes prior to collection with sodium
hydroxide, and it was also established that cells treated with
pronase were still able to exclude trypan blue.
It may be that chromaffin cells, although capable of specifically
binding tetanus toxin, do not possess a specific means of
internalising it; a very small amount may reach the interior of the
cell in some non-specific fashion, such that this event is
undetectable using this experimental approach. After all, the
tremendous potency of tetanus toxin means that very little of it is
required to bring about cellular intoxication, and the specific
activity of the radio-labelled toxin used may not have been
sufficiently high for such a low level of internalisation to be
detected. In any case, it was decided that this assay wais perhaps
not the best method for visualising toxin internalisation and that
an immunocytochemical approach might be more successful (see
Chapter 5).
4.4 SUMMARY AND CONCLUDING REMARKS
The work documented in this chapter set out to demonstrate the
specific binding of 1251-labelled tetanus toxin to cultured adrenal
chromaffin cells, a phenomenon not previously observed. This
binding was also to be characterised as much as possible, and its
similarity to toxin-binding to neuronal tissue assessed.
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Using cells grown as monolayers and radiolabelled tetanus toxin, we
were able to demonstrate a specific binding event. This binding,
like that observed with neuronal tissue, was found to be dependent
on ionic strength and pH; binding measured in physiological buffer
was of a lower capacity that than seen under conditions of lower pH
and ionic strength, although in both cases the affinity of binding
apparent
appeared to be similar. The calculated,^ values for toxin binding
to chromaffin cells were reasonably comparable to corresponding
values obtained with cerebral neurons or rat brain membranes, and
taken together with the calculated Bmax values would seem to
indicate that chromaffin cells express high affinity binding sites
for tetanus toxin, in significant number, on their cell surfaces.
It was not possible, however, to define the nature of these toxin
acceptors accurately; experiments with neuraminidase- and trypsin-
treated cells suggested that both sialic acid-containing and
protein-containing membrane components are important for toxin-
binding, but whether this is indicative of a sialoglycoprotein
receptor, or of the involvement of both a ganglioside and a








The results presented in Chapter 4 served to demonstrate that
tetanus toxin is capable of binding to chromaffin cells in a
specific fashion, and that the toxin-binding capacity of these
cells may be increased or reduced by various treatments. The aim
of the work detailed in the current chapter was to visualise toxin-
binding using immunocytochemistry, and to investigate whether
similar observations could be made using this approach; in other
words a qualitative back-up to the 125I-labelled toxin-binding
experiments. Further, this technique has the potential to show the
distribution of toxin acceptors on the cell surface.
Immunocytochemistry is a powerful technique for localising specific
biochemical components on the surface of, or within, particular
cells. Early procedures involved the use of antibodies (directed
against cell components) which were conjugated to fluorescent
molecules, but more recently antibodies conjugated to specific
enzymes have become common. These enzymes, such as horse-radish
peroxidase or alkaline phosphatase, convert their substrates into
densely-coloured reaction products; this facilitates the
localisation of the antibody-enzyme conjugate using bright-field
microscopy.
Other workers have previously used immunocytochemical techniques to
demonstrate the binding of tetanus toxin to various types of cells.
For instance, Zimmerman & Piffaretti (1977) have shown toxin-
binding to cultured mouse neuroblastoma cells using indirect
immunofluorescence (human antitoxin followed by fluorescently
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labelled anti-human immunoglobulin), while Mirsky et al. (1978)
used the same approach to demonstrate that tetanus toxin-binding is
a general property of all neurones, and can therefore be used to
distinguish them from non-neuronal cells. Similarly, Raju & Dahl
(1982) have stained cultured neurones from rat embryo with tetanus
toxin, while Eisenbarth et al. (1982) used immunofluorescence to
show that tetanus toxin binds specifically to the plasma membrane
of pancreatic islet cells.
5.2 METHODS
5.2.1 Dopamine-jS-Hydroxylase Staining of Chromaffin Cells
Chromaffin cells cultured on coverslips were washed twice with PBS,
fixed in 3.7% formaldehyde in PBS for 10 minutes, then rinsed
thoroughly with TBS to wash out excess fixative. Coverslips were
then incubated with 1% Triton X-100 in TBS for 5 minutes (to
solubilise cell membranes), washed in TBS and incubated for 3 hours
at 37°C with a mouse monoclonal antibody against dopamine-/?-
hydroxylase (provided by Bulent Tugal, Department of Biochemistry,
University of Edinburgh). This was followed by further washing in
TBS, then incubation with alkaline phosphatase-labelled sheep anti-
mouse IgG (1/400 dilution in TBS/5% FCS) for 3 hours at 37°C.
Cells were then incubated with chromogen, and examined as described
in Section 2.2.17.1.
5.2.2 Tetanus Toxin-Binding to Chromaffin Cells
Binding of tetanus toxin to cells cultured on coverslips was
visualised by immunocytochemistry as outlined in Section 2.2.17.
Toxin-binding to native chromaffin cells was investigated under
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both buffer conditions used in Chapter 4; the effects of pre-
treatment of cells with ganglioside GT1 (25 pg/ml in DMEM for 2
hours at 37°C), neuraminidase (0.1 IU/ml in pH 6.0 rinse buffer
[see Section 2.2.10] for 1 hour at 37°C), or trypsin (25^tg/ml in
pH 7.4 rinse buffer [see Section 2.2.10] for 10 minutes at 37°C),
prior to incubation with toxin, were also examined.
To confirm that treatment of chromaffin cells with neuraminidase
was in fact removing sialic acid residues from gangliosides (and
other glycolipids), the ability of peanut agglutinin to bind to
these cells before and after exposure to the enzyme was assessed
(neuraminidase treatment should expose galactose residues
previously masked by sialic acid residues, and therefore enable
cells to bind the agglutinin). Cells were fixed for 10 minutes
with 10% formaldehyde in PBS, washed thoroughly with TBS and then
incubated at 37"C for 1 hour with buffer containing 0.1 IU/ml
neuraminidase. After further washing, cells were incubated with
biotinylated peanut agglutinin (1/100 dilution in TBS) for 3 hours,
washed, then incubated with streptavidin-horseradish peroxidase
(1/300 dilution in TBS) for a further 60 minutes. Coverslips were
then washed, incubated with chromogen and examined as described in
Section 2.2.17.2. Control coverslips were incubated either with
buffer containing no neuraminidase, or with peanut agglutinin which
had been pre-incubated for 15 minutes with 200 mM galactose.
5.2.3 Internalisation of Tetanus Toxin by Chromaffin Cells
Two different approaches were taken in attempting to visualise the
internalisation of tetanus toxin by chromaffin cells. In the first
method, cells were incubated with tetanus toxin at 4°C for 3 hours
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as previously described, washed quickly with ice-cold rinse buffer
to remove unbound toxin, and then either fixed immediately, or
warmed to 37°C (in binding buffer containing no toxin) for 3 hours
prior to fixation and inmunocytochemical processing (as outlined in
Section 2.2.17). Coverslips were then examined by microscopy to
determine whether incubation at 37°C led to a reduction in the
level of surface-binding, indicating possible internalisation of
the toxin. The second method was very similar, except that after
incubation with tetanus toxin, cells were fixed and then treated
with 1% Triton X-100 in TBS (as described in Section 5.2.1) prior
to antibody incubations. It was envisaged that, since treatment
with Triton X-100 is presumed to solubilise the plasma membrane (at
least partially), any toxin located within the cells could be
visualised directly using this approach.
5.3 RESULTS AND DISCUSSION
5.3.1 Dopamine-jS-Hydroxylase Staining of Chromaffin Cells
The enzyme dopamine-j§-hydroxylase, which is involved in catechol¬
amine biosynthesis, catalyses the conversion of dopamine to
noradrenaline and is found in both soluble and membrane-bound forms
within the chromaffin granule. Since this enzyme is unique to
chromaffin granules, it may be used as a marker to identify
positively chromaffin cells in culture. Such an experiment was
conducted on the cell preparations to be used in this immunocyto-
chemical study, the results of which are shown in Fig. 5.1. It is
clear that the majority of the cells were stained by this procedure
and can therefore be identified sis chromaffin cells; observation of
cell cultures under phase contrast illumination did not reveal
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Figure 5.1 Dopamine-/S-Hydroxylase Staining of Chromaffin Cells
Chromaffin cells cultured on coverslips were fixed,
treated with Triton X-100, then sequentially incubated
with mouse anti-dopamine-j3-hydroxylase IgG and alkaline
phosphatase-labelled sheep anti-mouse IgG before
incubation with chromogen, as described in Sections
5.2.1 and 2.2.17.1. Cells were examined using a Leitz
Ortholux 2 microscope and a Leitz Vario Orthomat 2
automatic microscope camera.
(a) Control cells - not incubated with mouse anti-
dopamine-jS-hydroxylase antibody
(b) Bright-field micrograph of dopamine-^-hydroxylase
staining of chromaffin cells
(c) Phase contrast micrograph corresponding to (b)
Scale bar represents 5 um
The results shown are typical of 3 separate experiments.
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significant numbers of unstained cells. Further, the punctate
distribution of the label within the cells is typical of an
intracellular marker such as dopamine-jS'-hydroxylase. Another point
to note is the variable extent to which individual cells are
stained by this procedure; the reason for this is unclear, although
it could be related to the length of time of the cells in culture.
5.3.2 Tetanus Toxin-Binding to Native Chromaffin Cells
As mentioned above, previous studies have employed indirect immuno¬
fluorescence to visualise toxin-binding to cells. However, this
technique was not particularly successful in the present study.
The levels of non-specific background binding were relatively high,
and although enhanced antibody-binding to toxin-treated chromaffin
cells could be seen by eye through the microscope, the extent to
which the cells were fluorescently labelled was insufficient to
allow satisfactory photographs to be produced. It was decided,
therefore, to use alkaline phosphatase-labelled second antibodies
in these experiments.
Native chromaffin cells were shown by this method to bind tetanus
toxin under both non-physiological and physiological conditions of
pH and ionic strength (the same conditions as those used in the
binding studies in Chapter 4), as shown in Figs. 5.3 and 5.4
respectively; Fig. 5.2 indicates that levels of toxin-binding
achieved when one of either toxin, human anti-toxin, or enzyme-
con.jugated anti-human IgG was omitted were negligible. It is clear
from Figs. 5.3 and 5.4 that the staining of the cells by the toxin
is typical of toxin-binding to the plasma membranes of the cells.
Well-spread cells are uniformly stained, with dark edges of cells
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Figure 5.2 Controls for Inmunocytochemical Detection of Tetanus
Toxin-Binding to Chromaffin Cells
Chromaffin cells cultured on coverslips were processed
for immunocytochemical detection of toxin-binding in pH
6.0, low ionic strength buffer, as described in Section
2.2.17, except that in:
(a) cells were incubated with pH 6.0 buffer containing no
tetanus toxin;
(b) cells were incubated with TBS/5% FCS containing no
human anti-tetanus toxin IgG;
(c) cells were incubated with TBS/5% FCS containing no
alkaline phosphatase-labelled goat anti-human IgG.
Chromaffin cells cultured on coverslips were processed
for immunocytochemical detection of toxin-binding in pH
7.4, high ionic strength buffer, as described in Section
2.2.17, except that in:
(d) cells were incubated with pH 7.4 buffer containing no
tetanus toxin;
(e) cells were incubated with TBS/5% FCS containing no
human anti-tetanus toxin IgG;
(f) cells were incubated with TBS/5% FCS containing no
alkaline phosphatase-labelled goat anti-human IgG.
Cells were then examined using a Leitz Ortholux 2
microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
Scale bar represents 10 um




Figure 5.3 Inmunocytochemical Detection of Tetanus Toxin-Binding
to Native Chromaffin Cells in pH 6.0, Low Ionic
Strength Buffer
Chromaffin cells cultured on coverslips were incubated
for 3 hours at 0-4°C with tetanus toxin (10 jag/ml) in
pH 6.0, low ionic strength buffer (Section 2.2.10), then
processed for immunocytochemistry as described in
Section 2.2.17. Cells were examined using a Leitz
Ortholux 2 microscope and a Leitz Vario Orthomat 2
automatic microscope camera.
Scale bar represents 10 um
Results shown are typical of at least 5 separate
experiments.
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Figure 5.4 Imraunocytochemical Detection of Tetanus Toxin-Binding
to Native Chromaffin Cells in pH 7.4, High Ionic
Strength Buffer
Chromaffin cells cultured on coverslips were incubated
for 3 hours at 0-4°C with tetanus toxin (10^/ml) in
pH 7.4, high ionic strength buffer (Section 2.2.10),
then processed for immunocytochemistry as described in
Section 2.2.17. Cells were examined using a Leitz
Ortholux 2 microscope and a Leitz Vario Orthomat 2
automatic microscope camera.
Scale bar represents 10 urn
Results shown are typical of at least 5 separate
experiments.
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often being observed; this is in contrast to the staining of
dopamine-/§-hydroxylase (Fig. 5.1), where the intense (and, at high
magnification, punctate) staining is typical of an intracellular
antigen. The dark specks on the photographs are suggestive of some
precipitation of toxin on the coverslips, despite filtration of all
the solutions.
Interestingly, while it was observed in Chapter 4 that the toxin-
binding capacity of these cells was several-fold greater under less
physiological buffer conditions, this was not reflected in
immunocytochemical experiments; in general, the intensity of
staining of cells under both sets of conditions appeared to be
similar. This is presumably related to the rather non-quantitative
nature of this technique, and the difficulty of photographing
different cell preparations under identical conditions. There also
seemed to be some variation in the extent of staining of individual
cells subjected to the same treatment; the most obvious explanation
for this is that cells have varying levels of the receptor in their
plasma membranes. Whether this is also the case in vivo, or is due
to some aspect of the cell isolation procedure, for instance uneven
exposure of cells to protease and/or collagenase, is not known.
From these photographs, it appears that the tetanus toxin acceptors
in chromaffin cell membranes are evenly distributed over the whole
cell surface; both the cell bodies and the long axon-like processes
are stained with the toxin. This is in agreement with the findings
of Mirsky et al, (1978), who reported that in their experiments
showing the binding of tetanus toxin to a wide variety of neurones,
both the neuronal soma and the processes were stained. In
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contrast. Zimmerman & Piffaretti (1977) found that surface-bound
toxin appeared as bright fluorescent patches; they interpreted
these as aggregates of toxin due to migration of the receptor-toxin
complex within the membrane. These different observations may be
due to the fact that Mirsky's group conducted their toxin-binding
experiments at room temperature, while Zimmerman & Piffaretti
incubated their cells with tetanus toxin at 37°C; this increased
temperature would certainly facilitate the movement and subsequent
patching of the toxin-receptor complex within the cell membrane.
5.3.3 Effect of Exogenous Ganglioside on Toxin-Binding
In Chapter 4 it was reported that the incorporation of exogenous
GT1 ganglioside into chromaffin cell membranes led to an increase
in the capacity of the cells to bind 125I-labelled tetanus toxin,
both under physiological and non-physiological conditions of pH and
ionic strength. Similar observations were made when toxin-binding
was visualised by immunocytochemical techniques. Fig. 5.5
indicates that cells pre-treated with GT1 prior to incubation with
tetanias toxin were frequently significantly more stained than
untreated chromaffin cells, suggestive of higher levels of toxin-
binding. Further, the intensity of staining of the treated cells
is relatively uniform over the whole cell surface, indicating an
even incorporation of the exogenous ganglioside into the cell
membrane.
There appears, however, to be considerable variation in the
intensity of staining of individual GTl-treated cells. This would
suggest varying levels of ganglioside incorporation, although there
is no obvious reason why this should be the case, and indeed no
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Figure 5.5 Binding of Tetanus Toxin to Chromaffin Cells Pre-
Incubated with Ganglioside GTT1
Chromaffin cells cultured on coverslips were incubated
for 2 hours at 37°C with GT1 (25 yug/ml in DMEM), prior
to incubation with tetanus toxin (10 ^ug/ml) in either
(a) pH 6.0, low ionic strength buffer, or (b) pH 7.4,
high ionic strength buffer (Section 2.2.10) for 3 hours
at 0-4°C. Cells were then processed for immunocyto-
chemistry as described in Section 2.2.17, and examined
using a Leitz Ortholux 2 microscope and a Leitz Vario
Orthomat 2 automatic microscope camera.
Scale bar represents 10 urn
Results shown are typical of 3 separate experiments.
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evidence for this; in the experiments reported in Section 4.3.2,
investigating the incorporation of fluorescent GT1 into chromaffin
cell membranes, there was no large standard deviation in the
measurements obtained, suggesting that all cells incorporated
similar amounts of ganglioside. Further, this variability is not
likely to be due to toxin internalisation by some cells during
incubation, since although pre-incubation with ganglioside was
carried out at 37°C, incubation wTith toxin was always performed at
4°C.
5.3.4 Effect of Enzymic Treatments on Toxin-Binding
Both neuraminidase treatment and trypsinisation have previously
been shown to reduce the binding of 12 51-labelled tetanus toxin to
chromaffin cells (see Section 4.3.5). It was of interest in this
study to determine whether similar observations could be made using
an immunocytochemical approach.
After confirmation that incubation of the cells with neuraminidase
was in fact removing sialic acid residues from cell membrane
gangliosides and other glycolipids, (see Fig. 5.6), the effect of
this treatment on subsequent toxin-binding ability was evaluated.
Fig. 5.7 indicates that, in agreement with the observations made in
Chapter 4, the capacity of chromaffin cells to bind tetanus toxin
is noticeably diminished, but not abolished, by neuraminidase
treatment. Treated cells are less intensely stained, although the
remaining toxin-binding appears to be distributed similarly to that
occurring with native cells. Somewhat surprisingly, there does not
appear to be any significant difference between the effects of the
enzyme on toxin-binding observed under the two different buffer
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Figure 5.6 Action of Neuraminidase on Chromaffin Cells
(a) Chromaffin cells cultured on coverslips were fixed with
10% formaldehyde in PBS, then incubated sequentially
with neuraminidase (0.1 IU/ml in pH 6.0 rinse buffer),
biotinylated peanut agglutinin, streptavidin-horseradish
peroxidase and chromogen as described in Section 5.2.2.
Cells were then examined using a Leitz Ortholux 2
microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
(b) Control cells - incubated with pH 6.0 rinse buffer
containing no neuraminidase.
(c) Control cells - incubated with peanut agglutinin which
was pre-incubated for 15 minutes with
200 mM galactose.
Scale bar represents 10 urn
Results shown are typical of 3 separate experiments.
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Figure 5.7 Binding of Tetanus Toxin to Chromaffin Cells Pre-
Treated with Neuraminidase
Chromaffin cells cultured on coverslips were incubated
for 1 hour at 37°C with neuraminidase (0.1 IU/ml in pH
6.0 rinse buffer), prior to incubation with tetanus
toxin (10 ug/ml) in either (a) pH 6.0, low ionic
strength buffer, or (b) pH 7.4, high ionic strength
buffer (Section 2.2.10) for 3 hours at 0-4°C. Cells
were then processed for immunocytochemistry as described
in Section 2.2.17, and examined using a Leitz Ortholux 2
microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
Scale bar represents 10 um
Results shown are typical of 3 separate experiments.
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conditions, as was noted in the 125I-labelled toxin binding
experiments; presumably this is again related to the rather non-
quantitative nature of this approach.
Immunocytochemical visualisation of toxin-binding following mild
trypsinisation indicated that this treatment drastically reduces
the binding capacity of these cells under both physiological and
non-physiological conditions; Fig. 5.8 shows that staining of these
cells was not enhanced compared with that found with control cells.
This is in agreement with the results reported in Section 4.3.5,
and further suggests that toxin-binding to chromaffin cells is
mediated, at least in part, by a membrane protein.
5.3.5 Internalisation of Tetanus Toxin by Chromaffin Cells
Since previous attempts to demonstrate internalisation of tetanus
toxin by chromaffin cells had met with failure (see Section 4.3.7),
it was thought that an immunocytochemical approach might be more
successful. Figure 5.9 shows the results of such an experiment.
Comparison of the intensity of staining of cells in photograph (a),
where cells were incubated with toxin at 0°C then fixed, with those
in photograph (b), where cells were first heated to 37°C prior to
fixation, shows that the latter are somewhat less stained,
suggestive of lower levels of surface-bound toxin. (Interestingly,
there does not appear to be any evidence of patching of the toxin
on the cell surface). This could be due to internalisation of some
of the toxin, or alternatively to its detachment from the cell
surface during the rather long incubation time. However,
examination of photographs (c) and (d), where cells were treated
with Triton X-100 (so intracellular as well as surface-bound toxin
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Figure 5.8 Binding of Tetanus Toxin to Chromaffin Cells Pre-
Treated with Trypsin
Chromaffin cells cultured on coverslips were incubated
at 37°C for 10 minutes with trypsin (25 ug/ml in pH 7.4
rinse buffer), prior to incubation with tetanus toxin
(10 ug/ml) in either (a) pH 6.0, low ionic strength
buffer, or (b) pH 7.4, high ionic strength buffer
(Section 2.2.10) for 3 hours at 0-4°C. Cells were then
processed for immunocytochemistry as described in
Section 2.2.17, and examined using a Leitz Ortholux 2
microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
Scale bar represents 10 um
Results shown are typical of 2 separate experiments.
 
Figure 5.9 Internalisation of Tetanus Toxin by Chromaffin Cells
(a) Chromaffin cells cultured on coverslips were incubated
with tetanus toxin (10 ug/ml in pH 7.4, high ionic
strength buffer) for 3 hours at 4°C, washed with ice-
cold rinse buffer, fixed and processed for immunocyto-
chemistry as described in Section 2.2.17.
(b) Cells were incubated with tetanus toxin at 4°C for 3
hours and washed with ice-cold rinse buffer as above,
then incubated in pH 7.4 binding buffer at 37°C for a
further 3 hours, prior to fixation and immunocyto-
chemical processing.
(c) Cells were incubated with tetanus toxin at 4°C for 3
hours, washed, fixed and treated with Triton X-100 prior
to immunocytochemical processing.
(d) Cells were incubated with tetanus toxin at 4°C for 3
hours, washed, then incubated in pH 7.4 binding buffer
at 37°C for a further 3 hours. This was followed by
fixation and treatment with Triton X-100, prior to
processing for immunocytochemistry.
Cells were then examined using a Leitz Ortholux 2
microscope and a Leitz Vario Orthomat 2 automatic
microscope camera.
Scale bar represents 10 um




could be detected), suggests that some toxin internalisation is
indeed occurring. The intensity of cell staining is similar in
both cases, whereas it would be less in (d) if toxin had been lost
into the medium and no internalisation had occurred. It is not
possible, however, to state with any degree of confidence that the
staining pattern of the cells warmed to 37°C is significantly
different to those incubated with toxin solely at 0°C (i.e. that
there is any evidence for intracellular compartmentalisation of the
toxin), and so no firm conclusions can be drawn from this
experiment. Presumably, though, some internalisation must be
occurring in order for the toxin to inhibit exocytosis from these
cells; it may be, therefore, that the amount of toxin reaching the
cell interior is so little that immunocytochemical methods are not
sensitive enough to detect this event.
5.4 CONCLUDING REMARKS
Using a different experimental approach, it has been possible to
show again that tetanus toxin is able to bind to chromaffin cells,
in a manner that is sensitive to both neuraminidase and trypsin.
These observations serve as a qualitative back-up to the results
obtained in Chapter 4, and lend further support to the notion that
gangliosides (or at least some sialic acid-containing cell surface
moiety) and perhaps also a protein are required for toxin-binding
to chromaffin cells. Further, some evidence for internalisation of
tetanus toxin by chromaffin cells has been presented. In this
regard, then, chromaffin cells would appear to be similar to cells
of a more direct neuronal origin.
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CHAPTER SIX.
BIOCHEMICAL CHARACTERISATION OF TOXIN-BINDING
SITES ON CHROMAFFIN CELL MEMBRANES
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6.1 INTRODUCTION
Previously in this thesis, we have considered a wealth of
experimental evidence which suggests that tetanus toxin displays a
high affinity for gangliosides of the Gib series, and that it will
bind readily to nerve cells containing significant levels of these
compounds, or to other cells artificially supplemented with them.
It has also been noted that numerous other observations suggest
that the neurotoxic activity of tetanus toxin may be mediated by
membrane components other than gangliosides. Since the main aim of
this work is to assess the suitability of the chromaffin cell as a
neuronal model for this kind of study, it is of obvious interest to
define as specifically as possible the nature of the toxin-binding
moieties present in chromaffin cell membranes.
The results presented in Chapters 4 and 5 indicate that adrenal
chromaffin cells are able to bind tetanus toxin in a specific
manner, with considerable affinity and capacity. Further, in line
with the points made above, experiments with trypsin-treated and
neuraminidase-treated chromaffin cells suggest the possible
involvement of gangliosides (or some other sialic acid-containing
compound) and maybe proteins in mediating this toxin-binding. The
work presented in this chapter set out to study this binding on a
more analytical level, in an attempt to identify the component(s)
within the chromaffin cell membrane responsible for conferring
toxin-binding ability, and to ascertain their similarity to those
present in neuronal membranes.
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The ganglioside composition of the chromaffin cell plasma membrane
has not previously been investigated in detail, but chromatographic
analysis of extracted gangliosides should indicate whether or not
there are any likely toxin-binding species present. Any
interaction between these gangliosides and tetanus toxin can then
be detected by overlaying the separated gangliosides with
radiolabelled toxin. This technique has been used successfully to
demonstrate binding of cholera toxin to its receptor, ganglioside
GM1 (Magnani et al., 1980). Further, since any sialoglycoproteins
present will be insoluble in the organic solvents used and will
therefore not migrate on the chromatograms, it should be possible
to assess the relative roles of gangliosides and glycoproteins as
toxin receptors under varying conditions of pH and ionic strength.
Identifying a proteinaceous toxin receptor is not a straightforward
task. Although there is good evidence for the involvement of a
protein in toxin-binding to neuronal cells, such a protein has not
been isolated; no group has yet reported detectable binding of
12 5I-labelled toxin to rat brain membrane components separated by
SDS-polyacrylamide gel electrophoresis and transferred to
nitrocellulose sheets. This may be due to alteration of the
secondary or tertiary structure of the protein such that the toxin
can no longer recognise it; care must therefore be taken to
minimise denaturation of any potential protein toxin receptors.
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6.2 METHODS
6.2.1 Extraction of Gangliosides from Membranes of Adrenal
Medullary Microsomes
Membranes were prepared from adrenal medullary microsomes using the
procedure outlined in Section 2.2.2; isolation of gangliosides from
these membranes was then performed as described in Section 2,2.13.
The yield of extracted gangliosides was quantitated by measuring
lipid-bound sialic acid, as outlined in Section 2.2.15.
6.2.2 Analysis of Extracted Gangliosides
Gangliosides isolated from membrane fractions were analysed by
chromatography on thin-layer plates, followed by exposure to iodine
vapour or treatment with resorcinol reagent, as outlined in Section
2.2.14. Tentative identification of isolated ganglioside species
was made by comparing their mobilities on thin-layer plates with
those of standard gangliosides.
6.2.3 Ganglioside Overlay with 1251-Labelled Tetanus Toxin
Chromaffin cell gangliosides separated on TLC plates were examined
for their ability to bind tetanus toxin by using the overlay
procedure described in Section 2.2.16. Preliminary experiments
were conducted to confirm that, under the conditions used, tetanus
toxin-binding to ganglioside GTlb was stronger than that to other
ganglioside species.
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6.2.4 Binding of 12 5I-Labelled Tetanus Toxin to Membrane Proteins
of Adrenal Medullary Microsomes
Microsomal membrane components were separated by SDS-polyacrylamide
gel electrophoresis as described in Section 2.2.19, and were then
blotted onto nitrocellulose as outlined in Section 2.2.21. The
nitrocellulose sheets were then soaked for at least one hour at 4"C
in the specified buffer containing 3% bovine serum albumin, before
being examined for the presence of toxin-binding components by the
same procedure as that used for TLC plates.
6.3 RESULTS AND DISCUSSION
6.3.1 Extraction and Analysis of Gangliosides from Adrenal
Medullary Microsomes
In order to determine whether the ganglioside content of chromaffin
cells could account for their sensitivity to tetanus toxin, we
first analysed the distribution of these glycolipids in membranes
prepared from both adrenal medullary microsomes and chromaffin
granules. Previously, Dreyfus et aI. (1977) have reported that 95%
of the total gangliosides present in chromaffin granule membranes
are monosialylated GM3 species. These workers detected three
distinct GM3 bands on thin-layer chromatograms, which were shown to
differ in their fatty acid composition. Other gangliosides co-
migrating with GD3 and GDla standards were also detected, but these
accounted for less than 5% of the total ganglioside content of
these membranes. More recently, Marxen et a1. (1989) have analysed
the ganglioside content of whole chromaffin cells grown in
monolayer culture, and have reported that they contain small
amounts of GDla, but no detectable amounts of any other
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gangliosid.es, including GTlb, GDlb or GM3; however, their
chromatogram did contain unidentified lipids which migrated above
the GM1 standard; they do not comment on these, but it is possible
that one or more of these bands may be other monosialogangliosides,
perhaps GM3. Interestingly, Walton et al. (1988) have reported
that seven ganglioside species can be detected in extracts from
PC12 cells, with tri- and tetrasialogangliosides making up over 30%
of the total; they claim that GTlb is the major ganglioside
component in these cells.
Figure 6.1(a) shows a typical resorcinol-stained thin-layer
chromatogram of gangliosides extracted from adrenal medullary
microsomes; the same result was obtained using ganglioside extracts
from chromaffin granule membranes. Comparison with reference
gangliosides indicates that the most prevalent species in these
extracts is GM3, or at least a compound with the same mobility as
GM3; ideally, isolation of gangliosides and determination of their
structures should be carried out together with chromatographic
analysis to ensure positive identification. There is also a
detectable amount of a disialoganglioside present; this agrees with
the findings of Dreyfus and his co-workers, suggesting that
gangliosides found in adrenal medullary microsomes and chromaffin
granules are indeed similar. Quantitation of the proportion of
each species present in the extract by densitometric scanning is
not easy, since resorcinol staining increases proportionally with
the number of sialic acid residues present in the ganglioside, but
it would seem reasonable to state that the monosialylated component
represents at least 80% of the total extracted ganglioside.
Obviously, then, the ganglioside composition of chromaffin cell
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Figure 6.1 Thin-Layer Chromatography of Gangliosides Extracted from
Adrenal Medullary Microsomes
Gangliosides were extracted from membranes of adrenal
medullary microsomes as detailed in Section 2.2.13;
yield was auantitated by determination of lipid-bound
sialic acid (Section 2.2.15). A volume of extract
containing approximately 5 jag of extracted ganglioside-
sialic acid was applied to a thin-layer chromatographic
plate, together with 10 /ig each of the standard
gangliosides GM1, GM3, GDla and GT1. Chromatography was
performed as described in Section 2.2.14, and plates
were then either (a) sprayed with resorcinol reagent to
visualise gangliosides, or (b) exposed to iodine vapour
to reveal other lipids.
The results shown are typical of at least 3 separate







membranes (from both microsomes and granules) is quite unlike that
characteristic of the central nervous system, where polysialo-
gangliosides are the major constituents and monosialylated species
represent only a small proportion of the ganglioside population.
The yield of gangliosides extracted from both microsomal and
in three separate extractions
granule membranes^was typically within the range 2-4 jug
ganglioside-sialic acid/mg protein; this is similar to the figure
reported by Dreyfus for chromaffin granule membrane gangliosides
(3.8 + 0.9 jag ganglioside-sialic acid/mg protein). Figure 6.1(b)
indicates that the extraction procedure does not completely
separate gangliosides from other lipids; there are several non-
sialylated species evident on exposure of the chromatogram to
iodine vapour. The presence of these lipids, however, was not
thought likely to be a problem in future experiments using these
ganglioside extracts.
6.3.2 Detection of Toxin-Binding Gangliosides in Membranes of
Adrenal Medullary Microsomes
The technique of overlaying gangliosides separated on thin-layer
chromatograms with radiolabelled tetanus toxin, in order to
identify those species with toxin-binding ability, has been used
previously by several groups. Critchley et al. (1985), using
gangliosides from primary cultures of mouse spinal cord, have
demonstrated an interaction of toxin mainly with GDlb and GTlb, but
also some binding to GDla sund GM1. Later, they obtained similar
results using rat brain membrane gangliosides; binding of the
labelled toxin was shown to be blocked following its pre-incubation
with gangliosides, or by the addition of an excess of unlabelled
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toxin to the overlay buffer. Further, they showed that the pattern
of toxin-binding to these gangliosides was identical whether the
overlay buffer was Tris-acetate (pH 6.0) or Tris-saline (pH 7.4),
although binding was greatly reduced in the latter case, in
agreement with the notion of a lower affinity of tetanus toxin for
gangliosides under more physiological conditions of salt and pH
(Critchley et al., 1986). Habermann & Albus (1986) have similarly
shown an interaction of radiolabelled tetanus toxin with
gangliosides isolated from rabbit kidney membranes; these
unidentified gangliosides had a mobility greater than that of GDlb.
Finally, Nathan & Yavin (1989) have shown an interaction of tetanus
toxin with GTlb isolated from PC12 cells using this overlay
technique.
It was necessary to confirm that under the overlay conditions used,
binding of radiolabel to ganglioside GTlb was greater than that to
the other standard gangliosides available; GM1, GM3 and GDla. This
was carried out by overlaying a chromatogram to which equimolar
amounts of the standard gangliosides (5 nmoles) had been applied.
The result is shown in Fig. 6.2. Clearly there is very little
interaction with gangliosides other than GT1; the arrows indicate
the positions of very faint bands which may correspond to toxin
binding to GDla and GM1. (The dark spots on the autoradiograph
probably result from aggregated toxin binding non-specifically to
the chromatogram.)
Overlay experiments were next carried out, using gangliosides
extracted from microsomal and granule membranes. Figure 6.3 shows
the result of one such experiment, where the toxin was overlaid in
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GM1 GM3 GDla GT1
Figure 6.2 Binding of 125I-Labelled Tetanus Toxin to Standard
Gangliosides on Thin-Layer Chromatograms
5 nmoles of each of the standard gangliosides GM1, GM3,
GDla and GT1 were applied to a thin-layer plate;
chromatography was then performed as outlined in Section
2.2.14, followed by overlay with 125I-labelled tetanus
toxin as described in Section 2.2.16. Toxin was used at
1 x 106 cpm/ml (equivalent to 12 nM). Binding of radio-
labelled toxin was visualised by autoradiography
(Section 2.2.20).
This result was obtained in 2 independent experiments.
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A B
12 3 1 2 3
Figure 6.3
Overlay with 125I-Labelled Tetanus Toxin of Gangliosides from
Adrenal Medullary Microsomes and Chromaffin Granule Membranes
(a) Gangliosides extracted from membranes of adrenal medullary
microsomes (approximately 5 jag of ganglioside-sialic acid),
chromaffin granule membranes (approximately 1 jag of
ganglioside-sialic acid) and standard GT1 (10 /ig) were applied
to a thin-layer plate. Chromatography was then performed as
described in Section 2.2.14, followed by overlay with izsj-
labelled tetanus toxin as outlined in Section 2.2.16. Toxin
was used at 1 x 106 cpm/ml (equivalent to 12 nM). Binding
of radiolabelled toxin was visualised by autoradiography
(Section 2.2.20).
(b) Chromatography and overlay with radiolabelled tetanus toxin
was carried out as in (a), except that an excess of unlabelled
toxin (25 jug/ml, 170 nM) was included in the overlay buffer.
1 = standard GT1; 2 = microsomal membrane gangliosides;
3 = chromaffin granule membrane gangliosides
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low ionic strength, pH 6.0 buffer; there is clearly some
interaction with the ganglioside material extracted from microsomal
membranes. Surprisingly, the strongest band corresponds in
mobility to GT1, a species which was not detected by resorcinol
staining of microsomal gangliosides; the most plausible explanation
for this is that these membranes do indeed contain very small
amounts of GT1, which are not detectable by normal staining
procedures, but which are nevertheless able to bind substantial
amounts of tetanus toxin. There is also a significant amount of
toxin bound to the monosialylated species tentatively identified
earlier as GM3, as well as some interaction with a lower band which
corresponds in mobility to the disialoganglioside detected in Fig.
6.1. Further, there is some evidence of toxin interacting with
material of a higher mobility than GM3, albeit to a much lesser
extent. A virtually identical pattern of toxin-binding was seen
with the gangliosides extracted from chromaffin granule membranes,
although these bands are not so strong, because less material was
applied to the chromatogram. The second autoradiograph indicates
that inclusion of an excess of unlabelled tetanus toxin in the
overlay buffer (25 ^pg/ml, 170 nM) prevented binding of the labelled
toxin.
It perhaps seems puzzling that binding of toxin to chromaffin
granule membrane gangliosides was detected in this experiment,
while no binding to purified granules was noted in Section 4.3.6.
This can be explained, however, by the observation that the
oligosaccharide portions of gangliosides are located on the inner
face of the granule membrane (Winkler & Westhead, 1982).
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Fractionation of microsomal membranes was next carried out, in an
attempt to obtain a more pure plasma membrane fraction for use in
future experiments; the procedure used (Section 2.2.2) is presumed
to separate plasma (top interface), Golgi (middle interface) and
endoplasmic reticulum (bottom interface) membranes (Gavine et al.,
1984). However, the ganglioside profiles of the three fractions
were found to be identical (in two fractionations), and since the
recovery of membranes at each interface was relatively poor, it was
decided to pursue further experiments using gangliosides extracted
from unfractionated microsomal membranes.
It was envisaged that this overlay technique could be used to
ascertain whether toxin-binding to gangliosides from adrenal
medullary microsomes was reduced under more physiological
conditions of salt and pH. However, difficulties were encountered
upon carrying out further overlay experiments. In some cases, no
toxin-binding could be detected, and concentration of the
ganglioside extracts (in order to increase the amount of material
that could be applied to the chromatogram) was unsuccessful, since
the ganglioside material was prone to precipitation. Similarly,
increasing the concentration of radiolabelled toxin in the overlay
buffer to any extent resulted in unacceptable levels of non¬
specific background binding, and sometimes even "negative staining"
of the ganglioside bands. In conducting at least twelve overlay
experiments, it seemed impossible to achieve the correct balance of
ganglioside material and labelled toxin, given the low affinity of
the binding interaction, to obtain satisfactory results routinely.
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Alternative means of visualising an interaction between
gangliosides from adrenal medullary microsomes and tetanus toxin
were thus sought. One approach taken was a modification of the
conventional procedure for processing Western blots; gangliosides
separated on a chromatogram were overlaid with unlabelled tetanus
toxin (30 jug/ml, 200 nM), then sequentially incubated with human
anti-tetanus antibody and horseradish peroxidase-labelled anti-
human IgG prior to development with chloronaphthol reagent.
However, this procedure also failed to indicate any toxin-binding;
presumably this method was insufficiently sensitive to detect any
low affinity interaction. Similarly, a modified "enhanced chemi-
luminescence" technique did not produce any detectable binding.
So, although successful in demonstrating an interaction between
tetanus toxin and gangliosides from adrenal medullary microsomes,
we were unable to analyse this binding to any extent, or to acquire
any quantitative information. It would have been interesting, for
instance, to estimate the amount of toxin bound per microgram of
sialic acid on the chromatogram, and to relate this to the results
obtained from the direct binding experiments in Chapter 4. It is
possible that gangliosides, when organised in membranes, are more
accessible for toxin-binding than when they are adsorbed onto a
thin-layer chromatogram; in other words, it may be that whether or
not a binding interaction is detected, especially one of low
affinity, may depend on how the gangliosides are presented. For
instance, while Holmgren et al. (1980) detected binding of toxin to
GM1 and GDla in a solid phase assay using gangliosides adsorbed to
polystyrene, Habermann & Albus (1986) did not, using gangliosides
on silica gel plates as we have done. It may be that the blocking
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step, necessary to prevent non-specific binding of the radio-
labelled toxin, may abolish seme low affinity toxin-ganglioside
interaction. (It should be noted here that the affinity of (Ml for
cholera toxin does not seem to alter significantly when studied
using gangliosides inserted in membranes, adsorbed to plastic, or
free in solution; Critchley et al., 1989).
Another point to consider is the question of whether iodination of
the toxin may change its specificity for gangliosides. However,
this is not generally the case, since Critchley et al. (1986)
obtained identical results whether they used radiolabelled toxin,
or unlabelled toxin followed by anti-toxin and 125I-labelled
protein A.
6.3.3 Detection of Toxin-Binding Proteins in Membranes of Adrenal
Medullary Microsomes
Experiments were next carried out in an attempt to identify any
membrane proteins that could also interact with the toxin. Overlay
of microsomal membrane proteins (separated by SDS-polyacrylamide
gel electrophoresis and blotted onto nitrocellulose) with izsi-
in two independent experiments
labelled toxin did not, however ^result in any detectable binding
of the radiolabel to proteinaceous material, regardless of the
buffer conditions used in the incubation. Even when precautions
were taken to minimise possible irreversible denaturation of any
potential protein receptors (i.e. running membrane samples
dissolved in SDS without heating, with or without reduction with
/S-mercaptoethanol) there was no indication of any toxin binding.
Therefore it would seem that if there is a sialoglycoprotein
present in chromaffin cell membranes that is involved in toxin-
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binding, it is unlikely that the toxin is simply binding to the
carbohydrate portion of the molecule, since this should not be
inactivated by treatment with SDS. Instead, this result implies
that the secondary or tertiary structure of such a protein is also
critical for toxin-binding. This will make the identification of
the protein a difficult task.
6.4 CONCLUDING REMARKS
The work presented in this chapter indicates that there are some
similarities between the binding of tetanus toxin to its target
neurones and to chromaffin cells. It appears that gangliosides
present in the chromaffin cell membrane are able to bind tetanus
toxin, and may be able to mediate its action. Apart from the
possible involvement of a GTl-like species in this process, both a
disialoganglioside and a monosialoganglioside also seem to be
capable of toxin-binding, with the latter being a major binding
component; even if binding to this ganglioside is weak, its
importance presumably relates to its abundance in the chromaffin
cell membrane relative to other species. This is not a
particularly surprising result; previously, as mentioned above,
Holmgren et al. (1980) have reported some binding of tetanus toxin
to GM1, while Helting et al. (1977), using tetanus toxin adsorbed
to Sephadex and radiolabelled ganglioside, have claimed that toxin-
binding to GM1 is as strong as that to GDlb.
These findings are in agreement with the results of the binding
experiments conducted on neuraminidase-treated cells reported in
Chapter 4. Such treatment will convert the disialoganglioside (as
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well as any GT1 present) to GM1, while neuraminidase will also
remove the sialic acid residue from GM3 (Miller-Podraza et al.,
1982); presumably, the absence in GM3 of the terminal galactosyl-N-
galactosamine moiety of the tetrasaccharide backbone, which is
present in GM1, renders the sialic acid residue susceptible to
enzyme attack.
Attempts to identify any protein(s) of the chromaffin cell membrane
able to mediate toxin-binding were not successful. This problem
has been encountered by workers searching for toxin-binding
proteins in neuronal membranes also; obviously, alternative means
of showing such interactions will be required.
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CHAPTER SEVEN.
CONCLUDING SUMMARY AND FUTURE WORK
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Although it is well known that tetanus toxin acts in vivo to
inhibit the exocytotic release of neurotransmitters from certain
synapses, the means by which this blockade of secretion is achieved
is not clear. One of the main reasons for this is the fact that
the toxin's target neurones are difficult to isolate and culture in
vitro, and are therefore not very accessible to scientific studv.
A suitable neuronal cell model would therefore be useful for
investigation of its action. The main purpose of this study was
thus to investigate the interaction between tetanus toxin and
adrenal medullary chromaffin cells, with a view to assessing the
suitability of these cells as neuronal models.
Other workers (e.g. Penner et al., 1986; Ahnert-Hilger et a1.,
1989) have previously shown an inhibitory effect of tetanus toxin
on exocytosis from chromaffin cells. However, in these experiments
the toxin was introduced directly into the cytoplasm of the cells,
either by microinjection or permeabilisation of the plasma
membrane; further, it was the release of radiolabelled catechol¬
amines with which the cells had been preloaded that was measured.
Release of radiolabelled catecholamine frequently does not parallel
that of endogenous catecholamine, and extrapolation of the results
to the in vivo situation has been difficult in consequence.
The present study was to be conducted using intact chromaffin
cells, and initial experiments were aimed at demonstrating an
inhibitory effect of tetanus toxin on nicotine-evoked secretion
from these cells; the secretion of endogenous catecholamines was
measured, thus keeping conditions as close as possible to those
occurring in vivo. Tetanus toxin was shown to be capable of
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inhibiting exocytosis from intact chromaffin cells in a dose-
dependent fashion, with half-maximal inhibition being achieved at
0.7 nM toxin. Since it is not inconceivable that the toxin could
reach such concentrations in a tetanus victim, this would appear to
be a physiologically relevant effect. However, it would seem that
some as yet undiscovered property of these cells determines their
sensitivity to toxin, since about 50% of our cell preparations were
not affected by incubation with the toxin, and were able to secrete
their granule contents as efficiently as untreated cells. The
reason for this observation is not clear, but it may be that, for
instance, the differentiation state of the cells is an important
factor in determining their sensitivity to toxin; this has been
found to be the case with PC12 cells (Sandberg et al., 1989a), and
is perhaps worthy of future investigation. Alternatively, as
discussed in Section 3.3.5, it could be some feature of the cell
isolation procedure which is responsible for this lack of
consistency.
Catecholamine release evoked by Ba2 + ions was shown to be
unaffected by the toxin, while its effect on K+-evoked secretion
was never greater than 30% (compared with a maximal 75% inhibition
of nicotine-stimulated secretion). This finding, that the extent
to which evoked secretion from chromaffin cells is affected by the
toxin differs depending on the secretogogue used, may prove to be
very useful in future in the search for the toxin's intracellular
substrate. It is known, for instance, that nicotinic stimulation
of chromaffin cells results in disassembly of actin, while
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depolarisation by K+ ions does not: this would suggest that the
toxin is acting at the level of the cytoskeleton, and deserves
further investigation.
For the past 30 years, ganglioside GT1 has been considered a likely
candidate for the in vivo cell surface acceptor for tetanus toxin.
However, to date there has been no convincing demonstration of a
correlation between binding of the toxin to cell membrane
gangliosides and a subsequent cellular response (i.e. decreased
levels of exocytosis). We thought that it might be possible to
show such a correlation by incorporating exogenous gangliosides
into chromaffin cell plasma membranes and demonstrating a
subsequent enhancement of the toxin's inhibitory effect, due to the
introduction of new toxin-binding sites. Unfortunately, we
discovered that the ganglioside itself could inhibit nicotine-
evoked exocytosis, at least at the concentrations of GT1 being used
(5-24 ^jM), making it impossible to evaluate the role of GT1 in
mediating the action of the toxin. Time constraints prevented us
from conducting further experiments in this area, but it may be
worth pursuing this type of approach in the future, using lower
concentrations of GT1; there is no reason to believe that an
enhancement of toxin-binding, and hence inhibition of exocytosis,
could not be brought about by pre-incubation of chromaffin cells
with much lower levels of ganglioside. [It should be noted here
that the work of Marxen and her colleagues (Marxen & Bigalke, 1989;
Marxen et al., 1989), describing how exogenous gangliosides could
mediate the inhibitory effect of tetanus toxin on chromaffin cells,
was published after our experiments in this area were undertaken.
Furthermore, these workers used very high concentrations of
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gangliosides (1 mg/ml), and did not appear to check for any
inhibition of exocytosis due to the gangliosides themselves.]
Finally, in line with findings made later in this study (see
below), it would be interesting to investigate the effect of
neuraminidase treatment or mild trypsinisation of native chromaffin
cells on their subsequent sensitivity to tetanus toxin. These
experiments may provide further clues as to what type of cell
surface acceptor is actually mediating the cellular response to the
toxin.
With the knowledge that tetanus toxin is indeed able to inhibit
exocytosis from intact chromaffin cells, we next wished to
demonstrate the specific binding of the toxin to these cells.
Binding of 125I-labelled toxin to native chromaffin cells was
observed under both non-physiological and physiological buffer
conditions; this binding showed characteristics similar to toxin-
binding to cells of a more direct neuronal origin, with a
substantial capacity and a similar dependence on pH and ionic
strength. However, like the "inhibition-of-secretion" experiments
discussed above, results were not consistent, in that some
preparations of chromaffin cells were unable to bind the toxin;
the reason for this observation is not clear, and this should be
investigated in the future. It would also be very useful to be
able to correlate this lack of binding to a lack of susceptibility
to the toxin; this would be a good indication that the observed
binding was indeed mediating the toxin-induced inhibition of
exocytosis. Ideally, future binding studies should be carried out
using a wider range of toxin concentrations, in order to obtain
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apparent
more accurate values for^Kd and Bmfly; unfortunately this was not
possible in the present study owing to the limited availability of
tetanus toxin.
Binding of tetanus toxin to chromaffin cells under both conditions
studied was found to be a complex phenomenon, with at least two
components to binding in evidence, while experiments with
neuraminidase-treated and trypsinised cells suggested the possible
involvement of both sialic acid-containing and proteinaceous
moieties in mediating toxin-binding. Future work could perhaps be
directed towards identifying the cell membrane components that are
responsible for mediating these two apparently distinct types of
binding. This could perhaps be achieved by conducting more
detailed experiments with neuraminidase-treated cells; careful
analysis of the toxin-binding remaining after neuraminidase
apparent
treatment and calculation of^Kd may be useful in this regard.
Similarly, a more thorough investigation of the effect of trypsin-
isation on toxin-binding might be worthwhile, using much reduced
concentrations of trypsin.
Toxin-binding by chromaffin cells was also visualised using
immunocytochemical techniques. The difference in the toxin-binding
capacity of native chromaffin cells under the two different buffer
conditions was not so evident here as in the direct binding
experiments, although an effect of pre-incubation of cells with GT1
in enhancing toxin-binding was apparent. Similarly, neuraminidase-
treated and trypsinised cells were less intensely stained compared
to native cells. These findings serve to confirm the observations
made in the direct binding experiments.
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Further work was aimed at defining as specifically as possible the
nature of the toxin-binding components of chromaffin cell plasma
membranes. Analysis by thin-layer chromatography of gangliosides
extracted from adrenal medullary microsomes indicated that the
ma.jor species present was GM3; a small proportion of a disialylated
species was also evident. The identity of these gangliosides
should ideally be confirmed using specific antibodies. (Anti-
ganglioside antibodies could also perhaps be used to evaluate the
role of gangliosides in mediating the effect of the toxin on native
chromaffin cells, although they have been found to display rather
low affinity for their antigens; S van Heyningen, personal
communication). Overlay of adrenal medullary gangliosides with
radiolabelled toxin indicated that they were in fact able to
interact with the toxin (and that there might in fact be very low
levels of GT1 present which can bind substantial amounts of toxin),
adding further support to the idea that toxin-binding to native
chromaffin cells may be mediated, at least in part, by
gangliosides. Unfortunately, we were unable to characterise this
interaction as much as we would have liked; this is an aspect of
the study that future work may concentrate on. It would be useful
to be able to obtain some quantitative information on the binding
of tetanus toxin to these ganglioside species, and to compare this
binding under the two different sets of conditions used in the
direct binding experiments.
Attempts to identify a proteinaceous toxin acceptor in chromaffin
cell membranes were unsuccessful. This was presumably due to the
conditions used (separation of proteins by polyacrylamide gel
electrophoresis in SDS, followed by Western blotting and overlay
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with radioactive toxin) disrupting the secondary or tertiary
structure of the putative protein such that the toxin could no
longer recognise it. Perhaps an alternative approach to
identifying such a molecule, that could be taken in the future,
would be to screen for monoclonal antibodies that block exocytosis
from chromaffin cells, and to use these to characterise the
acceptor by Western blotting techniques.
Attempts to visualise the internalisation of tetanus toxin by
chromaffin cells met with limited success. Although there was some
suggestion that warming of the cells resulted in a reduction in the
levels of surface-bound toxin, there was no clear evidence of any
intracellular compartmentalisation of the toxin, and so these
experiments were somewhat inconclusive. It seems likely that the
methods used in this studv were insufficiently sensitive to allow
internalisation of the toxin to be detected, and that future
efforts in this area should therefore perhaps use the approach
taken by other workers (e.g. Parton et al., 1987, 1988) in using
toxin-colloidal gold complexes and electron microscopy. In this
way, the mechanism of toxin internalisation by chromaffin cells may
also be elucidated; however, it could be that these cells do not
possess a specific means of toxin internalisation, and that it is
toxin that reaches the cell interior in some non-specific fashion
that is responsible for the observed inhibition of exocytosis. It
does not necessarily follow that all, or indeed any, of the toxin
bound specifically to the cell membrane will eventually reach the
cell cytoplasm.
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The work presented in this thesis has gone some way towards
characterising the interaction between adrenal chromaffin cells and
tetanus toxin. It would appear that binding of the toxin to
chromaffin cells shows similar characteristics to toxin-binding to
its target neurones, and that it is mediated by similar components.
Further, the toxin is able to inhibit exocytosis from these cells
as it does from neuronal cells; indeed, the levels of inhibition
achieved in this study (up to 75%) are among the highest so far
reported. The general conclusion from these findings, then, would
seem to be that the chromaffin cell is a suitable neuronal cell
model, and that future experimentation with these cells has the








y = (M.Ab/Aa) - N
(Na.Ab/Aa) - Nb
x = N - y.Nb
Ab
where Aa = fluorescence of 1 nmol adrenaline at 395/490 nm
Ab = fluorescence of 1 nmol adrenaline at 436/540 nm
Na = fluorescence of 1 nmol noradrenaline at 395/490 nm
Nb = fluorescence of 1 nmol noradrenaline at 436/540 nm
M = sample fluorescence at 395/490 nm
N = sample fluorescence at 436/540 nm
It follows that: M = x.Aa + y.Na
N = x.Ab + y.Nb
Therefore: x = N - y.Nb
Ab
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